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Papillomaviruses (PV) are small non-enveloped double-stranded DNA tumour viruses, which 
are able to infect more than 80 different host species. They are a diverse group with over 400 
types discovered, of which almost half infect humans. Human papillomaviruses have been 
linked to a myriad of diseases, including multiple cancers, recurrent respiratory 
papillomatosis, and genital warts. The disease burden of HPV-related conditions is severe, 
and there is currently no treatment that can guarantee eradication of viral infection. All PV 
types characterised so far have a similar genomic structure, and contain the so called 'core 
ORFs' – E1, E2, L1 and L2 which are essential for viral genome replication and packaging 
into infectious virions. PV evolution and diversification appears to have been impacted by the 
availability of certain epithelial niches, with co-evolution and niche adaptation allowing PVs 
to develop a remarkable species and tissue specificity. Consequently, the function of the PV 
early proteins can vary between different PV species and types, but as a group they share 
important organisational similarities that reflect their common requirement to infect and 
persist in the epithelium following infection. This has allowed the use of animal models to 
gain insight into the basic virus/host interactions that are targeted by this group of viruses as a 
whole. The mechanisms by which HPV establishes a lesion, particularly in low-risk types, are 
not fully understood. However, the recently identified mouse model of PV infection is a 
useful biological tool to study this period of PV infection in vivo.  
 
This body of work aims to expand current knowledge of early events in the PV life cycle. To 
further understand the mechanisms of cell persistence during PV infection, immunodeficient 
mouse tail samples inoculated with MmuPV1 were examined to investigate early lesion 
formation. Five discrete stages of lesion formation were characterised in the immunodeficient 
animals. In parallel studies, microlesions were rarely observed in immunocompetent 
C57BL/6J mice, reaching stage three of lesion formation. In-depth tissue analysis suggested a 
modulation of basal cell density in infected epithelium, and a delay in normal differentiation 
commitment in E6/E7 expressing cells. Whole genome cell culture experiments were 
attempted in parallel with human high-risk types, which showed a post-confluent effect of 
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high concentration EGF on cell growth and genome copy number in cells containing HPV16 
genomes. A role for MmuPV1 E6 in growth of cell populations to significantly higher 
densities was shown through experimentation with cells exogenously expressing viral 
proteins. Differentiation was also delayed in the cells expressing MmuPV1 E6, demonstrating 
a recapitulation of events characterised in in vivo infections. Novel use of fluorescent cell 
lines in tandem with confocal microscopy allowed innovative analysis of a high-density 
monolayer cell culture model. These experiments revealed that MmuPV1 E6 expression 
resulted in preferential persistence of cells in the lower layer over cells expressing control 
vector only. Disruption of MmuPV1 E6 binding with MAML1 protein abrogated this 
phenotype, suggesting that this interaction was necessary for the lower layer persistence 
phenotype shown by MmuPV1 E6 expressing cells. 
 
Overall, the findings of this thesis suggest that expression of MmuPV1 E6 confers a 
competitive advantage on infected cells in the basal layer of the epithelium, allowing 
expansion of the reservoir of infection. Patterns of virus gene expression suggest a related but 
distinct life cycle phenotype for MmuPV1, a pi papillomavirus type, when compared to alpha 
papillomaviruses. Wherein, amplification begins immediately upon basal layer exit as 
opposed to the exit and reentry phenotype suggested in high-risk lesions. Further 
characterisation of these phenotypes will likely provide important information on key 
mechanisms in early lesion formation, and it is reasonable to consider that pi 
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BrdU  bromodeoxyuridine 
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LTR  long terminal repeat 
MAML mastermind-like protein  
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NLS  nuclear localisation signal  
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Papillomaviruses (PVs) are double-stranded DNA (dsDNA) tumour viruses that exclusively 
infect mucosal and cutaneous epithelium. They are a diverse family of viruses, with more 
than 405 reference genomes currently listed in the Papillomavirus Episteme 
(https://pave.niaid.nih.gov/). Recent research showed that ancestral anamniotes of the 
Palaeozoic era were infected with ancestral PV hundreds of millions of years ago, with the 
most recent common ancestor of amniotes estimated to have existed 184 million years ago. 
Examination of virus evolution suggested that three key evolutionary events have occurred 
since then: the primary evolutionary lineages were established following an initial radiation 
event, a second radiation of virus evolution in parallel with host evolution increased variation, 
and a final radiation specific to types within a genus of PVs termed Alphapapillomavirus 
occurred after emergence of the E5 protein (Willemsen and Bravo 2019). 
 
PV types characterised thus far all contain the so-called ‘core’ open reading frames (ORFs) – 
E1, E2, L1 and L2, which are essential for viral genome replication and subsequent packaging 
into infectious virions (Canuti, Munro et al. 2019). The diversification of PVs was impacted 
by the emergence of specific epithelial niches in their hosts, with parallel niche adaptation and 
evolution allowing PVs to develop a remarkable species and tissue specificity (Van Doorslaer 
2013). Consequently, the early proteins of different PVs can vary in terms of their precise 
functions, but overall, PVs share crucial similarities in their genome organisation that reflect 
their common life cycle requirement to infect and persist in the epithelium upon entering the 
cell. PVs are broadly organised into genera based on differences in the sequence of the L1 
ORF, which is highly conserved. If a difference of more than 60% exists between L1 ORF 
sequences, this is considered to be a different or new PV genus (Bernard, Chan et al. 1994). 
PVs can be further classified by species, which are determined to be discrete if more than a 
40% difference in the aforementioned L1 ORF sequence exists. A PV is considered to be a 
unique type if the L1 nucleotide sequence differs from that of other PV types by more than 
10%. PVs with differences of 2-10% in L1 sequence are considered to be subtypes. Finally, if 
differences of less than 2% in homology between one type and another exist, these are 
classified as a variants (de Villiers, Fauquet et al. 2004). In rare cases, unique viruses that are 
difficult to classify have been discovered, such as bandicoot papillomatosis carcinomatosis 
virus type 1 (BPCV1). This novel virus exhibits both the ORFs of the L1 and L2 protein 
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alongside ORFs encoding the large T and small t antigens commonly found in viruses of the 
Polyomaviridae (Woolford, Rector et al. 2007). This virus could be the result of ancient 
recombination events between members from each of the two virus families. 
 
1.2	VIRUS	STRUCTURE	AND	GENOME	ORGANISATION	
Despite differences in sequence, PVs have basic similarities. PV particles are around 50-
60nm in diameter, are non-enveloped and icosahedral in structure (Buck, Thompson et al. 
2005). Genomes are dsDNA episomes of approximately 8000 base pairs, although this size 
varies somewhat between types. The circular DNA genomes encode around 8 or 9 ORFs, (as 
shown in Figure 1.1, adapted from McBride 2017) however the number of proteins a PV can 
encode varies further due to the presence of multiple promoters and implementation of 
complex splicing patterns. ORFs are termed ‘early’ when expressed from the early promoter, 
located in the viral non-coding region (also referred to as the long coding region or the 
upstream regulatory region), prior to the productive stage of the life cycle. ‘Late’ proteins are 
expressed from the downstream late promoter during the synthesis of virus particles 
(Fehrmann and Laimins 2003). The activity of both the early and late promoters is regulated 
by differentiation, with early promoter activity in basal cells, and a differentiation-dependent 
increase in activity of the late promoter following virus DNA replication (Wang, Liu et al. 
2017). Aside from promoter activity, numerous splicing events can occur in viral transcripts, 
some of which are also regulated by differentiation. In high-risk human papillomavirus (HPV) 
types, E6 and E7 are transcribed together as bicistronic messenger RNA (mRNA). It has been 
shown that the majority of E7 proteins are translational products of mRNAs of a particular 
splice variant of E6, known as E6*I (Tang, Tao et al. 2006). In contrast to high-risk HPVs, 
other PV types transcribe E6 and E7 separately using two different promoters (Xue, 
Majerciak et al. 2017). As mentioned above, all PVs possess ‘core’ proteins: E1 and E2, 
which are involved in virus genome replication, and L1 and L2, which are crucial for proper 
packaging and release of the virus from the host (Zheng and Baker 2006). Variation between 
types is more apparent when considering the presence of further genes, E6, E7, E4 and E5. 
There is no E3 ORF due to an initial error in sequencing made in the analysis of bovine 
papillomavirus (BPV)1 genome (Lambert, Spalholz et al. 1987).  
 
E1 encodes a DNA helicase which is vital for the replication of PV genomes (Wilson, West et 
al. 2002). However, in depth studies have suggested that E1 is dispensable for maintenance 





Figure 1.1 The structure of the human papillomavirus genome 
Diagram shows the circular double-stranded DNA genome structure of an alpha type human 
papillomavirus. Core proteins required for replication, E1 and E2, are shown in blue. Core 
proteins L1 and L2 required for packaging and structure of virus are shown in green. URR – 
upstream regulatory region. PE and PL show the location of the early and late promoter 
respectively. pAE and pAL show the location of the early and late polyadenylation sites. The 






stages of the virus life cycle (Kim and Lambert 2002) (Egawa, Nakahara et al. 2012). 
Research has indicated that E1 interaction with the E2 protein is also fundamental in the 
establishment replication of genomes in vivo (Berg and Stenlund 1997). These stages are 
discussed in more detail in Section 1.7. E2 is multi-functional, with roles observed in genome 
partitioning, viral transcription, and replication of virus DNA, in various PV types (Lehman 
and Botchan 1998) (Skiadopoulos and McBride 1998) (McBride 2013). Despite its 
classification as an early ORF, a role for E4 in the later stages of the virus life cycle has been 
demonstrated due to it appearing as virus propagation begins, and it has been shown to be 
possibly involved in ameliorating virus exit from the surface of the epithelium (Doorbar 
2013). E5 is a protein that is sometimes termed oncogenic and is uniquely found in certain 
alpha PV types. E5 protein is believed to have a role in both immune evasion, and in 
improving the efficiency of genome amplification (de Freitas, de Oliveira et al. 2017). E6 and 
E7 are often termed as ‘oncogenic’ due to their effects frequently resulting in malignant 
phenotypes in the infected cell. One important difference between HPV types is that in low-
risk HPVs, E6 and E7 proteins are rarely seen to stimulate proliferation of the infected basal 
and parabasal cells, whereas in high-risk types interference with cell cycle entry and 
proliferative mechanisms is more common (Egawa and Doorbar 2017). The function of many 
of these proteins differs greatly between types, and even within different genera, resulting in a 
wide variety in the propensity of different HPV types to cause disease. This will be discussed 
in more depth in Section 1.8. 
 
1.3	HUMAN	PAPILLOMAVIRUSES	
To date, more than 200 distinctly characterised PVs have been shown to infect humans (Van 
Doorslaer and Dillner 2019) most of which cause asymptomatic infection (Dunne and 
Markowitz 2006). Early studies examined HPV isolated from plantar warts, and compared the 
PV particles with polyomavirus particles. While both were shown to be dsDNA viruses, 
differences in size of particles were noted following examination by electron microscopy 
(Crawford and Crawford 1963). Although the first HPV to be characterised was isolated from 
human warts (verrucae vulgaris and verrucae plantares) (Gissmann, Pfister et al. 1977), HPV 
is most well-known for its discovery as an infectious agent causative of cervical cancer in the 
1970s (zur Hausen 2009). The tissue specificity of individual HPVs is made further apparent 
when the sites of infection of different types are considered. For example, HPV6 commonly 
infects genital sites, and various studies show that it is detectable in 69-90% of genital wart 
samples while the closely related HPV11 was shown to be present in only 16-32% (Ball, 
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Winder et al. 2011) (Aubin, Pretet et al. 2008). HPV11 more commonly infects oral sites 
(Egawa, Egawa et al. 2015). For example, one study showed that HPV11 was present in 84% 
of the HPV-positive oral cavity samples analysed (Durzynska, Pacholska-Bogalska et al. 
2011). HPVs are classified into five broad genera: Alphapapillomavirus, Betapapillomavirus, 
Gammapapillomavirus, Mupapillomavirus and Nupapillomavirus (Bernard, Burk et al. 2010), 
with Gammapapillomavirus being the largest group of around 100 types, followed by 
Alphapapillomavirus and then Betapapillomavirus (Gheit 2019). The propensity to cause any 
disease or symptoms in humans differs considerably between these genera. 
 
1.4	HIGH-RISK	HPV	RELATED	DISEASE	AND	VACCINATION	
Alpha PVs encompass types of HPV that are known to cause a broad array of disease in 
humans. Different types of PVs preferentially infect either mucosal or cutaneous tissue, and 
symptomatic types can be further divided into so-called “low-risk” and “high-risk” types, 
with the latter having the ability to cause neoplastic changes in infected tissue that can 
progress to cancer. Conversely, low-risk types cause warts or benign epithelial proliferations 
(Doorbar, Egawa et al. 2015, Egawa and Doorbar 2017). Low-risk alpha PV types HPV6 and 
11 are perhaps most known as causative agents of genital warts and recurrent respiratory 
papillomatosis (RRP). A recent study found that 100% of the samples analysed contained at 
least one or both of these types (Omland, Lie et al. 2014). Whilst not life-threatening, genital 
warts are unpleasant for the sufferer, and repeated treatments are extremely costly to 
healthcare providers around the world (Raymakers, Sadatsafavi et al. 2012). RRP is a chronic 
disease that presents in both adults and children. In patients suffering from this condition, 
benign squamous cell papillomas proliferate within the aerodigestive tract. RRP usually 
occurs within the larynx, but it is possible for the condition to spread to the lungs, and the 
infection can even undergo malignant conversion in some instances (Derkay and Wiatrak 
2008). In extreme cases RRP can prove fatal due to severe obstruction of the airways, 
however the only method of treatment currently available is the ablation of warty papillomas 
from the inside of the respiratory tract, which then often recur. Consequently, this condition 
also poses an unpleasant and costly treatment regime for the sufferer (Ivancic, Iqbal et al. 
2018).  
 
High-risk HPV types cause a variety of cancers, including anal, oropharyngeal, penile, vulvar, 
vaginal and cervical cancers (Gillison, Chaturvedi et al. 2008) (zur Hausen, de Villiers et al. 
1981). Of all cervical cancer cases, more than 99% are associated with HPV infection, and 
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over 90% of squamous intra-epithelial lesions also contain HPV DNA (Walboomers, Jacobs 
et al. 1999). Prior to the introduction of a vaccine, HPV16 and HPV18 were found to be 
associated with roughly 70% of all cases of invasive cervical cancer worldwide, with some 
slight variation across different geographies (Smith, Lindsay et al. 2007, Li, Franceschi et al. 
2011). However following the introduction of a vaccine, rates of HPV16 and HPV18 
infection have fallen by 68% in some countries with greater than 50% vaccine coverage 
(Drolet, Bénard et al. 2015). The first vaccine to be introduced was the quadrivalent vaccine 
Gardasil (Merck & Co., Inc., Kenilworth, NJ, USA), which protected against the high-risk 
types HPV16 and HPV18, as well as the most common low-risk types causative of genital 
warts, HPV6 and HPV11 (McLemore 2006). Cervarix (GlaxoSmithKline), a bivalent vaccine, 
protective against HPV16 and 18 only (Harper, Franco et al. 2004) was introduced shortly 
after. In recent years, the Gardasil vaccine has been further improved upon to also protect 
against HPV31, HPV33, HPV45, HPV52 and HPV58 in the nonavalent vaccine Gardasil-9 
(Merck & Co., Inc., Kenilworth, NJ, USA). These HPV types are most commonly associated 
with cervical cancers globally after types 16 and 18 (Table 1.1). Therefore, it is estimated that 
this vaccine could protect against roughly 90% of cervical cancers worldwide, as well as 




Reproduced from HPV and Related Diseases Summary Report (Bruni, Albero et al. 2019) 
HPV type Number Tested HPV Prevalence % (95% CI) 
16 58,796 55.2 (54.8-55.6) 
18 58,380 14.2 (13.9-14.4) 
31 52,417 3.5 (3.4-3.7) 
33 53,804 4.2 (4.0-4.3) 
35 47,634 1.7 (1.6-1.8) 
39 46,420 1.5 (1.3-1.6) 
45 47,048 5.0 (4.8-5.2) 
51 44,674 1.0 (0.9-1.1) 
52 49,978 3.5 (3.3-3.6) 
56 46,019 1.0 (0.9-1.1) 
58 50,814 3.9 (3.8-4.1) 
59 46,703 1.4 (1.3-1.5) 
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All of the vaccines discussed above are made up of self-assembled pentamers of an L1 capsid 
protein, and are prophylactic. Administration of the vaccine is protective, as it induces the 
production of antibodies against the L1 protein, preventing future infection from occurring. 
However, this means that the vaccine is most effective when administered prior to sexual 
debut; the vaccine is in no way therapeutic and must be given before exposure to the virus to 
be protective (Mariani and Venuti 2010). Current vaccination uptake varies globally, and 
while countries with high uptake such as Australia have demonstrated a considerable impact 
on HPV-related diseases, countries struggling with vaccine hesitancy such as Japan have seen 
little to no changes in the incidence rates of cervical cancer (Patel, Brotherton et al. 2018, 
Utada, Chernyavskiy et al. 2019). 
 
In recent years, mounting evidence has suggested that universal vaccination is required to 
ensure that males are also protected; it is estimated that a vaccination rate of around 80% in 
women would be sufficient to successfully have herd immunity in the population, which 
means men are often left unprotected against HPV-related disease (Prue, Baker et al. 2018). 
For example, a study in South Korea found that following implementation of the vaccine, 
overall rates of anogenital warts in women declined, however they continued to rise in men 
over the same time period, demonstrating a need for the protection of men and surveillance of 
HPV-related disease in both sexes (Park, Kim et al. 2018). Males are already vaccinated in 
Australia, and recently the United Kingdom brought boys into the vaccination programme 
(Kirby 2012, Kmietowicz 2018). Despite issues with vaccine hesitancy, the overall reception 
for the HPV vaccines has been positive, and is already showing effects on rates of HPV-
related disease in the years since its introduction.  
 
Disease burden of cervical cancer is still high, predicted as the fourth most common cause of 
cancer death in women, behind breast cancer, colorectal cancer and lung cancer. Importantly, 
cervical cancer is the second most common cause of cancer death in countries with a lower 
human development index, emphasising the impact that economic and social inequalities have 
on the burden of this disease. Incidence of cervical cancer and mortality rates of the disease 
are shown in Figure 1.2. From the data generated it is clear to see that the burden of disease is 
disproportionately high in South-eastern Asia and Sub-Saharan Africa, emphasising the 
importance of overcoming barriers to screening and vaccination in these countries. Barriers to 
screening are numerous, and include poor government investment into effective screening 
programmes, limited access to healthcare resources, and the social stigma attached to a 




Figure 1.2 Graphic of global maps presenting the disease burden of cervical cancer 
A; Estimated age-standardised incidence rates of cervical cancer worldwide in 2018. B; 
Estimated age-standardised mortality rates of cervical cancer worldwide in 2018. Rates are 
shown as ASR per 100,000 people, as indicated by the key shown in the bottom left of each 
map. ASR – Age standardised rates. Source – GLOBOCAN 2018. 
Figure	1.2	Graphic	of	global	maps	presenting	the	disease	burden	of	cervical	cancer	
 
issues, incidence and mortality rates of cervical cancer will remain high in these countries 
with considerable HPV-associated burden of disease (Vaccarella, Laversanne et al. 2017). In 




Aside from the alpha types, causation of disease is less common in HPVs of other genera. 
Beta PVs are found so commonly at various sites, it has been suggested that they should be 
considered to be part of commensal flora in humans. Though most types cause 
inapparent infection, risk of more insidious disease development rises in 
immunocompromised patients, or when co-factors such as UV irradiation are involved 
(Sichero, Rollison et al. 2019). For example, beta PV types HPV5 and HPV8 have been 
shown to increase the risk of developing cutaneous squamous cell carcinoma (cSCC) in 
patients suffering from Epidermodysplasia verruciformis (EV) (Jablonska, Dabrowski et al. 
1972). EV is a rare hereditary skin disease wherein keratosis-like lesions can develop 
anywhere on the body, especially on those parts exposed to the sun. The WHO has termed 
HPV5 and HPV8 as possible etiological agents of cSCC in immunocompromised patients 
(Bouvard, Baan et al. 2009). Sequencing of HPV L1 DNA can help with diagnosis of this 
condition, emphasising the involvement of HPV in this disease (Bushara, Miller et al. 2019). 
 
Recent research has shown further evidence that functionality of the host immunity may 
affect HPV infection. Beta and gamma PV infections are substantially higher in men who are 
also infected with HIV compared to those who are HIV negative (Smelov, Muwonge et al. 
2018). Similar trends were also seen in studies concerning alpha, beta and gamma HPVs, 
wherein African men suffering from HIV were shown to be at a higher risk of HPV infection 
when compared with HIV-uninfected men (Meiring, Mbulawa et al. 2017). It is therefore 
likely that the general immunosuppression caused by HIV infection (Elfaki 2014) makes the 
microenvironment more amenable to infection with HPV due to the depleted immune 
response. Analysis of HPV prevalence in SCCs of transplant patients compared with non-
immunosuppressed patients showed that HPV DNA was detected much more frequently in 
SCCs of transplant patients, and that the HPV types found most frequently were beta types, 
indicating the importance of immune control in modulating infection with types of this genus 
(Meyer, Arndt et al. 2003). Despite these differences seen in human disease, all PVs share a 
broad life cycle strategy wherein infection of basal epithelial cells eventually progresses to a 







All PVs are known to infect basal cell keratinocytes to establish an infection, and their life 
cycle is completed alongside terminal differentiation of the infected cells. The structure of 
human epithelium can be seen in Figure 1.3. Basal cells make up the mitotically active lowest 
layer of the epidermis, and are responsible for the maintenance and replenishment of all layers 
of the skin. Recent mathematical modelling of basal homeostasis has suggested that there are 
three possible outcomes following basal cell division: two differentiated basal cells, two 
proliferative basal cells, or one of each type (Clayton, Doupe et al. 2007) (Doupe, Klein et al. 
2010). When a cell detaches from the basement membrane and exits the basal layer, it moves 
upwards towards the surface of the epithelium in the process of terminal differentiation, 
where it is eventually shed from the surface (Jones, Simons et al. 2007). In this way, the 
epithelium is maintained as a protective physical barrier. 
 
Figure 1.3 The structure of the skin 
Human skin has a thick epidermis with multiple cell layers. All layers of the skin are shown 
in the diagram. The basal layer, spinous cell layer, granular cell layer, and stratified cell layer 
together make up the epidermis. Differentiation markers are shown to the left of the diagram, 
Adapted from (Porter and Lane 2003, Pasparakis, Haase et al. 2014). 
Figure	1.3	The	structure	of	the	skin	
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Expression of different keratins at progressive stages throughout the differentiation process 
allows discrete layers to be discerned. In the human epithelium, there are four layers of the 
cutaneous epidermis: the basal layer, the spinous layer, the granular layer, and the cornified 
layer. Basal cells exclusively express keratin 5 and keratin 14, whilst expression of keratin 1 
(K1) and keratin 10 (K10) is seen in the spinous layers as differentiation begins (Fuchs and 
Green 1980). Expression of the early stage differentiation keratins K1 and K10 is then 
downregulated in the granular layer. Involucrin and filaggrin are precursors for late stage 
differentiation transcripts, which are upregulated in the cornified envelope (Zhu, Oh et al. 
1999). In mouse tissue similar patterns are seen, however the skin of a mouse is generally 
much thinner than that of a human, with only 2-3 layers that are 25 µm thickness or less as 
opposed to 5-10 layers that are 100 µm thickness or greater in human skin (Zomer and 
Trentin 2018). PV life cycles are tightly linked to this process of terminal differentiation.  
 
Mounting evidence suggests that one way in which healthy tissue is maintained is by the 
elimination of ‘unfit’ cells through competition. Recent research has demonstrated that this 
competitive removal of unfit cells is required to allow maintenance of heathy tissue, both in 
development and in adults (Merino, Rhiner et al. 2015). These studies with Drosophila 
showed that expression of a gene called azot led to the elimination of unfit cells from the 
population, while knockout of this gene lead to an increase in mutation rates. Research has 
shown that similar mechanisms exist in mammals, wherein transformed epithelial cells are 
apically extruded from a population only in the presence of normal epithelial cells, which 
suggests a method by which ‘unfit’ cells are lost by direct competition with other cells.  For 
example, in co-culture of normal cells with cells that have knockdown of Scribble, a tumour 
suppressor gene, mutant cells were apically extruded from the epithelium and underwent 
apoptosis (Norman, Wisniewska et al. 2012). Similarly, cell culture and ex vivo models 
showed that mutant p53 cells underwent programmed necrosis when co-cultured with normal 
epithelial cells and were basally extruded from epithelial monolayer (Watanabe, Ishibashi et 
al. 2018). However, this extrusion and necroptosis did not occur when p53 mutant cells also 
contained a mutation in the RasV12 gene, commonly in malignancy. This suggests that cells 
can overcome normal competition to persist in the epithelium. Current thinking terms this 
process ‘super-competition’, which can occur in cells with mutations that allow them to 
outcompete wild type (wt) cells. These mutations often occur in pathways that have been 
shown to be important for elimination of ‘unfit’ cells from the population, including p53, 
which is targeted by high-risk HPV protein E6 (Bowling, Lawlor et al. 2019). Altering the 




It is understood that HPV infection can only occur following a microwound or abrasion that 
exposes the basal lamina, allowing virus particles access to the basal cells (Stanley 2012). 
Research suggests that virus particles bind to the basement membrane first via heparan 
sulphate proteoglycans (HSPGs) (Giroglou, Florin et al. 2001). Research carried out with 
fluorescently labelled HPV16 pseudovirions suggests that viruses then subsequently infect 
basal cells by transferring to the migratory wound healing keratinocytes and ‘surfing’ towards 
the cell body (Schelhaas, Ewers et al. 2008). Virus particles are then internalised by a receptor 
that is likely specific to keratinocytes, however the identity of this specific receptor is not 
known. Secretion of an extracellular matrix (ECM) component exclusive to keratinocytes has 
been demonstrated, which was shown to colocalise with laminin-5, a keratinocyte ECM 
marker. Adsorption of HPV particles onto these keratinocyte-specific receptors suggested that 
intermediate association of the virions with these receptors following initial binding to the 
basement membrane via HSPGs might be the mechanism by which PVs preferentially infect 
keratinocytes during wound healing (Culp, Budgeon et al. 2006). This provides one 
reasonable candidate for the specific receptor involved in HPV particle internalisation. Recent 
research implementing Crispr-Cas9 also discovered potential candidates for this keratinocyte 
specific receptor, including solute carrier family 35 (adenosine 3’-phospho 5’-phosphosulfate 
transporter) member B2 (SLC35B2), which is involved in the sulphation of HSPGs (Fu, Tao 
et al. 2016). This research has not yet been followed up in subsequent publications, however 
another publication found that inactivation of the SLC35B2 gene did not affect binding of 
Zika virus to cells. Conversely, attachment of Dengue virus to the SLC35B2 deficient cells 
was decreased when compared with attachment to normal cells (Gao, Lin et al. 2019). Further 




After trafficking to the nucleus, the virus genome must initially be amplified to a low copy 
number to establish a reservoir of infection in the basal layer. Copy numbers were found to be 
50-100 copies per cell of rabbit oral papillomavirus (ROPV) genomes in the epithelial basal 
layer of benign oral papillomas in rabbits (Maglennon, McIntosh et al. 2011), and based on 
research carried out in episomal cell lines the copies per cell in HPVs are estimated to be 
around 200 copies per cell (De Geest, Turyk et al. 1993) (Stanley, Browne et al. 1989). 
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Research using inhibitors of different cell cycle stages has shown that inhibition of CDK1, 
which phosphorylates components of the nuclear envelope during prophase, inhibited HPV 
infection in a dose-dependent manner. However, inhibition of the formation of the mitotic 
spindle, which occurs in late prophase and metaphase, did not affect HPV infection of HaCaT 
cells. This research suggests that host cells must at least enter the early prophase segment of 
mitosis for virus gene transcription to take place (Pyeon, Pearce et al. 2009). This requirement 
could be one reason why PVs must infect basal cells; this is the only layer of the epithelium in 
which cells are mitotically active (Watt, Lo Celso et al. 2006). 
 
E1 and E2 are required for initiation of the establishment phase, and consequently are crucial 
for successful infection (Ustav and Stenlund 1991) (Ustav, Ustav et al. 1991). E1 binds to the 
origin of replication in cooperation with the E2 protein, and unwinds the PV DNA (Sedman, 
Sedman et al. 1997). This process is tightly regulated in a variety of ways, including post-
translational modifications of E1 to control localisation. E1 has been shown to directly 
interact with importins via its nuclear localisation signal (NLS) sequence, and 
pseudophosphorylation within this site prevents in vitro interaction of E1 with importin. 
Further, the use of a GFP tagged pseudophosphorylation mutant of E1 showed that nuclear 
localisation of E1 protein is disrupted in vivo as a result of pseudophosphorylation of two 
NLS residues (Bian, Rosas-Acosta et al. 2007). This is supported by research from another 
group, which showed that phosphorylation of Ser283 is required for shuttling of E1 between 
the nucleus and the cytoplasm in HeLa cells (Hsu, Mechali et al. 2007). The interference of 
cellular factors also plays a role in control of E1-dependent replication. For example, human 
TATA-binding protein has been shown to interfere with HPV11 E1-E2 protein complexes 
forming at the origin of replication. Similarly, transcription factor protein YY1 has been 
shown to prevent viral origin-specific replication of HPV18 by interacting with the E2 protein 
(Hartley and Alexander 2002) (Lee, Broker et al. 1998).  
 
1.7.3	MAINTENANCE	PHASE	
Following initial establishment of infection, viral episomes must then be stably maintained 
within infected cells to provide the reservoir of infection. This maintenance stage takes place 
in mitosis-capable basal cells that have not yet begun the process of terminal differentiation, 
and might be able to occur in the absence of E1 and E2. It is likely that this replication occurs 
once per S phase of the infected cell, and may be mediated by E2 (Murakami, Egawa et al. 
2019). Replication of PV genomes has also been shown to occur by random replication as 
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well as once per S phase. This depends on the level of E1 and E2 proteins present in the host 
cell and on the identity of the host cell itself (Hoffmann, Hirt et al. 2006). 
 
1.7.4	AMPLIFICATION	PHASE	
To successfully produce infectious virions, a final stage of genome amplification must occur. 
Two major promoters control HPV transcription: an early promoter located in the long coding 
region (LCR) termed p97 in HPV16, and a downstream late promoter termed p670 in the 
HPV16 genome. Levels of expression from these promoters are regulated by differentiation, 
and an increase in transcription from the late promoter has been shown to be dependent on 
differentiation (Wang, Liu et al. 2017). In some high-risk PV types such as HPV16, 
amplification occurs in cells in the mid to upper layers of the epithelium, prior to packaging 
into virions for release from the surface. The thickness of this proliferative layer increased in 
relation to the severity of cancer progression in HPV16 positive lesions (Middleton, Peh et al. 
2003). Increased levels of E1 and E2 are observed during this phase, allowing increase of 
viral copy numbers as a result of cell-cycle independent genome replication (Ozbun and 
Meyers 1998). As infected cells exit the spinous layer, gene expression is massively 
upregulated and the genome copy number can increase to thousands of copies per cell (Flores 
and Lambert 1997) (Doorbar 2007) (Chow, Broker et al. 2010). Differences are observed in 
different types of PVs during this stage of the life cycle. For example, in high-risk HPV types, 
the proliferating cell phenotype persists into the upper layers. Virus amplification continues as 
these cells enter a G2 phase state, following S-like phase of growth. Conversely, cells infected 
with low-risk HPV types appear to undergo a re-entry into an S-phase like state as they enter 
the mid to upper layers of the epithelium. Genome amplification of low-risk HPV genomes is 
thought to coincide with this cell cycle reactivation (Doorbar, Quint et al. 2012). There are 
wide ranging differences between the functions of E6 and E7 in different types of PVs, and in 
high-risk types the collateral effect these proteins have on the cell can eventually lead to 
cancer. These mechanisms will be discussed in detail in Section 1.8. 
 
1.7.5	RELEASE	OF	VIRUS	PARTICLES	
For packaging of virus genomes prior to release, the structural proteins L1 and L2 are 
required, which are also transcribed from the late promoter in the uppermost layers of the 
epithelium in the final stages of the life cycle (Ozbun and Meyers 1998). These proteins are 
typically only observed in cells that are positive for E1^E4 transcripts (Middleton, Peh et al. 
2003) and it is thought that the process of virus shedding may be aided by structural 
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alterations in the cornified cell layer caused by E1^E4 (Bryan and Brown 2000). The 
icosahedral capsids of PV particles are made up of 360 copies of L1 proteins and an estimated 
12 L2 protein copies (Modis, Trus et al. 2002). Genomes are packaged within these particles. 
Fully formed virus particles are shed from the skin during desquamation, wherein terminally 
differentiated keratinocytes are lost from the uppermost epithelial layer (Bryan and Brown 
2001). The release of virus within these desquamed cells may even improve virus survival or 
transmission (Egawa, N, personal communication). Although there are many differences in 
the function of different proteins between PV types, this general life cycle allows PVs to 
successfully infect and persist in basal cells of the epithelium, as shown in Figure 1.4. 
 
Figure 1.4 Generic life cycle of high-risk HPV 
Annotations to right of the diagram indicate initiation of viral gene expression and key stages 
of the life cycle. In lower layers, viral proteins E6 and E7 are expressed and drive the infected 
cells through the cell cycle (red coloured nuclei indicate cycling cells). In mid layers of the 
epithelium, proteins required for genome amplification are increased in infected cells. These 
cells also express viral E4 protein, and are often in the G2/S phase of the cell cycle despite 
having exited the basal layer (green colour of cells shows presence of E4, red nuclei show the 
cell is in the G2 or S phase). In upper layers of the epithelium, cells exit the cell cycle, and 
viral packaging proteins L2 and L1 are produced in some E4-containing cells. Virus genome 
is packaged in these cells. Virus particles are shed from the surface. PE – early promoter; PL 
– late promoter; PAE – early polyadenylation site; PAL – late polyadenylation site. Adapted 





As mentioned in the previous section, the abilities of different PV proteins can vary a great 
deal depending on the type. High-risk HPVs are mucosal types primarily found in the alpha 
genus that are associated with many anogenital cancers (Muñoz, Bosch et al. 2003). Due to 
the established link between certain cancers and high-risk types, and the transforming activity 
of E6 and E7 demonstrated in rodent and human cell lines, these proteins have been studied 
expansively (Bedell, Jones et al. 1987, Munger, Phelps et al. 1989). Carcinogenesis of high-
risk HPV-associated cancers is tightly linked to the expression and resulting oncogenic 
activity of their E6 and E7 proteins (Vande Pol and Klingelhutz 2013) (Roman and Munger 
2013). One well-known mechanism of E7 is its binding to retinoblastoma family proteins, 
which results in unscheduled passage of the infected cell through the G1/S cell cycle 
checkpoint due to the resulting release of E2F transcription factors (Münger, Werness et al. 
1989) (Dyson, Howley et al. 1989). E2F is then able to stimulate G1/S transition by activating 
transcription of genes involved in the cell cycle, such as cyclin A and E (Dyson 1998). 
Proliferation is also stimulated by E7 inhibition of p21WAF1/CIP1 and p27KIP1, which are 
inhibitors of CDK (Zerfass-Thome, Zwerschke et al. 1996) (Jones, Alani et al. 1997). E7 has 
also been shown to stabilise p53, a tumour suppressor that induces cell growth arrest or 
apoptosis in response to cellular stress (Demers, Halbert et al. 1994) (Haupt, Berger et al. 
2003). Therefore, E6 directed degradation of p53 allows infected cells to avoid the apoptotic 
cell death that would usually be triggered. High-risk HPV E6 binds to E6AP, a cellular 
ubiquitin ligase. Subsequent recruitment and degradation of p53 then takes place. p53 cannot 
be bound and degraded by either E6 or E6AP separately (Huibregtse, Scheffner et al. 1993) 
(Scheffner, Werness et al. 1990 ). The E6 protein of some high-risk HPV types has also been 
shown to abrogate the function of p53 by binding to histone acetyltransferase CBP/p300, a 
transcriptional coactivator of p53, and consequently downregulating p53 activity 
(Zimmermann, Degenkolbe et al. 1999). Finally, E6 binding to p53 alone can lead to 
inactivation of the p53 protein due to the resulting conformational changes (Lechner and 
Laimins 1994). 
 
An important function of high-risk HPV E6 is its ability to recognise and bind to PDZ-domain 
containing substrates via a short PDZ-binding domain found at the C-terminus of the protein 
(Kiyono, Hiraiwa et al. 1997) (Lee, Weiss et al. 1997). Indeed, research suggests that an intact 
PDZ domain-binding motif (PDM) is significant in pathogenicity of early high-risk infection, 
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particularly for the amplification of genome copy numbers (Lee and Laimins 2004). Past 
research has shown that high-risk E6 is able to direct the degradation of multiple PDZ-domain 
containing substrates, including Scribble, MAGI-1 and MAGI-3 (Massimi, Shai et al. 2008). 
A number of the PDZ proteins that have been shown to be targeted for degradation following 
interaction with high-risk E6 are involved in cell polarity, tight junction formation, and 
adhesion. Measurement of ZO-1, a tight junction component that colocalises with hSrib, 
demonstrated that expression of high-risk HPV E6 in Madin-Darby canine kidney (MDCK) 
cells resulted in a decrease in tight junction integrity (Nakagawa and Huibregtse 2000). 
MAG-1 is also associated with tight junctions, and restoration of MAG-1 levels by inducing 
expression of MAG-1 resistant to E6 PDZ-mediated degradation resulted in increased tight 
junction assembly within HPV18 positive cancer cells. An effect on cell proliferation and 
regulation of apoptosis was also shown, demonstrating the involvement of this PDM 
interaction by E6 on the integrity of cell junctional structures as well as proliferation and cell 
survival (Kranjec, Massimi et al. 2014).  
 
1.8.2	GENOMIC	INSTABILITY	CAUSED	BY	HIGH-RISK	HPV	E6	AND	E7	
Aside from these well-known functions, both high-risk E6 and E7 have also been shown to 
trigger genomic instability in infected cells. Long-term dysregulation of various cell processes 
in these ways results in the oncogenic transformation of cells infected with HPV. For 
example, E6 has been shown to dysregulate cdc2-associated histone H1 kinase activity 
leading to disruption of mitotic checkpoints, and E6 inhibition of p53 also results in induction 
of tetraploidy of cells (Thompson, Belinksky et al. 1997) (Incassati, Patel et al. 2006). E7 also 
contributes to genomic instability by abrogating the cell cycle checkpoint that occurs at the 
formation of the mitotic spindle. This process occurs independently of E6, perhaps through 
elevation of MDM2, which is an important negative regulator of p53 (Thomas and Laimins 
1998). Similar modulation of cell cycle regulatory proteins has also been shown in HPV58, 
which is highly associated with cervical cancers in Eastern Asia, suggesting important 
oncogenic consequences of the downregulation of retinoblastoma protein (pRB) and p130 
(Zhang, Li et al. 2010). 
 
1.8.3	IMPACT	OF	HIGH-RISK	HPV	E6	AND	E7	ON	DIFFERENTIATION	
Dysregulation of differentiation has also been shown to be a fundamental aspect in HPV 
positive tumours when compared to HPV negative tumours (Mendelsohn, Lai et al. 2010) 
(Hatterschide, Bohidar et al. 2019). As expected, high-risk HPV E6 and E7 have been shown 
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to affect differentiation in multiple ways. Raft culture of human keratinocyte cells expressing 
high-risk HPV E6 and E7 resulted in a decrease in differentiation observed throughout the 
layers of cells, which became more pronounced when cells of a later passage were used 
(Hudson, Bedell et al. 1990). Retroviral transduction to express coding sequences of E6 and 
E7 from a variety of high-risk mucosal HPV types also demonstrated an effect on 
differentiation when raft culture of these cells was attempted (Schutze, Snijders et al. 2014). 
Similar effects were observed in studies utilising mutant whole genomes of HPV16 in raft 
culture, further demonstrating the impact of E6 and E7 expression on normal cell 
differentiation (Bergner, Halec et al. 2016). 
 
The effect that high-risk HPV E6 and E7 can have on differentiation can also be shown with 
transcriptional studies comparing control cells with cells retrovirally transduced to express 
HPV16 E6 and E7. Results showed that the expression of several keratinocyte differentiation 
genes was downregulated by HPV16 E6 and/or E7 in primary human keratinocytes 
(Gyöngyösi, Szalmás et al. 2015). Earlier analysis of transcriptional differences was carried 
out using cDNA arrays. Results showed that in differentiating cultures, significant differences 
in expression of over 100 cellular genes were observed between control cells and 
experimental cells retrovirally transduced to express HPV16 E6 and E7. This suggests that E6 
and E7 are likely to impact upon gene expression to alter normal differentiation (Nees, 
Geoghegan et al. 2000). More recently, research has shown that HPV16 can inhibit the 
cleavage of NOTCH, a receptor known to be involved in the pathway of differentiation. In 
combination with p53 degradation this lead to promotion of proliferation in cell culture, and a 
reduced commitment to differentiation, which could result in higher persistence of infected 
cells in the basal layer of infected tissue when compared to non-infected cells (Kranjec, 
Holleywood et al. 2017).  
 
1.8.4	HIGH-RISK	HPV	E6	AND	E7	IMPACT	UPON	THE	IMMUNE	SYSTEM	
In addition to these other functions, E6 and E7 of high-risk HPVs have also been shown to 
have some effect on the immune system, which may be necessary for success of the virus in 
the host tissue. Early micro-array analyses demonstrated that, amongst other genes involved 
in regulation of cell growth, cells containing the HPV31 genome had a significant 
downregulation of several genes involved in the normal response to interferon (IFN). Of 
particular note, Stat-1 was shown to be downregulated. Given the significant role that Stat-1 
plays in IFN response, this suppression likely results in poor IFN responsiveness in vivo, and 
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may contribute to the evasion of the immune system by infected cells (Chang and Laimins 
2000). Similar results were seen in cDNA micro-arrays of cells expressing HPV16 E6 and E7. 
Whilst E7 showed a modest effect, co-expression of E6 and E7 or E6 alone resulted in 
notably decreased expression of genes responsive to IFN signalling and genes regulating cell 
cycle entry, and a significant induction of DNA binding activity for NF-kB (Nees, Geoghegan 
et al. 2001). NF-kB is a transcription factor involved in regulation of many immune functions, 
and has been shown to protect keratinocytes from apoptosis (Chaturvedi, Qin et al. 1999). 
Conversely, high-risk HPV infected keratinocytes were shown to impair the acetylation of 
NF-κB/RelA K310 through upregulation of the epidermal growth factor receptor (EGFR) to 
drive expression of cellular protein IFN-related developmental regulator 1 (IFRD1), which 
was shown to be instrumental in the acetylation process. This resulted in a decrease in 
production of pro-inflammatory cytokines and a subsequent decrease in immune cell 
attraction (Tummers, Goedemans et al. 2015). Another study has also shown that HPV16 E6 
could inhibit NF-kB by competitively binding to CBP, a co-activator of NF-kB. HPV16 E7 
protein binding to p300/CBP-associated factor (PCAF) also inhibited NF-kB, which resulted 
in a downregulation of IL-8, an important chemoattractant for T cells and lymphocytes 
(Huang and McCance 2002).  
 
1.8.5	IMPACT	OF	OTHER	E6	AND	E7	PROTEINS		
Given the difficulties in maintenance of other PV types in culture and their less prominent 
role in the causation of disease, the effects of E6 and E7 proteins of PV types aside from those 
high-risk types are less well studied. The E6 proteins of some beta papillomaviruses are able 
to bind p53, however they cannot target the protein for degradation (White, Kramer et al. 
2012). Beta papillomavirus types HPV5 and HPV8 E6 proteins are also able to bind to 
CBP/p300, however the mechanistic process behind the inactivation of function is different to 
that seen with the alpha types; beta type E6 prevents the phosphorylation of p300 required for 
protein stabilisation by AKT, which results in a reduced level of p300 in the cell. This was 
also shown to attenuate expression of some markers of differentiation, including K1 and K10 
(Howie, Koop et al. 2011). Studies also suggest that low-risk E7 is less able to induce 
hyperplasia and impair differentiation when compared to high-risk E7 (Ueno, Sasaki et al. 
2006). In particular, low-risk alpha type HPV6 E7 has been shown to destabilise p130, a 
member of the pRb family, and a decrease in expression of involucrin was observed in HPV6 
E7 expressing HFKs, suggesting a differentiation delay (Zhang, Chen et al. 2006).  
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More recently, proteomic approaches revealed that cutaneous E6 proteins of beta 
papillomavirus type HPV8, BPV1 (a delta type), and mu papillomavirus HPV1 were all 
shown to bind to mastermind-like protein 1 (MAML1), a transcriptional co-activator involved 
in Notch signalling. Binding of E6 proteins resulted in repression of transactivation of Notch 
in all cases (Brimer, Lyons et al. 2012). Similar results were seen in another proteomic screen 
of BPV1 E6 along with the E6 proteins of a more expansive group of beta papillomavirus 
types (8, 25, 98, 17a, 38,76, and 92) (Tan, White et al. 2012). Additionally, the E6 protein of 
a recently discovered pi papillomavirus type has also been shown to bind to MAML1 and 
SMAD2/3, leading to inhibition of both downstream pathways (Meyers, Uberoi et al. 2017). 
Large scale analysis of binding capabilities of 45 different E6 proteins demonstrated that PVs 
can be clustered based on their binding to E6-AP or MAML1. In the PV types investigated, 
types from all genera apart from the alpha genus preferentially bound to MAML1 over E6-
AP. Out of the animal types tested, E6 proteins from some pigs (SsPV1) and cetacean PVs 
were able to bind E6AP and subsequently target its degradation. Conversely, beta 
papillomavirus E6 proteins were shown to bind to MAML1, along with PVs from several 
other genera, including Delta, Pi, Gamma, and Mu. No E6 proteins were found to be capable 
of binding and interacting with both E6AP and MAML1, suggesting a key evolutionary split 
may have taken place (Brimer, Drews et al. 2017). While the function of proteins varies a 
great deal between PV types, this data suggests that the Notch signalling pathway is important 
in PV infection. 
 
1.9	THE	NOTCH	SIGNALLING	PATHWAY	
Both in vivo and in vitro, Notch signalling has been shown to act as a key determinant in the 
coordination of keratinocyte transition from proliferation to early stage differentiation 
phenotypes (Rangarajan, Talora et al. 2001). Generally, the Notch pathway is highly 
conserved, and has multiple roles in the modulation of cell fate in different tissues 
(McElhinny, Li et al. 2008). A summary of this pathway adapted from a review by 
Ranganathan and colleagues is shown in Figure 1.5 (Ranganathan, Weaver et al. 2011). The 
Notch receptor and its ligands (Delta and Jagged) are large transmembrane proteins consisting 
of EGF-like repeats. There are two classes of ligands in humans and mice: the delta-like 
proteins (including DLL1, DLL3, and DLL4) and the Serrate homologues (including Jagged1 
and Jagged2) (Kopan and Ilagan 2009). Two proteolytic cleavage events within the Notch 
receptor itself must occur before successful signalling. First, a furin-like convertase cleavage 
occurs, which results in the splitting of Notch into two segments: one is comprised of most of  
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Figure 1.5 The Notch signalling pathway 
Diagram showing the canonical Notch signalling pathway. 1; Activation of the Notch 
Signalling Pathway requires binding of a ligand, such as DLL1, or DLL4. 2; Binding of a 
ligand causes a conformational change in the notch receptor, which allows S2 cleavage by a 
metalloprotease tumour necrosis factor-a-converting enzyme. 3; Notch intracellular domain 
(NICD) is released from the plasma membrane after cleavage of the receptor mediated by the 
presenilin-g-complex. 4; NICD is translocated to the nucleus. 5; When NICD enters the 
nucleus, it forms part of a transcriptional activator complex with MAML1 and CBF1-Su(H)-
LAG1 (CSL). 6; Downstream transcription of target genes occurs, such as hairy enhancers of 




the extracellular domain, and the second comprises the rest of the Notch receptor structure 
(Logeat, Bessia et al. 1998). After a ligand binds to the receptor, the ligand is further 
processed, facilitated by a membrane metalloprotease ADAM-10. This protease causes 
proteolysis at the S2 site of the Notch receptor, which then allows further cleavage at sites 
within the membrane spanning region (S3 and S4) by the aspartyl protease γ-secretase (Bray 
2006). The Notch intra-cellular domain (NICD) can then be translocated to the nucleus, where 
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it forms part of a transcriptional complex with the CSL DNA binding protein 
(CSL: CBF1/RBP-Jκ in mammals, Su(H) in Drosophila, and Lag-1 in Caenorhabditis 
elegans) (Contreras-Cornejo, Saucedo-Correa et al. 2016) (Mumm and Kopan 2000). 
 
When NICD is absent, transcription is repressed by CSL association with histone deacetylases 
(HDACs) and ubiquitous co-repressor proteins. However, when NICD is present, it forms a 
complex with CSL, which could trigger a conformational change that allows transcriptional 
repressors to displace. A tri-protein complex is then formed with NICD, CSL, and 
Mastermind (MAML1 in humans and mice), which allows downstream transcriptional 
activation of target promoters (Ilagan and Kopan 2007). Interaction with MAML1 is 
necessary for signalling from all four of the Notch receptors (Wu, Aster et al. 2000). In 
keratinocytes, Notch activation has been shown to negatively target p63. p63, a member of 
the p53 gene family, has also been shown to negatively regulate Notch-dependent 
transcription, with Hes-1 being one of its direct negative targets (Nguyen, Lefort et al. 2006). 
Research has demonstrated that p63 can regulate adhesion and cell survival in keratinocytes; 
down regulation or upregulation of p63 resulted in corresponding changes in adhesion 
molecules in mammary cells (Carroll, Carroll et al. 2006). A role in the regulation of 
proliferation and differentiation of mature keratinocytes has also been demonstrated by using 
small interfering RNAs against p63 in rafts of primary keratinocyte cells (Truong, Kretz et al. 
2006). Impairment of adhesion generally has been shown to also lead to increased 
differentiation, which emphasises the intrinsic role of p63 in mediating the control of 
keratinocyte differentiation (Grose, Hutter et al. 2002). 
 
Inactivation studies have clearly demonstrated the role of Notch signalling in regulation of 
late stage differentiation in keratinocytes (Lin, Kao et al. 2011). Localisation studies have 
shown that Notch receptors are mainly found in the suprabasal cells, while ligands such as 
Dll1 have been found mostly in the epithelial basal layer (Watt, Estrach et al. 2008). In vivo 
experiments have shown that NICD complexes with CSL act at the juncture of the basal and 
suprabasal layer to induce spinous cell layers and downregulate basal fate in the cells. When 
RBP-J was first knocked out, the spinous layer could not form. In contrast, overexpression 
from Notch1 receptors resulted in expansion of the spinous layer. Expression levels of Hes-1 
downstream of the canonical Notch pathway were also shown to be related to stimulation or 
depression of signalling via this pathway (Blanpain, Lowry et al. 2006). Hes-1 itself was 
shown to be involved in the repression of spinous layer genes, but was not involved in basal 
cell marker repression. Overall, it is clear that Notch signalling plays a vital role in successful 
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maintenance of keratinocytes in a normal epithelium. Given the previously discussed ability 
of PVs to interact with this pathway, it is clear that this is likely implicated in PV modulation 




Over the past three decades, PVs have been predominantly researched in recombinant 
retrovirus models and transfection models in both primary and immortalised cells. Serial 
passaging of primary epidermal keratinocytes was first described in 1975 (Rheinwald and 
Green 1975). This was successful due to the introduction of an irradiated mouse fibroblast 
‘feeder’ layer, which provided important tissue factors to the keratinocytes. To study the virus 
life cycle, cells must be able to stably maintain extrachromosomal HPV DNA (Frattini, Lim 
et al. 1996). One of the most commonly used cell lines in HPV research is the W12 cell line, 
derived originally from a CIN1 lesion, that contains around 100 episomal copies per cell of 
the HPV16 genome (Stanley, Browne et al. 1989). When transplanted into immunodeficient 
mice, these cells can successfully differentiate and even generate infectious virus (Sterling, 
Stanley et al. 1990), which makes this a useful cell line to model behaviour of HPV-infected 
cells in monolayer. However, careful consideration must be given to the passage number of 
the cells; it has been shown that episomal DNA is lost over time, as cells with integrated HPV 
DNA dominate the culture population, which can impact experimentation (Alazawi, Pett et al. 
2002) (Pett, Alazawi et al. 2004). Therefore, comparison between experiments carried out at 
different passages can be difficult. Another cell line isolated from a low-grade cervical lesion 
is the CIN-612 cell line, which contains a mixed population of cells infected with HPV31b. 
Two sub-clones have been further isolated from this cell-line: the 9E cell line, which stably 
maintains episomal HV31b DNA, and the 6E cell line, which contains integrated viral DNA 
(Bedell, Hudson et al. 1991) (Hummel, Hudson et al. 1992).  
 
Use of immortalised keratinocyte cell lines to study HPV is also possible, although one 
drawback is that any cellular abnormality that caused immortalisation of the cell could have 
also disrupted important cellular processes, and may therefore affect the PV life cycle. N-Tert 
cells are derived from a population of primary keratinocytes that were purposefully 
immortalised by transduction of the telomerase catalytic subunit hTERT gene, and were later 
able to spontaneously bypass normal senescence as a result of a mutation in the gene p16INK4A 
(Dickson, Hahn et al. 2000) (Rheinwald, Hahn et al. 2002). This cell line has been used in PV 
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research, however its mutation in the p16 pathway can be problematic for investigation of 
oncogenic PV life cycles. Normal Immortalised Keratinocytes (NIKS) are sometimes used in 
PV research due to their being the natural host of HPV. These genetically stable cells were 
established spontaneously from a foreskin keratinocyte cell line, and are ‘normal’ aside from 
the presence of an extra isochromosome of the long arm of chromosome 8, which was shown 
to have no visible effect on the normal differentiation process of the cell (Allen-Hoffmann, 
Schlosser et al. 2000). Study of PVs in this cell line is useful because it allows investigation 
of low-risk PVs that are unable to immortalise infected cells, or HPV mutants generated to be 
defective in immortalisation of cells. Research demonstrated that stable maintenance of HPV 
genomes is possible in this cell line, and that it can also support the virus life cycle (Flores, 
Allen-Hoffmann et al. 1999). These cells have been used to study a wide range of PV biology, 
including immune evasion, genome maintenance, and the role of oncogenes in the virus life 
cycle (Cicchini, Blumhagen et al. 2017) (Lorenz, Rivera Cardona et al. 2013) (Murakami, 
Egawa et al. 2019) (Flores, Allen-Hoffmann et al. 2000) (Genther, Sterling et al. 2003). 
 
Recently, a novel method of cell culture has been established, which successfully infected 
primary keratinocytes with HPV16 quasivirions and pseudovirions by first allowing binding 
of particles to an ECM mimic. Generation of ECM-like depositions was achieved by first 
culturing HaCaT cells in the culture dishes prior to addition of HPV16 virus particles and 
subsequent seeding of the primary keratinocyte cells. This method aimed to more closely 
mimic real-life infection, and successfully showed completion of the virus life cycle in 3D 
culture of cells in organotypic rafts (Bienkowska-Haba, Luszczek et al. 2018). 
 
1.10.2	ORGANOTYPIC	RAFTS	
Cultivation of keratinocytes on a collagen surface when lifted to an air-liquid interface has 
been shown to allow culture of stratified epithelium in the form of organotypic rafts, as 
differentiation is triggered in keratinocytes when they are grown in this way (Fusenig, Amer 
et al. 1978). A diagram to show the methodology of this system is shown in Figure 1.6 
(adapted from (Anacker and Moody 2012). By growing keratinocytes positive for HPV in 
these raft systems, production of infectious virions in culture is possible, which is an 
incredibly useful and important system for the study of PVs (Meyers, Frattini et al. 1992). 
Recapitulation of a productive virus life cycle in N-Tert cells containing HPV11 episomes led 
to the production of infectious virus particles, showing the utility of this model for low-risk 
types as well as high risk (Fang, Meyers et al. 2006). Previous reports have also demonstrated 
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efficient infection of primary keratinocytes with HPV18 to consequently produce high titres 
of infectious virus in organotypic raft culture (Chow, Duffy et al. 2009) (Wang, Duffy et al. 
2009). Use of rafts has allowed important investigation of the virus life cycle in a model that 
closely resembles stratified epithelium. However closely this model mimics the epithelium, it 





Figure 1.6 Organotypic raft culture 
Diagram showing the methodology of organotypic raft preparation from Normal 







While much of the current knowledge of PVs concerns human types, the number of non- 
HPVs to be discovered has been increasing. Most of the PVs discovered thus far are in 
mammals, and it was originally thought that PV infection was restricted to amniotes (Rector 
and Van Ranst 2013). To date, nine non-mammal PV hosts have been discovered, including 
sea turtles (Herbst, Lenz et al. 2009), Adélie penguins (Varsani, Kraberger et al. 2014), and 
other species of bird (Terai, DeSalle et al. 2002) (Tachezy, Rector et al. 2002) (Gaynor, Fish 
et al. 2015). Almost all PVs are considered to be within the sub-family Firstpapillomavirinae, 
except for one PV type encoding only E1, E2, L1 and L2. Sparus aurata papillomavirus 1 is 
the only member of the Secondpapillomavirinae, associated with skin lesions of the gilt-head 
(sea) bream (Lopez-Bueno, Mavian et al. 2016) (Van Doorslaer, Chen et al. 2018). 
 
Historically, it has been understood that PVs exhibit extreme species specificity due to co-
evolving tightly with their hosts acquisition of new ecological niches over millions of years 
(Brooks and Ferrao 2005). In animal PVs, association with cancer is extremely rare, and has 
only been described in a few limited cases. For example, PV type RrpPV1 was isolated from 
a nasolabial tumour found in a free-ranging chamois (Mengual-Chulia, Domenis et al. 2014). 
Another study suggested that EcPV2 could have a causative role in genital tumour 
pathogenesis in horses; EcPV2 DNA was found exclusively in genital tumour samples (Scase, 
Brandt et al. 2010). A link between cattle cancer and papillomavirus infection was first 
suggested in 1978 (Jarrett, McNeil et al. 1978) and in 1986, a paper reported that BPV4 was 
the etiological agent causative of upper digestive tract papillomas, which could become 
cancerous if the animal fed on a specific bracken fern pasture (Pteridium aquilinum) (Campo 
and Jarrett 1986). Infection of the oesophagus with BPV4 subsequently provided a useful 
animal model of PV. While it is interesting to note the oncogenic potential of non-human PV 
types, these animals are not so conducive to a laboratory research environment. Although 
some evidence suggests that species specificity may be less strict among hosts that are 
genetically similar (Gottschling, Stamatakis et al. 2007), there has still been the need for more 
amenable animal models of PV infection in research. Due to the strict host specificity of PVs, 
no animal model that can be infected with HPV exists, however use of animal PVs to study 
general principles of infection is possible. A phylogenic tree recently generated by Doorslaer 
and McBride is shown in the below figure (Figure 1.7) (Van Doorslaer and McBride 2016). 
The locations of a high-risk and a low-risk HPV type in relation to different key animal types 








Figure 1.7 Maximum likelihood evolutionary tree of Papillomaviridae 
Diagram shows an evolutionary tree. Tree was generated using a portioned supermatrix 
generated from the E1, E2, L1 and L2 core nucleotide sequences. Some members of the 
Gamma genus have yet to be officially recognised as so, as demonstrated by the asterisk. 
Selected types have been labelled with black arrows to show their relative locations within the 
tree. The black arrowhead distinguishes CPV2, which is the root of the phylogenic tree 
shown. Classification was based on Bernard et al, 2010 and de Villiers et al, 2004. Adapted 








First described in 1933 (Shope 1933), research using rabbit PV infection was further 
established when use of a DNA clone of cottontail rabbit papillomavirus (CRPV) was shown 
to produce infectious papillomas in cottontail rabbit skin, providing a model of cutaneous 
infection (Brandsma and Xiao 1993). This type is officially termed SfPV1 in the 
Papillomavirus Episteme (http://pave.niaid.nih.gov), and can also be used to infect domestic 
rabbits, making experimentation more practicable (Syverton 1952 ). This model was useful 
because manageable lesions would grow at the site of infection and subsequently regress, 
allowing modelling of regression and even latency. Importantly, lesions were of sufficient 
size to provide a considerable quantity of material for molecular and histological analysis 
(Stanley and Nicholls 1997). Additionally, approximately 60-75% of infected sites persist and 
develop into squamous cell carcinomas, meaning this PV could be suitable for modelling 
high-risk disease (Reuter, Gomez et al. 2001). Early investigations into latency with this 
model showed infection of sites with low titres of virus did not result in visible papillomas. 
Despite the lack of visible infection, DNA was detected at the site up to 18 weeks later, and 
mechanical irritation of the infection site resulted in reactivation of infection, supporting the 
concept of latent infection (Amella, Lofgren et al. 1994). Further, studies demonstrated that 
protective immunisation of rabbits was possible using a L1 virus-like particle (VLP) based 
vaccine (Christensen, Reed et al. 1996). 
 
However, this type of PV cannot infect mucosal tissue. Conversely, another type of PV that 
infects domestic rabbits is ROPV, which has a tropism for oral mucosal tissue (Parsons and 
Kidd 1943). This type is officially termed OcPV1 in the Papillomavirus Episteme 
(http://pave.niaid.nih.gov). In terms of genomic structure and timings of the life cycle, ROPV 
infection is a reasonable mimic of low-risk infection of mucosal tissue by HPV6 and HPV11 
(Peh, Middleton et al. 2002). Over the years, this model has been used to investigate various 
aspects of PV biology, and has also been used to test therapeutic agents. In terms of latency, 
while DNA was not visible at the site of infection using in situ hybridisation visualisation, 
polymerase chain reaction (PCR) based methods were able to demonstrate presence of PV 
DNA following regression of lesions, providing further support for the theory that PVs can 
still persist following immune-modulated regression of infection (Maglennon, McIntosh et al. 





The transmissible nature of warts in dogs was first noted more than 100 years ago (Penberthy 
1898). Since then, this model has been used in a multitude of experiments that have furthered 
knowledge of PV biology immensely. As a mucosal PV, canine oral papillomavirus (COPV) 
(also called CPV1) has been widely used despite its high purchase and maintenance costs, and 
in particular has been of paramount importance in the study of immune involvement in PV 
infection (Nicholls and Stanley 1999). Immune modulation of PV infection was demonstrated 
in multiple experiments showing regression of lesions and later immunity to reinfection 
(Chambers, Evans et al. 1960) (Konishi, Tokita et al. 1972). Experiments in passive transfer 
of serum from previously infected immune dogs to naïve uninfected dogs showed that 
introduction of neutralising antibody to these dogs prior to infection was protective, however 
serum transfer to already infected dogs had no effect on lesion regression. This showed that 
humoral immunity was not involved in the clearance of infection (Suzich, Ghim et al. 1995). 
Further experiments into adaptive immune responses showed that T lymphocyte infiltration 
occurred alongside regression of lesions, and the canine model of PV infection was further 
used to demonstrate the excellent efficacy of formalin-attenuated virus as a vaccine (Bell, 
Sundberg et al. 1994). Such experiments were important in developing the concept of pre-
emptive protection against PV infection in humans. Although the use of canine PVs to model 
infection has greatly diminished due to availability of other animal models, recent 
retrospective analyses have emphasised the increasing incidence of viral papillomas with 
malignant transformation in dogs over the past decade (Thaiwong, Sledge et al. 2018). 
Investigation into the possible reasons behind this observation may prove useful. 
 
1.11.3	BOVINE	PAPILLOMAVIRUSES	
Although the least practically manageable of the animal models, BPV research has also been 
important. Early research demonstrated that BPV was an infectious agent causative of 
epithelial hyperplasia (Cheville and Olson 1964). In fact, BPV1 was the first PV genome to 
be fully sequenced (Chen, Howley et al. 1982). Since then, research with BPV has been 
incredibly useful for furthering the understanding of PVs despite dissimilarities in disease and 
mechanism (Munday 2014). Of the known BPV types, 12 have been shown to cause warts in 
cattle (Rector and Van Ranst 2013). Subgroups have been proposed, one for those types that 
cause epithelial warts, and one for those that cause fibropapillomas, which present with a 
considerable proliferative dermal component to the papilloma (Campo and Jarrett 1986). 
However, recent studies have demonstrated that multiple types of BPV can be detected within 
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the same lesion, therefore it is somewhat unclear which of the types might actually be 
asymptomatic (Schmitt, Fiedler et al. 2010). Following cloning and characterisation of BPV 
genomes (Campo and Coggins 1982), studies have been carried out in monolayer culture to 
investigate molecular biology and gene function (Jareborg, Alderborn et al. 1992) (Lentz, Pak 
et al. 1993). Interestingly, BPV1 and BPV2 have been shown to infect species other than 
cattle, such as horses (Potocki, Lewinska et al. 2012). Despite the useful research done with 
this model, high costs and complex husbandry requirements mean that a smaller, more 
manageable host for study is desirable.  
 
1.11.4	RODENT	PAPILLOMAVIRUSES	
 The animal most commonly used in research is the mouse but until 2011 no PV capable of 
infecting a laboratory mouse was known. However, PVs had been isolated from a range of 
other rodents, including hamsters, rats, and other types of mouse (Iwasaki, Maeda et al. 1997) 
(Kocjan, Hosnjak et al. 2014) (Schulz, Gottschling et al. 2012) (Van Doorslaer, Rector et al. 
2007). Histological analysis of samples taken from European harvest mice demonstrated the 
presence of a variety of skin lesions associated with the presence of PV (Sundberg, O'Banion 
et al. 1988). Research with rat PVs added to the case for latent disease, in that mechanical 
irritation of sites of latent Mastomys natalensis papillomavirus (MnPV) infection in the 
southern multimammate rat led to an increase in viral load at the site and earlier onset of 
MnPV-producing skin tumours (Siegsmund, Wayss et al. 1991). Some evaluation of 
therapeutic approaches to treat MnPV1-induced papillomas has also been carried out in more 
recent years. Use of a L1-based VLP vaccine proved effective in in the prevention of MnPV1 
induced skin lesions in M. coucha, whether the infection was natural or experimental, under 
both immunocompetent and immunocompromised conditions (Vinzón, Braspenning-Wesch 
et al. 2014). However, given the lack of detailed knowledge regarding how similar the 
immune system of M. coucha is to the human immune system, use of a laboratory mouse 
model is perhaps more relevant.  
 
In 2011, a strain of PV was discovered spontaneously in a closed colony of NMRI-
Foxn1nu/Foxn1nu mice. Excitingly, this was shown to be transmissible to immunocompetent 
mice, opening a new area of research in the PV field (Ingle, Ghim et al. 2011). Analysis 
showed that the genome was 7510bp in length, containing at least 7 ORFs: E1, E2, E4, E6, 
E7, L1, and L2. MmuPV1 was designated to the Pipapillomavirus genus, along with four 
other rodent types (Joh, Jenson et al. 2011). Shortly after this a variant of MmuPV1 was 
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discovered, along with three PVs discovered in Norwegian rats (Schulz, Gottschling et al. 
2012). Examination of the expression patterns of MmuPV1 L1 and L2 proteins demonstrated 
that prior to expression of L2, L1 sometimes localised to the cytoplasm in the lower layers of 
the epithelium, and expression was nuclear only in the presence of L2. Conversely, L2 was 
only observed in the upper layers (Handisurya, Day et al. 2013). Whilst different from the 
expression patterns of high-risk types, wherein neither L1 nor L2 are expressed in the lower 
layers (Florin, Sapp et al. 2002), this pattern of expression is comparable to that of HPV1 
(Egawa, Iftner et al. 2000). Given the ease of manipulation of this animal model, this is a 
valuable system with which to study PV infection, and in particular, the earliest stages of 
lesion formation. A diagram to show a comparison between the genome of MmuPV1, HPV8, 
HPV11, and HPV16 is shown in Figure 1.8, to demonstrate important similarities and 
differences. As shown, all four types possess the “core” proteins E1, E2, L1 and L2, as well 
as the “accessory” proteins E6 and E7. Notably, only the alpha types contain the E5 protein. 
 
Figure 1.8 Comparison of MmuPV1 genome with selected human types 
A; MmuPV1 genome. B; HPV8 genome. C; HPV11 genome. D; HPV16 genome. Early 
proteins are shown in green. Late proteins are shown in blue. Splice variants are shown in red 
and orange. The URR is shown in yellow. Genome graphics generated from 
pave.niaid.nih.gov. Adapted from (Van Doorslaer, Li et al. 2017). 
Figure	1.8	Comparison	of	MmuPV1	genome	with	selected	human	types	
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Initial research with the MmuPV1 PV model suggested that virus was only capable of 
infecting cutaneous tissue, and various groups have shown that development of lesions occurs 
on the muzzle, tail, ears, and back in immunosuppressed mice (Ingle, Ghim et al. 2011) 
(Handisurya, Day et al. 2013) (Uberoi, Yoshida et al. 2016). However, later research showed 
that MmuPV1 virus could also infect oral, anal and vaginal sites, and demonstrated that viral 
copies could be detected in lavage samples as early as 6 weeks following initial infection (Hu, 
Budgeon et al. 2015). This study also showed that wounding promoted infection and resulted 
in a higher viral DNA load being detected in subsequent sampling. Another study similarly 
demonstrated the development of vaginal papillomas in immunocompromised mice following 
MmuPV1 infection (Joh, Ghim et al. 2016) and showed that passive transfer of hyperimmune 
sera from C57BL/6 immunocompetent mice to immunodeficient mice prevented lesion 
development in the experimental mice. Infection with MmuPV1 at cutaneous sites can lead to 
development of secondary infection at mucosal sites, which further establishes the MmuPV1 
model as useful for in vivo study of PV disease (Cladel, Budgeon et al. 2013). 
 
As MmuPV1 was originally isolated from florid muzzle papillomas of immunocompromised 
mice (Ingle, Ghim et al. 2011), it was considered whether this PV type could successfully 
infect other mouse strains. An investigation into the effect of host strain background on 
infection was carried out by Sundberg and colleagues, which demonstrated a clear T-cell 
deficiency requirement in successful infection (Sundberg, Stearns et al. 2014). No lesions 
formed following infection of immunocompetent C57BL/6J wt mice, however this strain 
became susceptible to infection when mutated to lack B cells and T cells. Mutation to cause B 
cell deficiency alone was insufficient to allow MmuPV1 infection, showing that T cells are 
important in modulating infection. A similar investigation into the effect of immune status of 
the host on infection showed comparable results (Handisurya, Day et al. 2014). More recent 
work has highlighted two immunocompetent strains that support infection with MmuPV1 at 
mucosal sites whilst conversely managing to control disease at cutaneous sites (Cladel, 
Budgeon et al. 2017). These were mice of strains NU/J and Hsd: NU, both heterozygous for 
the nu mutation. Infected sites progressed to carcinoma in situ in NU/J infected mice, which 
suggests that the mouse model of PV infection could also be useful for the study of malignant 
progression of infection in an immunocompetent background. Research has shown that 
MmuPV1 infection can also occur in other strains if the immune system is sufficiently 
suppressed, for example, by ultraviolet irradiation (UVR) (Uberoi, Yoshida et al. 2016) or 
cyclosporine A immunosuppression  (Handisurya, Day et al. 2014). Overall MmuPV1 can be 
used to model various aspects of PV infection in a tractable, commonly used lab animal. 
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1.12	AIMS	OF	THE	THESIS	
PV warts are understood to be clonal in origin, expanding from a single infected cell (Alizon, 
Murall et al. 2017). As current treatment methods cannot ensure removal of all infected cells, 
there is no way to guarantee total eradication of infection during each treatment (Lipke 2006). 
Persistence is therefore problematic for effective treatment of certain conditions linked to 
HPV infection. Understanding what competitive advantages an infected cell must have to 
develop into a lesion is important; establishing the way in which single infected cells compete 
with their neighbours to successfully develop lesions could reveal significant mechanisms of 
infection. Such mechanisms may also explain how certain types of HPV are able to form 
productive lesions without the pro-proliferative capabilities of their high-risk counterparts. 
 
This thesis aims to study the homeostatic characteristics of infected cells with a view to 
understand how infections form and persist, by examining and modelling the generic 
characteristics of PV infection using the mouse model of PV infection, and subsequent cell 

























The murine J2-3T3 cells are a cell line of immortalised fibroblast cells established from 
embryos of Swiss albino mice (Todara 1963). A blastocidin resistance plasmid, pcDNA6-bsd 
(Invitrogen), was transfected into these cells and then selected for to establish blastocidin 
resistant J2-3T3 cells. These cells are irradiated and widely used to form monolayers of 
‘feeder cells’ to support NIKS cell growth. 
 
	2.2.1.2	Normal	Immortalised	Keratinocytes	(NIKS) 
NIKS are a cell line derived from spontaneously immortalised HPV-negative human foreskin 
keratinocytes. These cells are often used for experiments with HPV genomes. The cells 
originate from a neonatal foreskin cell line, BC-1-Ep, and spontaneously immortalised over 
serial passages (Allen-Hoffmann, Schlosser et al. 2000). 
Name Constituents 
LB Agar LB medium plus 2 % Bacto agar 
LB Media 1 % tryptone, 0.5 % yeast extract, 1 % NaCl 
50X TAE  242 g Tris base, 57.1 mL glacial acetic acid, 18.6 g EDTA 
PBS 1 % NaCl, 0.025 % KCl, 0.14 % Na2HPO, 0.025 % KH2PO4 
PBS EDTA PBS and 0.5mM EDTA 
FBS DMSO FBS and 5% DMSO 
Trypsin 0.8 % NaCl, 0.02 % KCl, 0.12 % Na2HPO4, 0.02 % KH2PO4, 
0.01% EDTA, 0.13 % trypsin, 0.001% phenol red. 
Blocking Buffer A 0.3 M Tris, 20% Methanol, 0.02% SDS 
Blocking Buffer B 25 mM Tris, 20% Methanol, 0.02% SDS 
Blocking Buffer C 25 mM Tris, 20% Methanol, 6-amino-caproic acid, 0.02% SDS 
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2.2.1.3	NIKS	containing	HPV16,	HPV11	or	MmuPV1	genomes	
NIKS were transfected with both recircularised replication competent HPV16 genomes 
(W12), HPV11 genomes, or MmuPV1 genomes, and a Blasticidin resistance gene contained 
within a pcDNA6 vector to allow for selection of successfully transfected cell lines. While a 
mouse cell line was considered for use with MmuPV1, NIKS cells were chosen to allow 
direct comparison across the different genomes in the available time-frame. Following the 
establishment of individual colonies, cells were expanded over time to make stocks. 
 
2.2.1.4	EF-1F	Human	Foreskin	Fibroblasts	
EF-IF foreskin cells have been maintained as a primary cell line, and were first isolated from 
human foreskin tissues. EF-IF cells have been utilised to create dermal equivalent in 
organotypic raft culture. 
 
2.2.1.5	293TT	cells	
HEK-293 cells were generated originally by treatment with sheared adenovirus type 5 DNA. 
This cell line was then treated with simian virus-40 DNA, which led to establishment of 293T 
cell lines. 293TT cells were generated by stable transfection of an SV40 Large T Antigen 
cDNA expression cassette in the 293T cells. These cells are widely used in the PV field for 







FI 375 mL F12-Hams (Gibco; UK), 125 mL high glucose DMEM 
(Gibco; UK). Supplements: 5 mL (100x stocks) of adenine, cholera 
toxin, hydrocortisone, insulin and pen/strep, 5 % (v/v) FBS 
FC 500 mL FI media with 500 µl 1000x EGF 
FC100 500 mL FI media with 5000 µl 1000x EGF 
FC500 500 mL FI media with 25000 µl 1000x EGF 
DMEM 500 mL DMEM (Sigma), 50 mL FBS and 5mL pen/strep 
Freeze media 45 mL FBS and 5mL DMSO 
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2.2.2.2	Supplements	
Media supplements were prepared as follows, with filtration sterilisation to minimise 
contamination risk. 
 
100x adenine – 121 mg of adenine (Sigma, UK) was dissolved in 25 ml of HCl (0.005M, 
247.4 µL concentrated HCl in 500 ml of water) 
100x cholera toxin – 1 mg of cholera toxin (Sigma, UK) was dissolved in 1.2 ml of sterile 
water to make up a 10 µM solution.  
Epidermal growth factor – 100 µg of EGF (R&D Systems, USA) was dissolved in 10 ml of 
sterile water. 90 ml of HBES containing 0.1% bovine serum albumin was added. Solution was 
filter sterilised and stored at -20°C. 
Foetal bovine serum – (labtech.com, UK) 
100x hydrocortisone – 25 mg of hydrocortisone (Calbiochem) was dissolved in 5 ml of cold 
100% ethanol to make a 5 ml/ml solution. 0.8 ml of this solution was added to 100 ml HBES 
and 5% (v,v) Foetal Bovine Serum (FBS) (Hyclone, UK). 
100x insulin – 12.5 mg of insulin (Sigma, UK) was dissolved in 25 ml of HCl (0.005M, 
247.4 µL concentrated HCl in 500 ml of water). Before adding to the insulin stock, 2 ml of 
FBS was passed through a 2 µm filter. 




JT-3T3 cells were seeded into a T-75 flask at 1x106 concentration in 10 ml of DMEM and 
stored at 37°C. Cells were passaged when they reached around 90% confluence. To harvest 
cells, media was first aspirated from the flask. Following this, cells were washed with 2 ml 
PBS and incubated in 1ml of trypsin at 37°C until cells detached in single cell suspension. To 
passage, trypsinised cells were resuspended in DMEM and from this suspension a new flask 
of J2-3T3 cells was cultured. Media was changed every two days. For long term storage at      
-80°C, cells were harvested, and spun down at 1500 rpm for five minutes using a benchtop 





NIKS were cultured in 10 ml of FC media on a monolayer of irradiated J2-3T3 feeder cells. 
J2-3T3 cells were irradiated for 14 minutes and 14 seconds (220kV, 14mA; resulting dosage 
was 60Gy). In routine experimentation, a monolayer of 1 x 106 irradiated J2-3T3 cells was 
seeded in a T-75 flask in 10 ml of DMEM or FC media and left for at least two hours to allow 
cell attachment. NIKS were cultured to around 80% before passage. To harvest the NIKS, 
media was aspirated and cells were washed in 2 ml PBS. Next, cells were incubated for five 
minutes in 0.5mM EDTA PBS at room temperature (RT) to detach feeder cells. Following 
aspiration of 0.5mM EDTA PBS, cells were washed twice in 2 ml of PBS. Finally, cells were 
incubated in 1.5 ml trypsin for 15 minutes to detach the NIKS in single cell suspension. Cells 
were then resuspended in 8.5 ml of FC media. Cells were reseeded at 1x106 concentration in 
10 ml of FC in a 75 ml flask seeded with irradiated J2-3T3 cells and stored at 37°C. FC media 
was changed every two days. For storage long term, cell suspension was spun down at 1500 
rpm for five minutes and resuspended in 500 µl freeze media at 4 x 106 concentrations.  
 
2.2.3.3	Cell	counting	of	NIKS	cell	lines	
Where necessary, all counting of cells was carried out with the Beckman Z1 coulter particle 
counter. To count the cells, 200 µl of each cell suspension was added to 9.8 ml of isoton (1:50 
dilution), which was counted. 
 
2.2.3.4	Monolayer	growth	assays	of	NIKS	cell	lines  
Growth assay experiments were carried out to assess the cell proliferation in culture over a 
period of nine days. Cells were counted in triplicate over the nine-day period. Around 1x105 
irradiated JT-3T3 cells were seeded into each well of a six-well plate in FI media and left to 
attach for at least two hours before seeding of 1x105 experimental or control NIKS cells into 
each well. Plates were left overnight at 37°C and on the following day media was changed to 
experimental media, which was changed every two days. To harvest cells for counting, each 
well was washed with 1 ml of PBS, after which cells were incubated in 1 ml of 0.5mM EDTA 
PBS to detach feeder cells. After this time, plates were tapped firmly to stimulate full 
detachment of feeders. Each well was washed twice with 1 ml of PBS and then 0.5 ml of 
trypsin was added to each well. Plates were then incubated at 37°C for at most 20 minutes, up 
until the cells had completely detached from the plate surface. To create single cell 
suspension for counting, 3.5 ml of FI media was added to each well and total volume of 
solution was pipetted up and down, before adding the contents of each well to a 15 ml falcon 
tube. Cells were counted as described above (2.2.3.3). 
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2.2.3.5	High-density	competition	assay		
For high-density competition assays, cells were seeded at a high density on 4 chamber 
polystyrene vessel tissue culture treated glass slides (Fisher Scientific, UK). To each chamber, 
4x104 irradiated J2-3T3 cells were added to provide a favourable growth environment. 
Immediately after this, 4x105 experimental cells were seeded at a 1:1 ratio of mCherry 
expressing cells versus EGFP expressing cells (2x105 cells of each group). Cells were cultured 
in FC media for up to 10 days. Media was changed the day after seeding and every other day. 
 
2.2.3.6	Genome	copy	number	monolayer	growth	assay 
T-25 flasks were seeded with PV-containing NIKS at a 3.3x105 concentration in 4 ml of 
media (FI media). The day on which cells are seeded was marked as day 0. Samples were 
collected on days one, two, three, four and seven. To collect samples, cells were handled as 
described above for NIKS cells, up to resuspension in FC media. Cell suspension was 
transferred to a 15 ml tube, spun down at 5,000 rpm for five minutes, washed in PBS and 
spun down. Pellet was resuspended in 200 µl PBS and frozen at -80°C. The media in 
remaining flasks was changed to experiment media concentration –FC, FC100 or FC500. 
Media in the flasks was changed every two days. To analyse samples, DNA extraction kit 
(Qiagen, UK) or DNA/RNA/Protein Minikit (Qiagen, UK) was used to extract DNA, then 
Syber green qPCR kit protocol followed). 
 
2.2.3.7	EF-1F	human	foreskin	fibroblasts		
EF-1F fibroblasts were grown in T-75 flasks in 10 ml of DMEM until around 80% confluent. 
To harvest, cells were gently washed in 2 ml of PBS. After removing PBS, cells were 
incubated at 37°C 5% CO2 in 1 ml of trypsin for 5-10 minutes. Following cells detachment 
from the flask, 9 ml of DMEM was added to the flask. The mixture was then transferred to a 
10 ml falcon tube. Mixture could be split between T-75 flasks for expansion of EF1Fs, or 
spun down at 2000 rpm for 5 minutes to stock. Cell pellet was resuspended in an appropriate 
volume of freeze media.  
 
2.2.3.8	293TT	cells	
293TT cells were grown in T-75 flasks in 10 ml of DMEM until around 90% confluent. To 
harvest, cells were carefully washed in 2 ml of PBS. After removing PBS, cells were 
incubated at 37°C 5% CO2 in 1 ml of trypsin for 5 minutes. Following cells detachment from 
the flask, 9 ml of DMEM was added to the flask. The cell suspension was then added to a 10 
ml falcon tube. Mixture was split between T-75 flasks for expansion of 293TTs or spun down 
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at 1500 rpm for 5 minutes to stock. Supernatant was removed and the cell pellet was 
resuspended in a volume of freeze media appropriate for the number of cells collected. 
 
2.2.3.9	Virus	infection	of	HaCaT	cells	
Wells of an 8-well slide chamber were coated with collagen prior to the seeding of cells. 
Collagen mix (as described in section 2.3.2), was diluted 1/1000 in DMEM. Diluted collagen 
mix was then left to solidify for 1 hour at RT prior to the seeding of cells. HaCaT cells were 
seeded at a density of 2 x 104 cells per well. Cells were cultured in DMEM for 24 hours prior 
to infection. Serial dilutions of virus genome equivalent (VGE)s were added to wells to 
calculate the approximate number of infectious units per VGE. VGE represents the estimated 
quantity of genomes to which plasmid DNA in a serially diluted sample compares. Media was 




Rafts were cultured in a level one containment hood, until collection of samples.  
 
2.3.1	MEDIA	AND	REAGENTS	FOR	RAFT	CULTURE	




Preparation of dermal equivalents was carried out entirely on ice, to ensure collagen did not 
solidify. First, 20 ml of rat-tail collagen was resuspended with 2.5 ml 10X DMEM, 460 µl 
10N NaOH, 250 µL of Pen/Strep (100x) and 2.5 ml FBS. Approximately 1 ml of this 
Media Components 
FI media 375 mL F12-Hams (Gibco; UK), 125 mL high glucose DMEM (Gibco; 
UK). Supplements: 5 mL (100x stocks) of adenine, cholera toxin, 
hydrocortisone, insulin and pen/strep, 5 % (v/v) FBS 
Cornification 
media 
500 ml FI media with 5% (v/v) FBS, 610 µl CaCl2 (final concentration 
1.88mM). Add fresh N 1,2-dioctanoyl-sn-glycerol (C8:0) (Sigma, UK) to a 
final concentration of 10 µM. 
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suspension was added to each individual transwell insert (Costar, UK), which was already 
placed within a deep 6-well plate (BD Biosciences; UK). This was left to solidify for 5 
minutes. EF-1F fibroblasts (600 µl of a 7.5 x 106 cells/ml suspension) were then added to the 
remaining collagen mixture, and once the 1 ml of collagen had set, 2.6 ml of this was added to 
the individual transwell inserts. The collagen was then left to harden for 30 minutes at 37°C 
5% CO2 until the dermal equivalent had solidified completely. Dermal equivalents were then 
left submerged in DMEM for 1-7 days. 
 
2.3.3	SEEDING	AND	DIFFERENTIATION	OF	KERATINOCYTE	CELL	LINES	
NIKS cells or NIKS cells exogenously expressing experimental proteins were trypsinised, 
counted and resuspended as described above. Cells were resuspended in FI media at 2 x 107 
concentration of cells/ml. Medium was removed from the inserts and 50 µl of the cell 
suspension (around 1 x 106 of cells) was added dropwise to the centre of each dermal 
equivalent. These inserts were left at 37°C 5% CO2 for 30 minutes to 2 hours to allow cells to 
properly attach to the dermal equivalent. After incubation, 12 ml of FI media was added to 
each well. These were left for 4 days at 37°C 5% CO2 and media was changed every other 
day. On the fourth day, the rafts were lifted. Medium was aspirated from each deep well and 
sterile cotton pads were placed under each insert to allow an air-liquid interface to be 
established. Raft cultures were subsequently fed with 12 ml of cornification medium from 
below, which was changed every other day, until harvesting. Rafts were cultured in this 
manner to allow differentiation for up to 12 days after lifting.  
 
2.3.4	HARVESTING	AND	FIXATION	OF	RAFT	SAMPLES	
Following differentiation, rafts were removed from their transwells for fixation by cutting off 
the base of the transwell using a scalpel blade. The raft was then immediately placed into a 
plastic vial containing 10 ml of 4% PFA. Rafts were fixed for 24 hours at 4°C, after which the 
raft was placed in PBS until sectioning. For longer periods between fixation and sectioning, 
rafts were placed in 70% ethanol. 
 
2.3.5	SECTIONING	OF	RAFT	SAMPLES	
Rafts were paraffin embedded by the Addenbrooke’s Hospital Tissue Bank facility. Paraffin 





Immunodeficient athymic Hsd:AthymicNude-Foxn1nu mice (purchased from Envigo, UK) 
and Female C57BL/6J immunocompetent mice (purchased from Charles River, Kent) were 
maintained under specific pathogen free (SPF) conditions in the Animal House, Department 
of Pathology, University of Cambridge. All mice were housed in aseptic micro-isolator cages 
in a category two facility. Animals housed and cared for in the Animal Facility and were 
handled with appropriate personal protection equipment. Mice used were between 8 and 12 
weeks of age. All procedures were performed in accordance with the Animals Scientific 
Procedures Act (1986) and licensed by the United Kingdom Home Office. 
 
2.4.2	VIRUS	PREPARATION	
Mature papillomas were harvested from the tail of a mouse and disrupted in phosphate 
buffered saline by homogenisation using an electric rotor stator homogeniser. Cellular debris 
was then removed by centrifugation at 8000 x g for 10 minutes, leaving the virus particles in 
the supernatant. To pellet virus particles, resulting supernatant was ultra-centrifuged in a 
swinging bucket rotor at 130,000 x g. The virus pellet was then resuspended in 10% FBS, and 
crude virus stocks were stored at -80°C. VGE was estimated by visualising infected HaCaT 
cells by detecting E6/E7 MmuPV1 transcripts using RNAscope in situ hybridisation. The 
infectious titre was then estimated using Reed-Muench method (Reed and Muench 1938).  
 
2.4.3	SCARIFICATION	AND	VIRUS	INFECTION	
In vivo infection was carried out by scarification of multiple sites along the tail with a 27-
gauge needle whilst mice were anesthetised, followed by inoculation with 4 µl of MmuPV1 
virus supernatant. MmuPV1 virus supernatant was applied to the tail by pipette. Mock 
infections were carried out as described with PBS. Tails were harvested and fixed overnight 
in 4% paraformaldehyde and then stored in PBS until embedding.  
 
2.4.4	INCORPORATION	OF	BROMODEOXYURIDINE	
Incorporation of Bromodeoxyuridine (BrdU) was analysed to assess replicating cell DNA in 
tissue. Mice were injected with 200 µl of 10 mg/ml BrdU solution (Sigma Aldrich, UK). 
Tissue was harvested 24 hours later. 
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2.4.5	MARKING	OF	THE	WOUND	SITE	
To attempt marking of the wound site, 4 µl of Carboxylate-Modified Microspheres 
(ThermoFisher Scientific, UK) was applied to the wound site and allowed to dry for five 
minutes. Alternatively, 4 µl of EZ-Link™ Sulfo-NHS-LC-Biotin (ThermoFisher Scientific, 
UK) was applied to the site and allowed to dry. When using the EZ-Link™ Sulfo-NHS-LC-
Biotin in combination with virus infection, the product was added after the inoculation of 
virus to the wound site as described above in 2.4.3. 
 
2.4.6	DISSECTION	OF	TISSUES	FOR	HISTOLOGY	
Mice were killed by cervical dislocation. Tissue samples such as lesions or entire tails were 
removed using sharp scissors. Tissue was immediately inserted into 4% PFA for around 24 
hours. Tissues were placed in 70% ethanol after fixation until processing. 
 
2.4.7	PROCESSING	OF	TISSUES	FOR	HISTOLOGY	
Tails were cut from end to end using a sharp scalpel blade on the opposite side to the infected 
sites. Skin was then carefully stripped away from the bone using a scalpel and forceps. 
Wound sites were cut transversely across the middle of the wound site. These small strips of 
skin were then placed into a plastic cassette between two pieces of foam, with the wound site 
edge facing to the right. Tissues were then processed using a Thermo Scientific Shandon 
Excelsior Tissue Processor on an overnight programme from neutral buffered formalin (10%, 
1 hour) through six absolute alcohols (99%, 45mins, 1hr, 1h15min, 1h15min, 1h15min, 
1h30min) to xylene (3 solutions; 1hr, 1h15min, 1h30min) to molten paraffin wax (3 solutions; 
1h, 1h15min and 1h30min).  
 
2.4.8	EMBEDDING	TISSUES	IN	PARAFFIN	
Embedding was performed on a Leica EG1160 embedding centre either by Helen Skelton, a 
histologist based at the Department of Pathology, or by an Addenbrooke’s Hospital Tissue 
Bank histologist. Molten wax was poured into inox moulds and mouse tail samples were 
orientated to provide a transverse section of the tail tissue. Wax was allowed to harden around 






Sections of 5µm thickness were cut using a microtome, floated onto water at 45°C to smooth 
out any creases and a glass slide was then placed underneath to allow adherence of the 
paraffin section to the slide as the section was lifted from the water. Slides were then allowed 
to dry out in an oven at 37°C. Sections were cut and mounted at the Human Research Tissue 
Bank, by a Research Support Biomedical Scientist. Slides were incubated at 37°C overnight 









Plasmids for the construction of expression vectors used were as follows: 
Table	2.5	Construction	plasmids	
Further details can be seen in the Appendix (Chapter 8.0). 
 
 
HPV Type Size 
(bp) 
Vector and size 
(bp) 
Restriction enzyme  Provided by 
HPV11 7931 pBR322 (4361) BamHI, Buffer 3.1 (NEB) Neil Christensen 
HPV16 7906 pTZH (4922)  BamHI, Buffer 3.1 (NEB) Margaret Stanley 
MmuPV1 7857 pAsylum (878) Xba1 Buffer 2.1 (NEB) Neil Christensen 
Vector  Size (bp) Provider 
pLXSN  7931 Clontech (631509) 




12352 Addgene (86849). Gift from Kevin Brindle & Duncan Jodrell 
(http://n2t.net/addgene:86849; RRID: Addgene_86849).  
(Koh, Mascalchi et al. 2017) 
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2.5.2	TRANSFECTION	OF	PV	GENOMES	INTO	NIKS 
For transfection of genomes, NIKS were harvested and plated in 60mm 6-well plates on a 
layer of 1x105 J2-3T3 irradiated feeder cells at a density of 2x105 cells per well. Cells were 
then cultured overnight in FI media. Transfections were carried out using the FuGENE® HD 
Transfection Reagent (Promega; E2311) using the protocol provided. Cells were transfected 
with up to a total of 1.6µg of circular DNA, purified from bacterial cultures, alongside 0.4µg 
of a circular blasticidin resistance plasmid for selection. Cells were passaged to T-75 flasks 24 
hours after transfection and cultured overnight in FI media. A further 24 hours following 
passage to the T-75 flasks, selection was started, with cell media being changed to FC media 
with 6µg/ml blasticidin. Media was replaced 48 hours later. Finally, culture medium was 
changed to FC a further 48 hours afterwards, completing the transfection procedure. 
 
2.5.3	TRANSFECTION	OF	EXOGENOUS	EXPRESSION	VECTORS	INTO	293TT	CELLS	
Production and subsequent infection of recombinant retroviruses was carried out as described 
previously (Naviaux, Costanzi et al. 1996). One day prior to transfection, 293TT cells were 
seeded at 5x105 in a 6 well plate. The following day, 2 µg of maxiprepped plasmid DNA was 
made up to a total volume 100 µl in opti-MEM™. To check transfection efficiency, 1.5 µg of 
plasmid along with 500 ng of an EGFP plasmid were used. In a separate Eppendorf, 6 µl of  
Polyethyleneimine (PEI) was added to 94 µl of opti- MEM™. DNA and PEI mixtures were 
mixed together and incubated for 30 minutes at RT. During this incubation, media on 293TT 
cells was changed to fresh DMEM. DNA-PEI mixture was added dropwise to the well and 
incubated for 24 hours at 37°C 5% CO2. Media was changed after 24 hours. Upon confluence, 
293TT cells were collected, or media was collected and filtered for virus. Cell suspension was 
spun down at 1500 rpm, washed with 2 ml of PBS, and spun down a second time at 1500 
rpm. After a final wash in 2 ml of PBS, cells were spun down at 1500 rpm and then 
resuspended in RIPA buffer. Pellets were stored at -20°C until protein extraction. 
 
2.5.4	VIRAL	TRANSDUCTION	
NIKS cells were seeded one day in advance of transduction on a bed of γ-irradiated J2-3T3 
feeder cells. Transduction was carried out by incubation with retrovirus for 2-6 hours with 
4µg/ml of Polybrene (SantaCruz, Texas). Cells were selected in G418 400 ng/µl for 48 hours 
and expanded through two passages before use in experiments. Expression was confirmed by 
transient transfection in 293TT cells. 	
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2.5.5	BACTERIAL	TRANSFORMATION 
Plasmid DNA was transformed into chemically competent cell line One Shot® TOP10 E. coli 
or One Shot® Stbl3™ Chemically Competent E. coli (ThermoFisher Scientific, UK). 
Manufacturers protocol was followed and the transformed bacterial culture was plated out 
onto LB agar plates with appropriate selection; ampicillin (100 µg/ml), kanamycin (50 
µg/ml). Plates were left at 37°C overnight for around 16 hours to allow growth. 
 
2.5.6	BACTERIAL	PLASMID	DNA	EXTRACTION	
Before extraction of plasmid DNA from successful colonies, single colonies were isolated 
using a pipette tip, which was then added to a tube containing 2-3 ml of LB broth (100 µg/ml 
ampicillin). Cultures were shaken at 220 rpm at 37°C overnight for around 16 hours. 
Extraction of plasmid DNA from culture was carried out using a Qiagen spin mini-prep kit 
(Qiagen, UK) with 1.5 ml of the expanded culture. DNA extraction and elution was carried 
out following the manufacturer protocol and supplied buffers. For large-scale DNA 
extraction, 250 µl of the expanded culture was added to 250 ml of LB broth containing 100 
µg/ml ampicillin, which was then cultured overnight at 37°C with shaking at 220 rpm. 
Plasmid DNA from resulting expanded culture was extracted with the EndoFree plasmid maxi 
kit (Qiagen; UK, manufacturer protocol and supplied reagents used). 
 
2.5.7	EXTRACTION	OF	GENOMIC	DNA	FROM	HPV16	NIKS 
To prepare cells for DNA extraction from cell culture, cells were pelleted by centrifuge (1500 
rpm for five minutes), resuspended in 500 µl PBS and then pelleted again using a 
microcentrifuge (1500 rpm for five minutes). Cell pellets were put on ice immediately and 
stored at -80°C until extraction of DNA. Extraction of total genomic DNA was carried out 
using QIAamp DNA Blood Mini kit (Qiagen; UK). The complete set of buffers and reagents 
required were provided within the kit.  
 
2.5.8	EXTRACTION	OF	GENOMIC	DNA,	RNA	AND	PROTEIN	 
To simultaneously extract total DNA, RNA and protein, cells were harvested, washed in PBS, 
and stored as a pellet at -20°C. Extraction of DNA, RNA and protein was carried out using an 
AllPrep DNA/RNA/Protein Mini Kit (Qiagen) and QIAshredder® kit (Qiagen) according to 
the protocol provided. RNA was stored at -80°C in 2µg aliquots. DNA and protein samples 
were stored at -20°C. 
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2.5.9	QUANTIFICATION	OF	PLASMID	DNA	AND	RNA	
Plasmid DNA and RNA was quantified using a Nanodrop 8000 spectrophotometer.  
 
2.5.10	REVERSE	TRANSCRIPTION 
To synthesis cDNA, reverse transcription of RNA was carried out using the SuperScript™ III 
First-Strand Synthesis Kit (Life Technologies). A volume of approximately 1µg of extracted 
RNA was added to two tubes, each containing 2 µl of dNTP mix and 2 µl of oligo(dT)20 
primers. These volumes were then made up to 20 µl using DEPC-treated water. Mixtures 
were incubated for five minutes at 65°C in a four-bay DNA Engine Tetrad 2 Peltier Thermal 
Cycler (Bio-Rad, USA), and then placed on ice for a minimum of one minute. Following this, 
a master mix was added to each tube, the components of which are described in Table 2.6. To 
the first tube, 2 µl of SuperScript™ III reverse transcriptase was added, while 2 µl of DEPC-
treated water was added to the subsequent tube to act as an internal control. Tubes were then 
incubated for one hour at 50°C, and then incubated for five minutes at 85°C to terminate the 
reaction. Following this, samples were chilled on ice before collecting the reactions by brief 
centrifugation. Next, 2 µl of RNAse H was added to each reaction and incubated at 37°C for 











Quantitative real-time polymerase chain reaction (qPCR) was carried out to analyse RNA 
samples utilising cDNA as a template for the reaction. To assess levels of transcripts, forward 
and reverse primers (Table 2.7) were used (Griffin, H, 2016). GAPDH primers were used as 
endogenous controls. The qPCR technique was also employed to allow quantification of PV 
genome copy number per cell by quantifying both PV genome copy number and GAPDH 
copy number. GAPDH was used as an internal housekeeping gene to quantify the number of 
cells. Forward and reverse primers for both the PV DNA and GAPDH were designed to target  
cDNA Synthesis Mix (per reaction) 
10X RT Buffer  4 µL  
25mM MgCl2 8 µL 
0.1M DTT 4 µL 
RNaseOUT™ (40 U/µL) 2 µL 
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these sequences. The GAPDH region chosen for amplification was selected based on it being 
the region with the lowest level of homology to mouse GAPDH DNA. This was to minimize 
any readout interference as a result of mouse J2-3T3 fibroblast contamination in the sample. 
Amplification of DNA in the reaction was achieved using a SyberGreen ROX mix reagent 
containing a hot start DNA polymerase. Samples were run in the reaction in triplicate for each 
primer set in 96 well plates (ABgene, UK) and an ABI 7000 sequence detector system was 





Primers used for qPCR 
HPV16 E5 (cDNA) Forward: TGTGCTTTTGTGTGTCTGCC 
Reverse: AAACACCTAAACGCAGAGGCT 
HPV16 E6FL (cDNA) Forward: TGGGAATCCATATGCTGTATGTGA 
Reverse: ACGGTTTGTTGTATTGCTGTTCT 
HPV16 E6T (cDNA) Forward: CAGGAGCGACCCAGAAAGTT 
Reverse: CTGTTGCTTGCAGTACACACA 
HPV16 E1 (cDNA) Forward: GGGTGGTTGCAGTCAGTACA 
Reverse: TGCTAACATTGCTGCCTTTG 
HPV16 E7 (cDNA) Forward: CATGGAGATACACCTACATTGC 
Reverse: AGATCAGTTGTCTCTGGTTGCA 
GAPDH (cDNA) Forward: GATTTGGTCGTATTGGGCGC 
Reverse: TTCCCGTTCTCAGCCTTGAC 
HPV-16 E4 Forward: GACTATCCAGCGACCAAGATCAG 
Reverse: CTGAGTCTCTGTGCAACAACTTAGTG 
GAPDH Forward: CCTCCCGCTTCGCTCTCT 
Reverse: CTGGCGACGCAAAAGAAGA 
HPV-11 Forward: ATCTCGATTTTTGCACGCGCCGTTTGTGT 
Reverse: ATAGATCTCACAACTTAGTCACTGGGTGTAAC 
MmuPV1 E6 Forward: GGTGCTTGTATTGTGTGCCGC 
Reverse: TGCCAGCCATGCACTCTACC 




Power SYBR® Green Blue PCR Master-Mix (ThermoFisher Scientific, AB4163A) was used 
to amplify and detect cDNA or DNA in 364-well PCR plates (ThermoFisher Scientific, 
4309849) using an ABI-7500 Real-Time PCR System. Before loading the plate, a new 
reagent master mix was prepared for each set of primers used. The final volume in each well 
was 10 µl, and each sample was plated in triplicate. A master mix of reagents was made up 
each time the experiment was carried out. Primers were first diluted to 1µM working stocks in 
sterile H2O. Total volume of master mix made depended on the number of reactions being 
analysed. After mixing, 32 µl per reaction was added to 2 µl of DNA, which was tapped well 








Plating of samples was carried out in triplicate to ensure statistically significant data 
collection. Following the qPCR cycles, running of a dissociation programme was also carried 









qPCR mix (per reaction) 
Primer mix  3.2 µl 
SYBR Green 16 µl 














Step Number of cycles Time per cycle Temperature 
1 1 2 minutes 50°C 
2 1 15 minutes 95°C 
3 45 15 seconds 95°C 













s Step Number of cycles Time per cycle Temperature 
1 1 15 seconds 95°C 
2 1 20 seconds 60°C 
3 1 95 seconds 95°C 
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2.5.15	QPCR	STANDARD	CURVES	AND	CALCULATIONS	
For each experiment and each primer set, a standard curve using known quantities of 
sequence-containing construct was generated. For genome quantification, six ten-fold serial 
dilutions of a vector containing the appropriate PV sequence were plated out using methods 
described above in triplicate. To generate a standard equation to determine the number of 
copies of HPV present in each reaction, concentrations of serially diluted DNA were 
converted into their corresponding copy numbers. For GAPDH quantification, six ten-fold 
serial dilutions of a pDrive vector containing the GAPDH ORF were plated out using 
methods described above in triplicate. Where standard curves were not produced, set standard 
curves were applied to the data, and these were as follows: 
 
HPV16: y = -3.332x + 32.335 
GAPDH: y = -3.4x + 30.339 
HPV11: y = -3.269 + 28.787 
MmuPV1: y = -3.167 + 29.019 
 
These equations fit the format of y=mx + c, a linear equation. In this equation, y represented 
the number of cycles taken to amplify one copy DNA. The value m represented was the 
efficiency of the primer sets; -3.33 is considered a perfect linear relationship between the 
cycle threshold (Ct) value and the DNA copy number. This equation was utilised to establish 
the total copies of virus genome and GAPDH in each reaction. Each triplicate (Ct) of values 
was averaged. If y=mx+b where y is the Ct value, m is the slope, x is the unknown, and b is 
the y intercept, solving for ln-1x should give the total number of copies within a reaction. The 
GAPDH value was initially divided by four; this would give the total number of cells in each 
reaction because as well as the two existing sequences, the NIKS genome was found to 
contain two GAPDH pseudogenes. Following this, the Ct value for the virus genome can be 
divided by the number of cells to finally give genome copy number per cell. 	
	
2.5.16	SITE	DIRECTED	MUTAGENESIS 
Inverse PCR mutagenesis was used to insert additional bases into a known vector to build a 
new construct. Or, to introduce a protein tag to the protein of interest. Primers were designed 
to correspond to area of interest in the construct, with additional sequence at the ends of the 
sequence to allow addition of two restriction enzyme sites or the protein tag. 
























After the final cycle, temperature was decreased to 4°C and held to complete. The provided 













     CATACGATGTTCCAGATTACGCTgaaatcggcaaaggctacactctcg 










PCR Reaction mixture 
PCR grade water 35 µL 
2mM dNTPs 5 µL 
Primer A 1.5 µL 
Primer B 1.5 µL 
Plasmid template DNA (50 ng/µl) 1 µL 













s Step Number of cycles Time per cycle Temperature 
1 1 2 minutes 94°C 
2 1 10 seconds 98°C 
3 45 13 minutes 68°C 
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2.5.17	GATEWAY	CLONING	TECHNOLOGY	SYSTEM	FOR	VECTOR	CONSTRUCTION	
A gateway cloning kit (ThermoFisher) was used to establish exogenous expression vectors. 
Following PCR amplification of the desired entry sequence, LR reactions were carried out 
according to manufacturer’s protocols. Reactions were transformed into competent E. coli as 
described above. Following selection and DNA extraction of the donor reaction, BP reactions 
were carried out according to manufacturer’s instructions. Reactions were then transformed 
into competent E. coli and selected once again, before DNA extraction for experimentation. 
 
2.5.18	AGAROSE	GEL	ELECTROPHORESIS	
TAE buffer (1X) was made up using water and TAE (50X). One gram of agarose powder was 
measured out using a Sartorius scale set and powder was then added to 100 ml of TAE buffer 
(1% agarose gel). The solution was microwaved at 70W with periodic swilling of mixture 
until powder completely dissolved. The gel was left to cool until the temperature was low 
enough to add to the gel tank and was then allowed to set. Gels were cast and run at a constant 
voltage of 100V using a Mupid-One Submarine gel electrophoresis system. For staining, the 
gel was added to TAE buffer containing SybrSafe (1 µl SybrSafe added per 10 ml solution). 
Gels were visualised using UV. 
 
2.5.19	DNA	EXTRACTION	FROM	AGAROSE	GEL	
DNA was extracted from agarose gel using a Wizard SV Gel and PCR Clean-Up system 




To collect monolayer keratinocytes to carry out immunocytology, cells were seeded on a bed 
of irradiated J2-3T3 feeder cells (1x104 cells per well) at a density of 1x104 per well in a four-
chamber culture slide (Falcon, 354104). Cells were cultured for three and seven days to 
provide pre and post-confluent samples. To overcome cell density variation due to plating 
error, cells were plated in quadruplet at serially increasing densities in 8 well slide chambers 
(Thermofisher, UK). Cells were plated at 1x104 cells per well or 8x104 cells per well. These 
cells were then grown for two days, with a media change after 24 hours. After this time, 




Cells were fixed with 5% paraformaldehyde for 30 minutes at RT. Growth medium was first 
aspirated from the wells, and cells were washed twice with PBS. Following incubation in 
PFA, cells were washed three more times with PBS and stored at 4°C in PBS. 
 
	2.6.1.2	Immunocytology	and	mounting	monolayer	slides	
All steps were carried out at RT. The PBS solution was aspirated from each well. For 
permeabilisation, cells were incubated for 30 minutes in PBS added 0.2% Triton X-100 
(Promega), then washed in PBS. All cells were blocked in 10% normal goat serum (NGS) 
(Cell Signalling Technology) in PBS for one hour. For K10 staining, anti-keratin 10 antibody 
DE-K10 (Neomarkers, mouse monoclonal antibody) diluted in 10% NGS in PBS at a 1:250 
dilution was applied to the slides and left for one hour. Next, slides were washed in PBS three 
times. An anti-mouse Alexa 488-conjugated secondary antibody (1:150 dilution in 10% NGS 
in PBS) was used to detect the primary antibody; the secondary antibody was left for one 
hour. DAPI was added alongside the secondary antibody at a 1:1000 dilution as a nuclear 
counterstain. Subsequently, the slides were rinsed three times in PBS then dried gently. 
Finally, a drop of Citifluor® reagent was added to each well space and a coverslip was placed 


















Antibody Target Species Clone Dilution Incubation Supplier 
Primary K10 Mouse DE-K10 1:100 16 hr. RT Neomarkers 





Target Species Clone Dilution Incubation Supplier 
K10 Mouse DE-K10 1:100 o/n 4°C ThermoFisher 
K17 Rabbit ab53707 1:100 o/n 4°C Abcam 
Tenascin C Rabbit ab108930 1:100 o/n 4°C Abcam 
BrdU Rat ab6326 1:200 o/n 4°C Abcam 
HES-1 Rabbit D6P2U 1:100 o/n 4°C Cell Signaling 
H3 ps10 Rabbit 06-570 1:500 o/n 4°C Merck 
E4 Rabbit MusE4 1:200 o/n 4°C In house 
L1 Rabbit MusL1 1:200 o/n 4°C In house 
Involucrin Rabbit sc-28557 1:100 o/n 4°C Santa Cruz 










1:200 1 hr RT ThermoFisher 
Anti-Rat Goat ab150160 1:1000 1 hr RT Abcam 
Biotin n/a S11227 1:200 1 hr RT ThermoFisher 
DAPI n/a n/a 
1:1000 / 5% 
NGS 
1 hr. Sigma 
Tyramide n/a n/a 
1:200 Amp. 
diluent 
10 minutes Perkin Elmer 











To carry out immunohistochemical analysis on mouse tissue or raft samples, samples 
embedded in paraffin went through a process of dewaxing and rehydration. To dewax the 
section, slides were submerged into a container of xylene for 10 minutes, with occasional 
agitation. They were then placed into a second container of xylene for a further 5 minutes. 
After the removal of wax, rehydration of tissue sections was achieved by submerging the 
slides in graded alcohols for 2 minutes at a time (twice in 100% ethanol, followed by once in 
80%, 50% and 30% ethanol). Slides were then submerged in dH2O for at least 5 minutes. A 
bench top oven was then used to carry out the step of epitope exposure. Slides were incubated 
in DAKO Target Retrieval Reagent (Aligent, USA) for 10 minutes at RT, before being heated 
to 110°C for 15 minutes in a Decloaking Chamber (Biocare Medical, USA). The sections 
were then allowed to cool to below 90°C before the pressure cooker was opened. This process 
took around 1 hour to complete.  
 
2.6.2.3	Application	of	primary	and	secondary	antibodies	to	tissue	sections.		
Immediately following epitope exposure, slides were incubated in PBS for 5 minutes. 
Sections were then blocked in 10% normal goat serum (NGS) (v/v) in PBS for at least 20 
minutes in a humidity chamber at RT. Following the blocking step, primary antibodies were 
diluted in 10% NGS and applied to the sections overnight at 4°C. Primary antibodies were 
removed by washing in PBS for five minutes three times at RT. Secondary antibodies diluted 
in 10% NGS were applied to the sections for 1 hour at RT. In addition to the secondary 
antibody, DAPI was also applied to slides at this time at a 1/1000 dilution. Secondary 
antibodies were removed by washing in PBS for five minutes three times at RT. Detailed 
information for antibodies are described in Table 2.14.  
 
2.6.2.4	Primary	antibody	amplification	
For some antibodies, amplification of the signal was required. In this case, instead of applying 
an Alexa conjugated secondary, Vector labs amplification reagents described in Table 2.14 
were applied to the section following washing. Slides were incubated for 1 hour in a humidity 
chamber at RT. Following removal of the Impress reagent by washing as described above, 
tyramide (diluted 1/1000 in amplification diluent) was applied to each section and incubated 
for 10 minutes in a humidity chamber at RT. The slides were washed again as described 
above before incubating with 1/1000 DAPI for at least 20 minutes. After a final wash step 




To examine pathology of raft cultures and tissue sections, staining with haematoxylin and 
eosin (H&E) reagents was carried out by the Addenbrooke’s Hospital Tissue Bank facility.  
 
2.6.2.6	Mounting	tissue	sample	coverslips	for	microscopy	
To prepare samples for microscopic analysis, coverslips were mounted onto the slides. Drops 
of Citifluor® reagent were applied to each section and a coverslip was carefully placed on top. 
Light pressure was applied to remove excess reagent and sections were then kept in the dark 
at 4°C for future analysis. Negative control stains can be seen below in Figure 2.1. 
 
2.6.3	RNASCOPE	IN	SITU	HYBRIDISATION	
The RNAscope 2.5 HD BROWN assay (Advanced Cell Diagnostics, USA) was carried out 
according to the manufacturer’s instructions until visualisation of amplified probes at the step 
titled “Detect the Signal”. At this stage, visualisation was achieved with fluorescein instead of 
dab as described in the RNAscope® Fluorescent Multiplex Kit User Manual. This was to 
allow fluorescent immunofluorescent (IF) staining with other molecules of interest. To detect 
MmuPV1 E6/E7 RNA, the probe used was MusPV-E6-E7 (Cat No. 409771). A probe directly 
targeting E6 RNA only was designed in collaboration with Advanced Cell Diagnostics (Cat 
No. 521071). To detect HES1 RNA, the probe used was Mm-Hes1-C2 (Cat No. 417701-C2). 
More details can be seen in the ACD Target Probe catalogue. Control stains can be seen 
below in Figure 2.1. 
 
2.7	MICROSCOPY	AND	IMAGING	SOFTWARE	
For analysis of H&E stained tissue, samples were scanned using a Panoramic MIDI II (3D 
Histech, Hungary) following manufacturer’s instructions. Images could then be exported as 
digital files for further analysis. For imaging, fluorescently stained cells and tissues were 
viewed with a Zeiss A1 microscope equipped with fluorescent filters. A Carl Zeiss 
Microscopy AxioCam MRm camera was used for image capture and images were viewed 
using Axiovision software. Confocal images were obtained with a LSM 700 confocal 
microscope (Zeiss). Acquisition of z-stacks was carried out at X63 magnification. All image 






Figure 2.1 Negative control staining for antibody-based immunofluorescence and 
RNAscope experiments 
A. Antibody-based immunofluorescence negative control stains. No primary antibody was 
added to mouse tail tissue, and slides were then incubated with the secondary antibodies only. 
Three panels show representative images selected to indicate a lack of tissue autofluorescence 
or false positive signal from the secondary antibodies. Control staining was carried out as 
described in Section 2.6.2. Scale bar: 100 µm. B. RNAscope negative and positive control 
stains. ACD positive control probe Mm Ppib (Cat No. 313911) and negative control probe 






Cells were grown in appropriate media and collected at desired time point. To collect the 
cells, RIPA buffer was added directly to cells and agitated to detach cells from the surface. 
Cells were then pelleted by centrifugation at 2000 rpm and washed twice in PBS before 
resuspending in 100 µl of lysis buffer. Samples were stored at -20°C until use, or used straight 
away. Samples were defrosted on ice and pipetted up and down to break cells apart. Samples 
were then sonicated for ten minutes and spun down at 14,000 rpm for 10 minutes at 4°C. The 
soluble supernatant was then stored at -20°C for subsequent analysis.  
 
2.8.2	IMMUNOPRECIPITATION	
Immunoprecipitation protocol was carried out on ice. Protein was resuspended in 1 ml of 
buffer and then sonicated for 10 min. Protein suspension was run through a syringe several 
times and then spun down at 4°C at max speed (14,800 rpm) for ten minutes. During spin 
down, 150 µl of either HA or FLAG bead mix was made up to 1 ml in buffer and inverted 
many times to mix. Solution was spun down at 4°C at 3000 rpm for 2 mins. This wash was 
repeated three times. Bead mix was then applied to eppendorfs at appropriate volumes (e.g. 
for three samples, beads were resuspended in 1 ml and split 300 µl per Eppendorf to ensure 
bead suspension was consistent across samples). Bead suspension was spun down at 4°C at 
3000 rpm for 2 mins and the resulting supernatant removed. Then 40 µl of each protein 
sample supernatant was set aside to act as input (Whole Cell Extract) (stored at -20°C). The 
remainder of the protein lysate was added to the beads. Samples were then placed in a tube 
rotator at 4°C for four hours to allow binding. Samples were then spun down, and washed 5 
times with buffer after removal of supernatant. Final wash supernatant was removed, and the 
beads were resuspended in 20 µl of buffer. Samples could then be used in normal western blot 
protocols as described below.  
  
2.8.3	PROTEIN	QUANTIFICATION		
Quantification of protein samples was carried out using Pierce BCA assay kit (Thermo 





Prior to running on a gel, proteins were denatured. To each sample, the appropriate volume of 
4X buffer and b-Mercaptoethanol (must make up 2.5% of total volume) was added and mixed 
well by flicking. Samples were then boiled for ten minutes at 80°C. For immunoprecipitation, 
20 µl of the corresponding input was added to 10 µl 4X buffer 0.25 µl of b-Mercaptoethanol 
and boiled at 80°C for 10 minutes at the same time as the immunoprecipitated sample. After 
cooling, soluble proteins were separated using 4–12% gradient polyacrylamide-SDS-Tris-
Tricine denaturing gel (Invitrogen, USA). Gels were submerged in 500 ml SDS running 
buffer in a Bio-Rad gel tank. Protein separation was carried out at 60mA for 50 to 80 minutes 
depending on the size of the protein. 
 
2.8.5	MEMBRANE	TRANSFER	OF	GELS	FOR	WESTERN	BLOT		
Polyacrylamide gels were transferred onto PDVF membranes (Bio-Rad, USA). Buffers used 
in membrane transfers are described in Table 2.1. Membrane was submerged in methanol for 
ten minutes and then transferred to buffer C. Paper was submerged in each of buffers A, B 
and C. Gel was incubated in buffer C for ten minutes. Membrane transfer was carried out 
using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad, USA). Two pieces of buffer A 
paper were placed, followed by one buffer B. On top of this the membrane was placed, and 
the gel was placed on top of the membrane. Finally, two pieces of buffer C paper were placed 
on top of the gel. Transfer was carried out at 120mA for 45 minutes. 
 
2.8.6	BLOCKING	AND	ANTIBODY	INCUBATION	OF	WESTERN	BLOTS		
Membranes were incubated in 1% milk/PBS Tween-0.01% (v/v) for one hour at RT after 
transfer. Membranes were then cut if necessary to allow probing with multiple antibodies. 
Membranes were next incubated with primary antibodies diluted in 1% milk/PBS Tween-
0.01% at 4°C overnight. Antibodies used in Western Blotting are detailed in Table 2.15. 
Membranes were washed 3 times for five minutes in PBS Tween-0.01% following overnight 
incubation. They were then incubated with the appropriate secondary antibody for one hour at 
RT. Secondary antibodies were diluted in 1% milk/PBS Tween-0.01% at 1:5000. After 
incubation, membranes were washed 5 times for 5 minutes before being allowed to dry 












Cells were sorted for fluorescent intensity with a BD Aria Fusion sorter. A 488nm laser was 
used to detect GFP positive cells in the 530/30nm channel. A 561nm laser was used to detect 
mCherry positive cells in the 610/20nm channel. Cells were sorted into four quartiles based 
on fluorescent intensity, and the highest expressing cells were used in the subsequent colour 
competition assays.  
 
2.9.2	FLOW	CYTOMETRY	
For analysis of the Fucci expressing NIKS cells, different densities of cells were seeded in 6-
well plates (1x105, 4x105 and 8x105 cells) on a bed of irradiated feeder cells (5x104). After 24 
hours following seeding, media was changed and cells were then collected after a further 48 
hours. To collect, samples were washed with 1 ml sterile PBS two times. Feeder cells were 
then removed by incubation with trypsin at 37°C 5% CO2 for 2 minutes. Trypsin was then 
replaced with 1 ml of trypsin-EDTA and remaining cells were incubated for up to 20 minutes 
at 37°C 5% CO2. Detached cells were neutralised by adding 2 ml of FC medium. Cells were 
then pelleted by centrifugation at 1500 rpm for 5 minutes at 4°C. Supernatant was then 
aspirated, and cell pellets were suspended in 1 ml of FACS running buffer (2% FBS and 
Primary Antibodies for Western Blots 
Target Clone Dilution Supplier 
HA ab130275 1:1000 Abcam 
FLAG M2 1:200 Sigma 
MAML1 D3E9 1:500 Cell Signaling 
SMAD2 D43B4 1:1000 Cell Signaling 
SMAD3 C67H9 1:1000 Cell Signaling 
GAPDH MAB374 1:2000 Millipore 
 60	
0.5mM EDTA in PBS). Samples were kept on ice until analysis was carried out. Prior to 
FACS analysis, cell suspensions were filtered through a 70mm cell strainer (Corning, USA) 
to maximise removal of doublet cells. Flow cytometry was carried out using a Cytek® DxP8 
machine. For the mAG signal, the filter setting used was F 530/30. For Mko2 signal the 
setting used was 615/25. For detection of AlexaFluor 647/DRAQ5, the filter setting used was 





To quantify RNAscope E6/E7 expression, an equation was generated to evaluate the pixels 
within each individual cell (region of interest). The intensity of green fluorescence per pixel is 
represented as a numerical value ranging from 0 (black) to 255 (highest intensity). The 
equation is shown below where 𝑁 is the number of pixels in the cell and	𝑖 is the intensity of 
fluorescence. Index 1 can be viewed as representing a measure of how much a cell is “turned 
on” (in terms of the green fluorescence). This index normalises the intensity by taking the cell 

















To calculate cell eccentricity, the following principles were applied. The eccentricity e of an 
ellipse is the ratio of the distance c between the centre of the ellipse and each focus to the 
length of the semimajor axis a. The eccentricity e is such that 0< e <=1. The closer the e is to 
1, the flatter and more elongated the ellipse. The centroid of a cell is its barycentre. The 
centroid C (cx, cy) is a point in the image with the x-axis coordinate 𝐶J and the y-axis 









where 𝐴-is the area of a pixel. For each image, the cells were segmented by hand and the 
obtained mask was converted into a binary image (cells in white and background in black). 
The elliptical approximation of each cell was built by making the centroid of each cell 
coincident with the approximating ellipse. From the centroid of each cell the major and minor 
axis of the cell were derived and the corresponding approximating ellipse were built. 
 
2.10.2	SPLINE	INTERPOLATION	
Spline interpolation was used to most accurately predict unknown time functions in time 
course experiments by using a sample of generated data points (Hall and Meyer 1976). Spline 
interpolation is based on a concept that aims to mathematically fit polynomials between 
known data points. The above concept is applied by minimising the curvature of a curve, 𝑦 𝑡  






Specifically, cubic splines were used to construct piecewise third-order polynomials 𝑦- 𝑡 , 
since they are known for their accuracy and production of smooth interpolation curves when 
compared to other types of polynomials, such as quadratic and Lagrange polynomials 
(Hazelwinkel, 2001).  
 
Each polynomial y is defined as: 
	𝑦- 𝑡 = 	𝑎- +	𝑏-𝑡 +	𝑐-𝑡? + 𝑑-𝑡S 
 
where 𝑎-, 𝑏-, 𝑐- and 𝑑- are parameters to be estimated by the minimisation algorithm.  
 










The life cycle of HPV has been widely studied through immunohistochemical analysis of 
human tissue, as well as tissue collected from various animal models of PV infection. 
Culturing of keratinocyte cell organotypic rafts has also provided a model in vitro system in 
which to study the life cycle of HPV further in the context of epithelial differentiation (Allen-
Hoffmann, Schlosser et al. 2000). PVs are known to exclusively infect epithelial sites, either 
cutaneous or mucosal. Human biopsy material has provided valuable insight to the life cycle 
of high-risk PVs in particular, however such samples can be difficult to obtain and are 
valuable due to associated costs (Ferry-Galow and Chen 2019). Furthermore, biopsy samples 
can often be quite small, limiting the range of analyses that can be carried out. Therefore, use 
of animal models of PV infection has helped to bridge the gap between cell culture 
experiments and human biopsy samples (Campo 2002). 
 
Until relatively recently, no PV type that could infect a laboratory mouse had been 
discovered. In 2011 MmuPV1 (originally designated MusPV (Ingle, Ghim et al. 2011)) was 
identified in the Pipapillomavirus genus (Joh, Jenson et al. 2011). Although this virus was 
initially described as being strictly cutaneous, subsequent research has shown it is also able to 
infect a range of mucosal sites (Cladel, Budgeon et al. 2016) (Hu, Budgeon et al. 2015) 
(Cladel, Budgeon et al. 2015) (Cladel, Budgeon et al. 2013). More recently, it has been used 
to attempt to model disease of the female reproductive tract, furthering its relevance as an 
important model of human disease (Spurgeon, Uberoi et al. 2019). This research into the 
female reproductive tract model suggested that MmuPV1 is oncogenic, which is surprising 
given its distant relation to high-risk human disease-causing PV types. Therefore, careful 
consideration should be given when applying these models. The availability of MmuPV1 
provides the opportunity to model PV infection in a convenient animal system, which is 
amenable to manipulation. Since its discovery, several labs have studied MmuPV1 in order to 
develop a broader understanding of PV biology, and to develop a better understanding of 
HPV associated disease (Handisurya, Day et al. 2013, Wang, Jiang et al. 2015, Uberoi, 
Yoshida et al. 2016, Hu, Cladel et al. 2017, Jiang, Wang et al. 2017). 
 
Recent studies involving MmuPV1 have demonstrated that this PV type was able to bind to 
the protein MAML1 to affect downstream signalling, similar to HPV8 of the beta genus of 
PV (Meyers, Uberoi et al. 2017), which is associated with a range of pathologies such as 
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squamous skin cell carcinoma in humans. Given this shared pathway interaction with a type 
known to infect humans, the mouse model provides a useful system with which to study 
aspects of persistence and cell competition in vivo by examining the mechanics of basal cell 
expansion. Overall, this chapter aims to characterise the earliest stages of lesion formation 




The mouse model of PV infection has only been introduced within our lab in the past three 
years. Previously published literature concerning the experimental wounding of mouse tails 
describes various processes by which to wound the tail site, such as abrasion of the site using 
a rotary device (Handisurya, Day et al. 2013), or removal of epithelia by scarification of the 
site with a 27-gauge needle to an extent that does not cause bleeding (Uberoi, Yoshida et al. 
2016). Whilst the method of wounding using a needle is well established, and was used 
initially in our lab, we considered whether a more reproducible method of wounding the tail 
skin might be beneficial to our model. For instance, reproducibility of early time course 
experiments might be negatively impacted as a result of erratic wounding by human hand. 
Consequently, it was decided that two methods of wounding would be attempted and 
compared to determine which approach was more consistent before initiation of longer 
experiments.  
 
The first method of wounding selected was the standard scarification of the mouse tail site 
using a 27-gauge needle to scratch the tail surface until the basal layer was exposed. The 
alternate method of wounding attempted was to use an Auto Derma Pen Microneedle Stamp 
Device (Carer, T&B, Guangzhou, China), which is an automated device wherein 12 
microneedles of adjustable length are repeatedly pressed superficially into the epidermis. The 
needles were adjusted to a length of 0.25mm and the mouse tail was then subjected to ten 
seconds of wounding with the device pressed firmly onto the tail. Mice were wounded either 
with a 27-gauge needle or with the Auto Derma pen, and tail samples were then collected 1, 4 
and 7 days after wounding for analysis. Six mock wound sites were investigated at each time 
point within each group, and a representative image of H&E stained tissue sections is shown 
from each cohort in Figure 3.1. Wound sites were preliminarily identified by the presence of 
scabbing over the recently wounded tissue; this was expected to be visible by light 
microscope without necessitating further processing or analysis of the tissue. Another 
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Figure 3.1 Haematoxylin and eosin staining shows cell morphology with two different 
methods of wounding 1, 4 and 7 days after wounding 
Panels show wounding by scratching with a 27-gauge needle and using an Auto Derma pen 
for each time point. The white dotted lines indicate the position of the basal layer. Scabs are 
outlined with a red dotted line. Red arrow shows inflammatory cells. Scale bar: 200 µm. 
Data representative of 2 independent experiments, n=3. 
Figure	3.1	Haematoxylin	and	Eosin	staining	shows	cell	morphology	with	two	different	methods	of	wounding	1,	4	and	7	days	
after	wounding	
criterion used to identify healing wound sites was the presence of inflammatory cells at the 
site of infection, which can also be broadly identified with H&E staining alone (Ross and 
Pawlina, 2006). Some scabbing of the wound was evident at day one in both groups 
(highlighted with a red dotted line outlining the scabbed area), making the wound site itself 
reasonably simple to locate. However, whilst the wound site was still easily identifiable by 
location of the scab at day four in the group wounded with the 27-gauge needle, it proved 
harder to locate in the samples from those wounded with the Auto Derma pen, and 4 of the 6 
sites analysed for this group appeared to not contain wounded tissue. At day 7, the tail 
samples scarified with a 27-gauge needle were identified by the presence of inflammatory 
cells observed beneath the epidermis (marked with a red arrow) in each of the six samples. In 
comparison, inflammatory cells were only located at one of tail sites analysed in the second 
group wounded with the Auto Derma pen, whereas the other 5 sites contained no 
inflammatory cells and no scabbing above the epidermis. Consequently, we decided that the 
needle method of scarification would be the best method to use; despite the somewhat greater 
scope for the introduction of human error and variability, this method resulted in 100% of the 
sites collected being wounded sites. In comparison, the sites wounded with the Auto Derma 
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pen were rarely easy to define as a wound site beyond the day one time-point. Further, the 
introduction of many small sites in a relatively large area of tissue would result in greater 
difficulty in locating wounded sites upon in-depth tissue analysis. Since one of the main 
methods intended for application to subsequent samples was to be RNAscope (ACD, USA), 
an expensive process, it was important to keep the number of tissue samples required for 
processing low. Finally, use of this standard method of wounding would allow more 
straightforward comparison with some of the other work in the field of mouse PV research. 




Previous research in the field has found it difficult to locate low levels of PV DNA in situ in 
the basal layer during the early stages of lesion formation; detection methods such as 
traditional fluorescent in-situ hybridisation (FISH) lack the necessary sensitivity to amplify 
such small amounts of DNA. While commonly used approaches do exist that can determine 
the presence of viral DNA in other ways, including various methods utilising PCR 
quantification of viral DNA (Molijn, Kleter et al. 2005), it was important to be able to locate 
infected basal cells in tissue samples to allow immunohistochemical analysis of the earliest 
stages of lesion formation. A previous study in detecting viral DNA in COPV lesions found 
that DNA was detectable from 4 weeks following wounding onward, and even then, only in 
some of the samples analysed (Nicholls, Doorbar et al. 2001). Similar studies examining 
ROPV were also unable to detect DNA in the basal layer using FISH (Maglennon, McIntosh 
et al. 2011). In analysis of some human samples, it has been impossible to detect viral DNA 
in the keratinocyte basal layer of established lesions (Egawa, Iftner et al. 2000). To date no 
studies have successfully shown DNA in the basal layer of infected tissue using in situ 
methods. Therefore, it was decided that RNAscope in situ hybridisation technology would be 
employed to detect expression of E6/E7 RNA. 
 
A brief diagram detailing methodology of RNAscope can be seen in Figure 3.2A. Following 
permeabilisation of tissue, double Z shaped (ZZ) probes corresponding to RNA target sites 
bind in tandem in lengths up to 20 ZZ probes long. These probes are then sequentially 
amplified before labelling of amplified probes allows visualisation with a microscope. E6 and 
E7 are considered to be early proteins, known to express in infected basal cells (Doorbar 





Figure 3.2 Basic principles of RNAscope and double ZZ probe design 
A; Graphic representation of RNAscope protocol. Tissue is permeabilised, probes are 
hybridised to target RNA sequence up to 20 in a row, binding of amplifiers to ZZ probe 
allows amplification of signal, signal can be visualised using microscopy. B; Schematic 
diagrams of MmuPV1 ORFs, mapped viral promoters (P), and polyadenylation cleavage sites 
(pA CS) in the MmuPV1 genome. The numbers shown above each ORF are the first and last 
nucleotide of the ORF sequence, except for E4 which requires splicing. LCR – long control 
region. Probes are shown in blue (E6/E7 15 ZZ probe) and green (E6 9 ZZ probe) above their 
target sequence region. Numbers shown above each probe are the first and last nucleotide of 
the target of each probe (Adapted from Xue et al, 2017). C; Comparison of expression pattern 
for both the E6/E7 and the E6 only probe. D; Image taken at X40 magnification to clearly 
show detection of RNA expression in the basal layer (examples annotated with white arrows). 
MmuPV1 RNAscope probe signals shown in green. Nuclei were counterstained with DAPI to 
show host DNA. Dotted white lines indicate the position of the basal layer. Scale bar: 100 





that a probe targeting E6 or E7 only might also be useful to compare expression levels of each 
protein. Therefore, a second probe was designed to specifically target E6. The location of 
both probes is shown in Figure 3.2B alongside a full transcript map of the MmuPV1 genome, 
to indicate the stretches of RNA that each probe targets. The E6 probe was shorter in length at 
only 9ZZ probes, compared to the 15ZZ E6/E7 probe. As shown in the example microscope 
images in Figure 3.2C, it was found that the expression pattern of E6/E7 appeared to be 
similar to the expression pattern observed with the E6 only probe. It is possible that this is due 
to the 9ZZ E6 only probe overlapping with the promoter site located at p360, which could 
lead to additional detection of some transcripts transcribed from this promoter. Or, there may 
be saturation of signal, making it difficult to discern higher levels of expression. However, it 
was not possible to investigate this further by designing a shorter probe; probes targeting such 
a short sequence would be unlikely to function well. A minimum of 6 ZZ probes are required 
to result in successful amplification of a signal. Therefore, as it was unclear whether the E6 
only probe truly only targets E6, RNAscope was carried out for detection of E6/E7 RNA in 
subsequent experiments. While other methods described above provided plausible alternative 
methods by which to detect virus DNA, we proceeded with RNAscope because it provided a 
way to visualise expression of viral RNA, an early event in the virus life cycle and in lesion 
formation, in situ. Importantly, detection of RNA expression in the basal layer of the 
epithelium was successful, as demonstrated in Figure 3.2D. 
 
3.2.3	DETERMINING	THE	INFECTIOUS	TITRE	OF	MMUPV1	USING	RNASCOPE	
Compared to some other viruses, PVs do not form plaques in monolayer culture of cells, and 
no obvious cytopathic effects can be observed in infected cells to determine which of the 
population are infected in a rapid manner. The most common method to quantify PV titre is to 
employ qRT-PCR, usually using E1^E4 as an indirect transcript measure of infection; this is 
the most abundant viral transcript (Chen, Xue et al. 2014). However, relation of this data to 
real infectivity is still challenging. To investigate the effect of the amount of virus applied to 
each site, 8 serial dilutions of virus stock were used to inoculate groups of mice. These mice 
were then observed over time, and the appearance of a lesion at the site of infection was noted 
(this experiment was carried out by Dr Nagayasu Egawa). Results shown in Figure 3.3A and 
B demonstrated that while there was no clear difference between inoculation with 2 x 109 
virus genome equivalents (VGE, quantified using qPCR) when compared with 2 x 108 VGE, 
the remaining titrations showed a strong correlation between decreased virus titre and  
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Figure 3.3 Virus titer correlates to lesion formation time and determination of infectious 
units  
A; Mice were inoculated with 8 titrations of virus and the appearance of lesions was 
monitored over time. B; Average time for a lesion to appear is shown for each virus titration. 
C; HaCaT cells were infected with different titrations of MmuPV1, and the MmuPV1 E6/E7 
positive cells were counted to determine the percentage of infected cells for each titration. 
Calculations then allowed estimation of the number of infectious units per virus genome 
equivalents. Representative images shown were taken at 40X magnification. MmuPV1 E6/E7 
RNAscope probe signal shown in green. Nuclei were counterstained with DAPI to show host 







increased lesion formation time. To correlate the amount of virus with infectivity, HaCaT 
cells were infected with different quantities of VGE (as described in 2.2.3.9). The consequent 
number of infected cells per VGE was quantified by detecting the presence of MmuPV1 in 
infected cells using RNAscope targeting MmuPV1 E6/E7, as shown in Figure 3.3C. Data 
suggested that there was approximately one infectious unit per 286 VGE (standard error of 
21). Using this data, it is possible to estimate that the number of infectious units applied to 
each wound site was roughly 69,000 infectious units per site when applying 2 x 109 VGE. 
 
3.2.4	LOWER	VIRUS	TITRE	RESULTED	IN	FEWER,	SMALLER	LESIONS	FORMING	WITHIN	A	SET	TIME		
To examine the in vivo effect of virus titre in greater detail, mice were inoculated with 2 x 109 
or 2 x 106 VGE (3 inoculation sites per group). When the first mouse of the experimental 
group began to show macroscopic signs of lesion formation on the tail, all of the animals in 
that group were collected; this should show the extent of lesion formation in lower titre mice 
at the same time point. In the mouse inoculated with 2 x 109 of virus, 2 of the 5 tissue samples 
analysed showed evidence of lesion formation (example shown in Figure 3.4A). RNAscope 
analysis was used to locate areas of infected tissue, whilst staining for E4 protein was also 
carried out to correlate with RNA expression. In comparison, in the mouse inoculated with 2 
x 106 VGE (Figure 3.4B), only one site of infection could be located, which was notably 
smaller than those observed in the highest titre. For quantification, length of infected basal 
layer in tissue from each group was measured. The total length of infected basal cells spanned 
139 µm in the tissue sample taken from the mouse inoculated with 2 x 106 VGE, whereas in 
the tissue sample taken from the mouse inoculated with 2 x 109 VGE, the total length spanned 
by infected basal cells was 1423 µm. The higher titre of virus resulted in a considerably larger 
lesion forming in the same time span within the centre of the wounded site. These sites of 
infection were not investigated with great depth; sections were taken from the approximate 
centre of the wound site only to give an indication of the extent of viral infection present at 
the chosen time point. Sites analysed also showed multiple foci of infection as opposed to one 
continuous span of infected cells in the basal layer. This observation gave some credence to 
the idea that tail lesions might initially form from multiple different infected cells, which will 
be considered in more detail in Section 3.2.7. These results fit well with the previous data 
demonstrating that virus titre correlated to lesion formation time. Therefore, for future 
experiments, it was decided that the highest titre of virus, 2 x 109 VGE, would be used to 




Figure 3.4 Comparison of lesion formation between high and low titre virus infection 
Panels show images collected at 5X magnification representing IF detection of viral protein 
MmuPV1 E4 (red) and RNAscope detection of MmuPV1 E6/E7 (green). Nuclei were 
counterstained with DAPI to show host DNA. Block coloured lines beneath E6/E7 panels 
show regions of infection (red) and regions of uninfected epithelium (blue). Dotted white 
lines indicate the position of the basal layer. Scale bar: 200 µm. A; high titre virus infection (2 
x 109). B; low titre virus infection (2 x 106). Data representative of 2 independent 






To characterise lesions, immunohistochemical analysis was carried out on lesions collected 
more than 3 weeks after wounding and virus inoculation, termed ‘established’, in comparison 
with lesions collected immediately upon becoming macroscopically visible, termed ‘early-
visible’. These time points were chosen to determine whether the expression pattern of viral 
proteins changed significantly from when the lesion is first palpable to when lesions have 
become extremely florid. Examination of the expression of key virus proteins E4, L1, and 
E6/E7 RNA at these two discrete time points was carried out. IF staining demonstrated that 
expression of MmuPV1 E4 protein started in the parabasal layer and was continually 
expressed up to the surface of the epithelium. This pattern of expression was seen in both 




Figure 3.5 Spatial localisation of virus proteins and RNA expression  
Panels show images collected representing IF detection of viral protein MmuPV1 E4 (MusE4, 
in house), L1 (MusL1, in house) and RNAscope detection of MmuPV1 E6/E7 (Cat No. 
409771). Nuclei were counterstained with DAPI to show host DNA. Dotted white lines 
indicate the position of the basal layer. A; Established lesion collected 4 weeks following 
infection with MmuPV1. Scale bar: 200 µm. B; Early-visible lesion collected at 10 days 




Expression of E6/E7 RNA was detectable in the basal layer, and was expressed in much 
greater amounts from the parabasal layer upwards. This pattern of expression suggested that 
MmuPV1 may begin the amplification stage of its life cycle immediately after the cell exits 
from the basal layer. Expression of L1 protein was observed towards the surface of both 
established and early-visible lesions, demonstrating that these infections are productive. 
Unlike the staining described by another group previously (Handisurya, Day et al. 2013), no 
cytoplasmic L1 staining was observed in these samples. The presence of L1 protein also 
showed that it was possible for a productive lesion to develop only 10 days after initial 
infection and possibly earlier, as the early-visible lesion shown was collected ten days after 
wounding and inoculation took place. It was noted that of the two lesion types analysed, 
established lesions already showed considerable papillomatosis, whereas at ten days 
following wounding extensive papillomatosis was not yet apparent. To understand the timings 
of these various events in more detail, a time course experiment was considered.   
 
3.2.6	IDENTIFICATION	OF	SIX	DISCRETE	STAGES	OF	WOUND	HEALING	
As the next set of experiments planned to look at the earliest stages of lesion formation prior 
to the macroscopic appearance of a wound, and it was clear from the data shown in Figure 3.5 
that lesion formation occurred fairly rapidly, the physical process of wound healing in the 
mouse tail epithelium was examined. Understanding of mock wounded tissue was important 
as this would be a necessary control in future experiments. By analysing mock wound site 
tissue, it would be clear what morphological changes were due to normal wound healing, and 
what might then be attributable to presence of a MmuPV1 virus infection. Three classes of 
markers were selected to examine the wound sites. These were K10, keratin 17 (K17) and 
Tenascin C. K10 is a marker of early stage differentiation routinely used in the analysis of 
keratinocytes, and indicates presence of differentiated epithelium (Schweizner and Winter 
1983) (Eichner 1986). K17 is used as a marker for migratory cells, and is known to be 
upregulated during wounding as reepithelialisation of the wound site takes place (Pastar, 
Stojadinovic et al. 2014). Tenascin C is an extracellular matrix molecule, important in 
reformation of the normal epithelium following wounding. Tenascin C was selected as a 
wound healing marker due to its rapid induction upon injury, and its well documented 
involvement throughout the entire wound healing period (Midwood and Orend 2009). Using 
these markers, 6 discrete phases of wound healing were characterised, which are shown 













Figure 3.6 Spatial localisation of markers during healing of mouse tail epithelium 
Panels show images collected representing Haematoxylin and eosin staining (panel A in each 
wound healing phase) and corresponding IF detection of Tenascin C (panel B in each wound 
healing phase), K10 and K17 (panel C in each wound healing phase). Subsequent panels 
show higher power magnification of selected images taken at 40X magnification. Nuclei were 
counterstained with DAPI to show host DNA. Dotted yellow line shows denudated 
epithelium. Dotted white lines show location of the basal epithelium. Scabbing is shown with 
red dotted lines. Scale bar: 200 µm, unless specified as otherwise. i; control IF detection of 
markers Tenascin C (A), K10, and K17 (B) in unwounded epithelium. Arrow indicates hair 
follicle. ii; phase one, two hours following wounding; no wound healing activation iii; phase 
two, 1-3 days following wounding; activation of wound healing at wound periphery iv; phase 
three, days 3-4 following wounding, re-epithelialisation under scab of wound v; phase four, 
days 5-8 following wounding, reformation of normal basal layer vi; phase five, days 9-12 
following wounding, epidermal bulge corresponds to near completion of wound healing vii; 
phase six, two weeks following wounding, wound healing is considered complete. Data 





In normal unwounded epithelium (Figure 3.6i) Tenascin C was largely absent. K10 was 
restricted to the parabasal layer and above, and K17 staining occurred only sporadically, or in 
the hair follicles (an example of a hair follicle is indicated with a white arrow). Phase 1 
(Figure 3.6ii) shows the wound site two hours after wounding has taken place. The basal layer 
had been severely disrupted, shown with a yellow dashed line. Presence of a scab is indicated 
with a red dotted line. Tenascin C staining was negative, and the epithelium at the periphery 
of the wound site remained normal for K10 and K17 staining; K10 was observed above the 
basal layer and K17 was only observed in the hair follicles, not in any basal keratinocytes. 
Phase 2 (Figure 3.6iii) shows the wound site 1-3 days after wounding. Tenascin C induction 
could be seen at the periphery of the wound site, and K17 activation could be seen in basal 
cells to either side of the wound site. K10 was still observed in some parabasal cells, however 
K17 could also be observed in the parabasal layer. Phase 3 (Figure 3.6iv) shows re-
epithelialisation of the wound site underneath the scab from 3-4 days following wounding. 
Reepithelialising cells were all positive for K17, which was expected given the 
aforementioned involvement of K17 in migration of keratinocytes. Strong induction of 
Tenascin C was observed beneath the entirety of the wound site. In phase four (Figure 3.6v) 
reformation of the basement membrane and basal layer was apparent, with distortion of the 
basal layer evident in all samples examined from days 5-8. K17 expression localised with 
strong Tenascin C induction, indicating that this area represented the centre of the healing 
wound. In phase five (Figure 3.6vi) wound healing was seen to be almost complete, and a 
bulge in the epidermis was seen at the centre of the healing wound. Again, strong induction of 
Tenascin C localised to the same area as keratinocyte cells that were still positive for K17. At 
the edges of the healing wound, most keratinocytes had returned to normal patterns of 
K10/K17 expression. This phase was observed around 9-12 days after wounding had taken 
place. By two weeks after wounding (Figure 3.6vii) the epithelium had mostly returned to 
normal expression of all three markers examined, aside from a mild induction of Tenascin C 
observed at the site. Following this phase, would healing was considered to be complete.  
 
To corroborate with wound healing analysis, and to aid in location of early pre-visible lesions, 
marking of the wound site was attempted. To do this, use of fluorescent microspheres 
(Thermofisher Scientific, UK) was first attempted. The beads used are small spheres of only 
0.2 µm in diameter made from a type of polystyrene. These commercially available 
FluoSpheres are loaded with a fluorescent dye to allow visualisation under a fluorescent 
microscope. The bead mixture was applied to a wound site following scarification, and the 






Figure 3.7 Marking of the site of wounding with FluoSpheres or crosslinking reagent 
A; Low resolution images of FluoSphere fluorescence visualised with fluorescent microscope 
prior to tissue processing on the surface of the mouse tail (outlined with white dotted lines). 
Approximate region scarified on tail is shown above image as red lines. B; Higher 
magnification images of mouse tissue prior to processing show fluorescence of FluoSpheres 
on the surface of the tail epithelium 4 and 7 days following wounding and inoculation of the 
site with FluoSphere suspension. White dotted line indicates edges of the mouse tail tissue. C; 
Panels show IF imaging of crosslinking reagent Sulfo-NHS-LC-biotin visualised with 
streptavidin conjugated to Alexa594 (red) on day 1, 4 and day 7 following wounding and 
inoculation with the crosslinker. Nuclei were counterstained with DAPI to show host DNA. 
Red dotted lines show presence of a scab above the wound site. Dotted white lines show 






The sites were marked successfully, with macroscopic visualisation of the beads being 
possible under a fluorescent microscope. However, no fluorescent signal was observed within 
the tissue following processing (data not shown), suggesting that the fluorescent signal had 
been lost from the material during processing for histochemical analysis. A crosslinking 
reagent EZ-Link™ Sulfo-NHS-LC-Biotin (ThermoFisher, UK) was also examined in parallel 
experiments. The aim was to apply this compound during wounding so that it would crosslink 
to surrounding wounded tissue and become assimilated into the site without having great 
impact on the cell microenvironment. Mice were scarified at three sites along the tail and the 
crosslinker reagent was applied to the skin surface at each site. Retention of the crosslinker at 
the wound site was examined over seven days, as shown in Figure 3.7C. On day one and day 
four, the crosslinker was detected in the scab above the wound site, and was readily detectable 
from day 2 to 7 under the site of the wound. 
 
It was important to ensure that the crosslinker colocalised beneath the K17 expressing cells, to 
demonstrate that the site of wounding was being properly marked. It was also necessary to 
determine whether virus inoculation of the wound site in the presence of the crosslinking 
reagent would lead to successful lesion formation. As shown in Figure 3.8A, the Sulfo-NHS-
LC-Biotin crosslinker colocalised well with the region of K17 positive cells, and MmuPV1 
E6/E7 gene expression still occurred at the site of infection (Figure 3.8C). The lesion shown 
in this figure was macroscopically visible 8 days after wounding, suggesting a similar rate of 
lesion formation when compared to the early-visible lesions collected previously. However, 
when lesion sites of mice inoculated with both MmuPV1 and crosslinker were more closely 
analysed, it was found that the pattern of gene expression had been affected. As shown in 
Figure 3.8D and E, E6/E7 gene expression in the basal layer of the epidermis was extremely 
high, and discrete foci could not be discerned. When compared to E6/E7 gene expression in 
tissue inoculated with MmuPV1 only, the difference in expression was stark (Figure 3.8F). 
Unfortunately, it was plausible to consider that the crosslinking reagent had also crosslinked 
to and between virus particles, leading to higher quantities of virus infecting individual cells. 
We decided that subsequent experimentation should proceed without use of the crosslinking 
reagent; such high levels of virus gene expression may lead to changes to infection that could 
be incorrectly attributed to the timing of lesion formation. The colocalisation of the 
crosslinking reagent with the subset of cells expressing K17 indicated that the use of K17, 
K10 and Tenascin C was reasonable to locate the centre of a healing wound. Overall, further 
efforts into optimisation of the FluoSpheres were not made; we decided that use of the set of 





Figure 3.8 Crosslinking reagent colocalises with K17 and interacts with MmuPV1 
A; IF detection of K17 (green) and crosslinker reagent Sulfo-NHS-LC-Biotin (red) at site of 
wounding. B; IF detection of K17 (green) and crosslinker reagent Sulfo-NHS-LC-Biotin (red) 
at unwounded epithelial site. C; IF detection of E6/E7 RNAscope (green) and crosslinker 
reagent Sulfo-NHS-LC-Biotin (red). D, E; Images showing E6/E7 RNAscope detection 
(green) in sites co-inoculated with both crosslinking reagent and MmuPV1, taken at 40X 
magnification. F; Images showing E6/E7 RNAscope detection (green) in sites inoculated with 
MmuPV1 only, taken at 40X magnification. White dotted lines indicate location of basal 
layer. Red dotted lines in D-F show location of E6/E7 positive basal cells. White arrows 
further highlight location of infected cells. Nuclei were counterstained with DAPI to show 






To observe early lesions, athymic nude mice were scarified at three discrete regions along the 
tail and infected with approximately 69,000 infectious units of MmuPV1 virus at each site. 
When a lesion first became macroscopically visible at any site (early-visible), the entire tail 
was collected, allowing collection of “pre-visible” lesions present elsewhere on the same tail. 
To locate even earlier stages, mouse tails were also collected from day one to five following 
wounding. Using all of the samples collected, five discrete stages during the formation of an 







Figure 3.9 Localisation of MmuPV1 E6/E7 expression, E4 and L1 protein in early lesion 
formation of infected tissues 
Time course analysis of early lesion formation of sites infected with MmuPV1 cell-free virus 
extract. Each set of panels (A-F) shows H&E staining, E6/E7 RNAscope IF (Cat No. 409771, 
green), and IF detection of E4 (MusE4 – in-house, red) and L1 viral proteins (MPV.B9 – Neil 
Christensen, green) at a discrete stage of lesion formation. Staining was carried out on 
adjacent sections. Nuclei were counter-stained with DAPI for host DNA. White dashed lines 
show the location of the basement membrane. Schematic of early wound healing also shown 
in C alongside microscopy image showing basal expression of E6/E7 RNA (highlighted in red 
box) to the right of wound centre. Scab is shown with red dotted line and green arrow shows 
direction of healing wound. Data collected from two independent experiments, n=5. Tissue 




Stage one (Figure 3.9A) depicts the earliest lesion formation events detectable. At this stage 
only E6/E7 RNA is expressed, as shown at 40X magnification in the red box. Expression can 
be seen in parabasal cells and in a few basal layer cells (shown with white arrows in higher 
magnification panel). This was observed as early as day two following wounding during 
analysis. In the 48 samples collected to investigate early stage infection, any early expression 
of E6/E7 RNA observed was only ever seen in cells where re-epithelialisation had already 
occurred at that region, suggesting the wound must have healed beyond certain wound 
healing checkpoints discussed above (Figure 3.6) before viral genes can be expressed. An 
example of this observation, along with schematic representation of the early stages of wound 
healing are shown in (Figure 3.9C). MmuPV1 E6/E7 RNA expression can be seen in the left 
side of the image, while scabbing can be observed to the right side, highlighted with a red 
dashed line. In stage two, MmuPV1 E4 protein expression (annotated with white arrows) is 
also present alongside the E6/E7 RNA expression. E6/E7 RNA shows greater levels of 
expression in the upper layers at this stage. A slight morphological change was barely 
perceptible in the infected cells, highlighted in a black box (Figure 3.9B). This is underlined 
in red in the 40X image. Cells appear to be more densely packed than the normal epithelium 
visible to the left. In the third stage, the first evidence of MmuPV1 virus production is 
apparent in the uppermost layers (highlighted in a green box, Figure 3.9D), indicating that this 
is now a productive infection site. Further, discrete foci of infection (shown with red dotted 
lines) were apparent as the development of a lesion progressed. This phenotype was 
commonly observed in our model, and suggests that lesions could develop from multiple 
discrete foci to form one lesion (McBride and Warburton 2017). In the fourth stage, high 
basal cell density in the lesion site was observed, as can be seen throughout the basal layer of 
the example lesion shown. One continuous region of infection has developed, compared with 
the multiple foci of the previous stage. Finally, in the fifth stage of lesion formation induction 
of papillomatosis was observed in a lesion that was macroscopically visible upon collection 
(Figure 3.9E). From characterisation of lesions beyond this stage, it is understood that lesions 
simply continue to grow in an uncontrolled manner from this point onward, into increasingly 
florid papillomas. 
 
To investigate viral gene expression in an immunocompetent host, C57BL/6J mice were 
selected due to their established use in the study of immunological responses and well 
documented genetic background (Song and Hwang 2017). Infection of C57BL/6J 
immunocompetent mice with MmuPV1 crude virus did not result in the formation of 
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papillomas at the tail sites, whereas nude mice began to show macroscopically visible lesions 
within the same time frame (Figure 3.10A). Thorough analysis of tissue samples led to the  
 
	
Figure 3.10 Infection in immunocompetent C57BL/6J mice 
A; Diagrammatic representation of inoculation sites on mouse tail tissue shown with 
photographs of immunodeficient and immunocompetent mouse tails following collection. 
Inoculation sites are shown in red, and the 1cm spaces between the centre of each wound site 
are annotated. The first wound site is located 1cm down from the base of the tail. 
Approximate locations of wounding sites are shown with red lines above photographs of tails 
collected 2 weeks following inoculation with MmuPV1. B; Panels show haematoxylin and 
eosin staining of two sites of C57BL/6J mouse tail tissue where MmuPV1 microlesions were 
located, alongside corresponding IF staining of E6/E7 RNA, E4 and L1 viral proteins. Nuclei 
were counterstained with DAPI to show host DNA. Data collected from two independent 
experiments, n=14 in experiment one, n=11 in experiment two, due to alteration of the days 
on which samples were collected. White dotted line shows location of basal layer. Tissue 
collected post-infection - B: D10, B: D7. Scale bar: 100 µm. 
Figure	3.10	MmuPV1	infection	in	immunocompetent	C57BL/6J	mice	
 
discovery of productive microlesions in C57BL/6J mouse tail tissue at some of the sites of 
infection. The first microlesion was discovered 9 days following wounding. In this lesion, 
expression of E6/E7 RNA was evident in the basal cells, and persisted up through the layers 
of the epidermis to near the skin surface. This strong cytoplasmic expression pattern differs to 
the less clearly defined basal expression seen in our athymic nude immunodeficient model. 
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Similarly, E4 protein can be seen colocalising to this area, confirming the presence of a 
microlesion. Finally, IF staining also indicated presence of small amounts of L1 in the upper 
layers and at the surface, which supports the claim that this is indeed a productive microlesion 
(Figure 3.10Bi). A second microlesion was found in tail epithelium collected 7 days following 
wounding (Figure 3.10Bii). As seen in the first lesion, E6/E7 RNA had much higher 
cytoplasmic expression when compared to observations in athymic nude mice. E4 protein was 
found to localise to the same site, indicating presence of a real infection. However, in this 
microlesion, no L1 expression was detected. 
 
3.2.8	BASAL	CELL	DENSITY	IS	INCREASED	IN	THE	EARLY	STAGES	OF	LESION	FORMATION	
A possible correlation between E6/E7 RNA expression and an increase in basal cell density 
was observed from stage two of lesion formation onwards. Since this phenotype was seen 
from a very early stage in lesion formation in the basal layer, an involvement of one of the 
viral early proteins was suspected in this altered cell behaviour. To examine this further, 
quantitative analysis was carried out. Uninfected epithelium and mock-infected epithelium 
were used as control groups. For the early-visible lesion category, lesions that were collected 
10 days following wounding (at which point they were confirmed to be macroscopically 
visible) and were identifiable with RNAscope probes directed to E6/E7 were selected. Mock-
infected sites were selected at the same time point of 10 days, using the 3 classes of wound 
healing markers described above to confirm suitability. For quantification, 40 image sets of 
DAPI stained tissue at 20X magnification were collected for each category: uninfected 
epithelium, mock wound sites, early visible lesions and established lesions (mice n=4 per 
group). The number of basal cells was counted along a stretch of approximately 450 µM in 
each image (examples of regions counted are shown with red lines beneath the basal layer of 
tissue shown in each representative image). These counts were then averaged to give a mean 
cell count per micrometer for each of the categories, as shown in Figure 3.11.  
 
Results showed that basal cell density was significantly increased in the early visible lesions 
when compared to all other categories, with approximately 0.22 cells per µm 
(****p ≤ 0.0001). Basal layer densities in the uninfected epithelium and the mock wound site 
were quantified at 0.18 and 0.16 cells per µm respectively, and this slight difference in 
density was also shown to be significant (*p ≤ 0.05). Interestingly, there appeared to be no 
significant difference between the mock wound site and that of an established lesion, which 
was also quantified at approximately 0.16 cells per µm.  
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Figure 3.11 Cell density is increased in basal layer of early-visible lesions 
Quantitative analysis of basal cell density in four categories of tissue (left panel); uninfected 
epithelium, mock wound sites, early visible lesions (samples collected at 10 days following 
wounding and validated using E6/E7 RNAscope), and established lesions (samples collected 
from florid tail lesions more than 3 weeks following wounding). Basal cell density was 
quantified by measuring 450 µm stretches of epithelium in 40 image sets taken from different 
mice (n=4 per category). P-values were calculated with Kruskal-Wallis test with Dunn’s 
correction; * = P ≤ 0.05, **** = P ≤ 0.0001. Representative 5X magnification microscopy 
images are shown (right panel) for each category. Two examples the of measurement method 
are shown with solid red lines under the basal layer of each microscopy image, with nuclei 
counterstained with DAPI to show host DNA. These indicate approximate lengths measured 
in repeats to approximate cell density. White dotted lines indicate location of basement 
membranes. Data representative of 2 independent experiments, n=4, 10 measurements per 
site. 16,601 discrete cells counted in total. Uninfected, mock wound, and early visible lesion 
tissue collected on D10 post-infection; established lesion tissue collected at 3 weeks post-
infection. Scale bar: 200 µm. 
Figure	3.11	Cell	density	is	increased	in	basal	layer	of	early-visible	lesions	
To consider whether increased cell division was the cause of the increase in cell density, 
staining for a mitosis-specific marker, phosphorylated histone 3 (H3 ps10), was carried out. 
There is a strong correlation between early prophase mitotic chromosome organisation and 
phosphorylation of histone 3 (Veras, Malpica et al. 2009), therefore the use of an antibody 
specifically targeting phosphorylated histone 3 allows location of mitotic cells. 
Immunohistochemistry (IHC) was carried out on samples to determine which cells were 
positive for phosphorylated histone, and these were counted to calculate the percentage of 
positive cells in each of the four categories (n=5) from the previous analysis: uninfected 
epithelium, mock wound, early visible lesion, and established lesion. Data is shown below in 
Figure 3.12. Although on average the percentage of mitotic cells was higher in both the 




Figure 3.12 Increase in mitotic cells in MmuPV1-infected basal cells 
Quantitative analysis of the percentage of H3 ps10 positive cells in the above four categories 
(one independent experiment, n=3). P-values were calculated with Kruskal-Wallis test with 
Dunn’s correction. Error bars, SD. Representative fluorescent images are shown to the right 
of the graph. Nuclei were counterstained with DAPI to show host DNA. White dotted lines 
indicate location of basement membranes. White arrows indicate the location of some of the 
positive cells. One independent experiment, n=3. Uninfected, mock wound, and early visible 
lesion tissue collected on D10 post-infection; established lesion tissue collected at 3 weeks 
post-infection. Scale bar: 200 µm. 
	Figure	3.12	Increase	in	mitotic	cells	in	MmuPV1-infected	basal	cells	
 
difference between the four categories. It was considered that with a greater number of 
samples to analyse, these differences may become statistically significant, and the observed 
trend fit with the expectation that cell division might be higher in infected cells. However, it 
was also postulated that the snapshot in time provided by tissue sample analysis may make it 
more difficult to analyse the populations of mitotic cells; a high number of samples would 
have to be processed to remove standard error relating to unusually high or low populations of 
mitotic cells apparent due to chance timings, and mitotic cells in the epithelial basal layer can 
be challenging to locate in general (Noske, Stark et al. 2016). Therefore, a different approach 
was considered. 
	 87	
To investigate this phenomenon in a different way, analysis was carried out to determine if 
the number of cells driven to replicate their DNA was altered in virus infected basal cells, and 
whether this differed between early and established lesions. Incorporation of the thymidine 
analogue BrdU was monitored by collecting tissue samples 24 hours after intraperitoneal 
injection with the substance. During cell replication, BrdU is incorporated into cellular DNA, 
which allows tagging of cells that have entered S phase during the period of incubation with 
the nucleoside analogue (Takagi, McFadden et al. 1993). IHC was carried out on samples to 
determine which cells within each of the four categories from the previous analysis were 
BrdU positive. Before quantification, a brief pilot study was carried out to determine the 
optimal conditions for the visualisation of BrdU in mouse tissue. Incubation with HCl during 
the normal staining procedure is required to denature DNA and allow binding of the anti-
BrdU antibody. Incubation in 1M and 2M HCl for 15 and 30 minutes was attempted, as 
shown in Figure 3.13A. As incubation in 2M HCl for 30 minutes provided the clearest signal, 
this was utilised for the subsequent experiment. The number of cells that were BrdU positive 
was counted to calculate the percentage of positive cells in uninfected epithelium, mock 
wound, early visible lesion, and established lesion. Results showed a statistically significant 
increase in the proportion of BrdU positive cells in the basal layer of the early visible lesion 
when compared to uninfected epithelium (Figure 3.13B).  
 
In uninfected tail epithelium and mock infected tail sites, only 14% and 13% of basal cells 
were BrdU positive respectively. No significant difference was found between these two 
groups. In the early visible lesions, 25% of cells in the basal layer were positive for BrdU. 
There was also no significant difference in percentage of BrdU positive basal cells between 
early visible lesions and established lesions, in which 24% of basal cells were positive for 
BrdU. The percentage of BrdU positive cells in early visible and established lesions was 
significantly higher than in both uninfected epithelium (*p ≤ 0.05) and mock wounded 
epithelium (**p ≤ 0.01). BrdU positive cells in the upper layers of both categories were 
deemed attributable to virus DNA amplification. Representative images of each group can 
also be seen in Figure 3.13C. These results suggested that the change in cell density observed 
as a lesion is first beginning to form is not solely caused by an increase in cell proliferation. 
The basal cell density in early visible lesions was significantly higher than that of the 
established lesions, whereas there was no significant difference in DNA synthesis between the 
two groups. As a result, any disruption of normal basal cell differentiation pathways was the 






Figure 3.13 Increase in cells entering the cell cycle in MmuPV1-infected basal cells 
A; optimisation of anti-BrdU fluorescent staining. Images showing IF detection of BrdU in 
four different conditions are shown. Scale bar: 100 µm. B; Quantitative analysis of the 
percentage of BrdU positive cells in the above four categories (n=3). P-values were calculated 
with Kruskal-Wallis test with Dunn’s correction; * = P ≤ 0.05, ** = P ≤ 0.01. Error bars, SD. 
C; Representative images of BrdU staining (red) for each of the four categories. Nuclei were 
counterstained with DAPI to show host DNA. White dotted lines indicate location of 
basement membranes. Two independent experiments, n=5. Uninfected, mock wound, and 
early visible lesion tissue collected on D10 post-infection; established lesion tissue collected 








To examine the involvement of E6/E7 RNA expression in basal cell exit, IHC was carried out 
for K10, an established early stage marker of cells entering terminal differentiation. Double 
immunostaining for MmuPV1 E6/E7 RNA and K10 demonstrated that in the presence of the 
early MmuPV1 E6/E7 RNA, K10 is completely absent (Figure 3.14). To investigate the 
differentiation pathway further, HES1 RNA expression patterns were visualised using 
RNAscope ISH. The Notch signalling pathway is generally understood to be involved in the 
process of differentiation in keratinocytes, and HES1 (hairy and enhancer of split protein 1) is 
one of its downstream target genes. Therefore, presence of HES1 RNA demonstrates 
activation of the Notch signalling pathway (Blanpain, Lowry et al. 2006). As shown in Figure 
3.14, expression of HES1 was not noticeably delayed and was expressed throughout the basal 
and parabasal layers. In fact, quantification of HES1 RNA expression per cell in the basal 
layer of lesions versus uninfected tissue demonstrated a significantly higher level of HES1 
RNA expression in the infected basal cells (Figure 3.14B). 
 
This data suggested that the Notch signalling pathway was active. Therefore, it is not total 
inhibition of the pathway by E6/E7 that leads to the observed delay in differentiation, where 
cells exited the basal layer without differentiating. The differentiation status of the 
immunocompetent microlesion shown in Figure 3.15 was also characterised by 
immunostaining for K10. As seen in the experiments carried out with immunodeficient mice, 
there is also a decrease observed in K10 staining that correlates with the presence of E6/E7 
RNA. Further, it appeared that in this lesion, HES1 RNA expression was also expressing 
highly in cells that are positive for E6/E7 RNA, which demonstrated that the elevated HES1 
phenotype was also present in immunocompetent microlesions. Data indicated that in both 
immunocompetent and immunosuppressed backgrounds, MmuPV1 infection delayed 
differentiation commitment in the parabasal layers, which could enhance basal layer 
persistence of the infected cell, as well as facilitate viral genome copy number rise in the 
parabasal and suprabasal cell layers. It was noted that the expression of E6/E7 RNA was 
extremely heterogeneous; even cells immediately adjacent to each other in the same layer of 
cells could have extremely different levels of expression. Therefore, a more thorough analysis 








Figure 3.14 Differentiation is delayed in MmuPV1 E6/E7 expressing cells  
A; Representative IF analysis of an early visible lesion from an Hsd: AthymicNude-Foxn1nu 
mouse. Panels show counter-staining of nuclei with DAPI for host DNA (upper left), K10 
(upper right), E6/E7 RNAscope (middle left), HES-1 RNAscope (middle right), DAPI HES1 
K10 merge (lower left) and DAPI HES1 K10 merge of uninfected epithelium (lower right). 
Tissue collected 10 days post-infection. Scale bar: 100 µm. B; Box plot to show intensity of 
HES1 RNA expression in the basal layer of cells of uninfected epithelium in blue (n=10) 
versus lesion in green (n=10). P-values were calculated with a Kolmogorov-Smirnov t-test; 
**** = P ≤ 0.0001. IF images in the panel on the right demonstrate the difference in intensity 








Figure 3.15 Differentiation is delayed in MmuPV1 E6/E7 expressing cells in 
immunocompetent mice IF analysis of two differentiation markers in a microlesion from a 
C57BL/6J mouse. Panels show counter-staining of nuclei with DAPI for host DNA (upper 
left), K10 (upper right), E6/E7 RNAscope (middle left), HES-1 RNAscope (middle right), 
DAPI HES1 K10 merge (lower left) and DAPI HES1 K10 merge of uninfected epithelium 
(lower right). Data collected from two independent experiments, n=14 in experiment one, 
n=11 in experiment two, due to alteration of the days on which samples were collected. 








As an increase in basal cell density could not be attributed to increased cell replication alone, 
it was postulated that MmuPV1 E6/E7 expression may lead to persistence of infected cells in 
the basal layer by overcoming normal cell density modulation and contact inhibition. To 
investigate this in tissue, the expression level of E6/E7 RNA in individual cells was 
scrutinised in greater detail by measuring the E6/E7 RNA fluorescence per cell in the basal 
cells of 8 randomly selected early visible lesions. To quantify the E6/E7 RNA expression in 
whole cells, z-stack confocal images of a cell layer thickness were collected and then plotted 
as maximum intensity images. Figure 3.16A shows an example of one of the images that was 
analysed in the left panel. To quantify E6/E7 RNA expression, individual DAPI-stained cells 
were manually selected as regions of interest using only the blue channel of the images 
(shown with red lines in the middle panel), which were then plotted on to the corresponding 
green channel that showed E6/E7 RNA expression, as demonstrated in the right panel. This 
allowed quantification of E6/E7 RNA expression per cell without bias. Following quantitation 
of E6/E7 RNA expression within these single cells, the spread of data was plotted in a 
histogram, shown in Figure 3.16B. 
 
Interestingly, a weak bimodality was observed in the expression pattern of the cells, 
suggesting the presence of two discrete subsets of infected cell; a larger one in which E6/E7 
expression occurs at a lower level, and a smaller group of highly expressing cells. Statistical 
tests of bimodality found that the bimodality of the spread of data was not statistically 
significant (Hartigan’s dip test, p=0.914). However, the dataset was also significantly not 
normal when three different statistical tests for normality were applied to the set (D’Agostino 
& Pearson normality test, p=<0.0001; Shapiro Wilk normality test, p=<0.0001; KS normality 
test, p=<0.0001). Further, when attempting to fit curves to the dataset, the sum of Two 
Lorentzian curves (shown as a red line on the histogram in Figure 3.16B) was found to fit the 
data extremely well, which could suggest the presence of two discrete groups with wide tails 
within the dataset. 
 
To expand upon this analysis, examination was carried out on larger datasets using a 
mathematical model to quantify levels of RNA expression by pixel intensity, shown with a 
graphic in Figure 3.17A. This algorithm, generated by Dr Alberto Giaretta, measured the 
intensity of individual pixels within the selected region of interest and attributed each a 
numerical value based on the intensity of expression. For example, for the mock pixel 
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Figure 3.16 Heterogeneous expression of E6/E7 RNA demonstrates potentially bimodal 
distribution 
A; Example of images used in the calculation of E6/E7 RNA expression intensity. Left panel 
shows maximum intensity merge of confocal z-stack of MmuPV1 infected tissue region (63X 
magnification). Middle panel shows DAPI channel only, with red selections demonstrating 
how single cells were isolated as regions of interest. Right panel shows corresponding E6/E7 
RNA channel, with previous selection overlaid onto the image. B; Distribution of RNA 
expression levels in basal cells of early visible lesions (number of cells counted = 458) is 
shown in a histogram. Intensity of expression per cell (AU) is grouped into bin centres for 
bimodal analysis. Eight discrete lesions from three different mice, n=5 images analysed per 
site. Data were pooled from these to build histogram datasets. A Sum of Two Lorentzian 
distribution line is fit to the data, shown with a red line. Hartigan’s dip test, p=0.914. 
D’Agostino & Pearson normality test, p=<0.0001; Shapiro Wilk normality test, p=<0.0001; 





Figure 3.17 Heterogeneous expression of E6/E7 RNA may be linked to basal exit 
A; Graphic to demonstrate method of pixel intensity calculation. Each pixel within selected 
cells is allocated a numerical value based on intensity, negative pixels are given a value of 
zero. B; Distribution of E6/E7 RNA expression levels in basal cells of early visible lesions 
calculated by mathematical analysis (n=1147) is shown in a histogram. Intensity of expression 
per cell (AU) is grouped into bin centres for bimodal analysis. C; Distribution of E6/E7 RNA 
expression levels in second layer of cells of early visible lesions calculated by mathematical 
analysis (n=1015) is shown in a histogram. Intensity of expression per cell (AU) is grouped 
into bin centres for bimodal analysis. D; Distribution of E6/E7 RNA expression levels in third 
layer of cells of early visible lesions calculated by mathematical analysis (n=704) is shown in 
a histogram. Intensity of expression per cell (AU) is grouped into bin centres for bimodal 
analysis. Hartigan’s dip test p=0.00059. E; Distribution of E6/E7 RNA expression levels for 
the first three layers of cells plotted together to show relative frequency. Eight discrete lesions 
from three different mice, n=5 images analysed per site. Data were pooled from these to build 
histogram datasets. Tissue collected 10 days post infection. 
Figure	3.17	Heterogeneous	expression	of	E6/E7	RNA	may	be	linked	to	basal	exit	
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shown in Figure 3.17A, the black pixels shown in each corner would have a value of 0 
whereas green positive pixels could have a range of values as demonstrated. This method of 
indexing also normalises by the size of the cell, which allowed more precise analysis of 
fluorescent intensity per cell. 
 
Using this method, larger datasets were analysed by Dr Alberto Giaretta, and the bimodality 
was not as evident but was still weakly present (Figure 3.17B). It was postulated that the cells 
expressing higher levels of E6/E7 RNA might be exiting the basal layer. Consequently, the 
same analysis was carried out on the second and third layers of cells in addition to the first. 
The bimodality of expression became more apparent in layer 2 (Figure 3.17C), and the 
bimodality was found to be statistically significant in layer 3, which is shown in Figure 3.17D 
(p = 0.00059). These three layers were then plotted together on the same histogram in relative 
frequencies to account for the slight differences in the size of the individual groups (Figure 
3.17E). The data clearly showed an increase in individual cells expressing greater levels of 
E6/E7 RNA as the layers are progressed through from the bottom upward. These data also 
demonstrated that a subset of cells expressing lower levels of E6/E7 RNA are still present in 
the second and third layers. 
 
It was considered whether further analysis of the data might identify the subset of cells 
expressing high levels of E6/E7 RNA by considering another variable, such as the 
morphology of the cell. To look at morphology, ‘eccentricity’ of the cell was calculated using 
the centric point of the cell to estimate “roundness”. The further from a perfectly round shape 
the cell was, the more ‘eccentric’ it was considered to be. The methodology behind this 
concept is demonstrated in Figure 3.18A. Mathematical calculations of the eccentricity of 
cells were carried out by Dr Alberto Giaretta. The calculated eccentricity of each cell was 
plotted against the level of expression of E6/E7 RNA of the same cell. Plotting of these data 
showed that there was a visible trend between increasing eccentricity and increasing E6/E7 
expression, however this was found to be statistically not significant (Figure 3.18B). 
 
While eccentricity gives a crude measurement for the roundness of cells, this is not a perfect 
correlate with basal exit; our lab considers decreasing contact with the basement membrane to 
be indicative of detachment and entry into subsequent differentiation programmes, and this 
link between detachment and differentiation in keratinocytes has been considered in the 
literature (Grose, Hutter et al. 2002). Therefore, the original datasets for each lesion were 




appearance suggested they may be exiting the basal layer. For example, if the cell body was 
thin and considerably longer lengthways than the length of the cell that was attached to the 
basement membrane, or if the cell shape was notably wide at the top with limited attachment 
at the basement membrane, these cells were selected. Examples of such cells are shown with 
yellow dots and white arrows in (Figure 3.19A). 
 
Selection of cells based on morphology was once again carried out using only the DAPI 
images of the lesion basal cells to allow unbiased selection. Results showed that E6/E7 
expression in the selected cells group (n=89) was significantly higher than in the unselected 
cells group (n=369) (Figure 3.19B). These data suggested that basal exit and increased 
expression of E6/E7 above a certain threshold might be linked in the MmuPV1 model of PV 
infection. IHC has the drawback of only being able to examine cells in the snapshot in time at 
which the tissue was sampled. Consequently, gaining a more in-depth understanding of the 
mechanics behind the phenotype observed was difficult without substantial time investment 
and high usage of an expensive process. PVs have long been known to affect commitment to 
differentiation (McCance, Kopan et al. 1988), therefore it was decided that examination of 
this phenotype in a cell culture model wherein individual protein functions can be discretely 
analysed would be carried out. 
Figure 3.18 Eccentricity of cells correlates with increasing E6/E7 expression intensity  
A; Diagram to demonstrate how eccentricity is calculated. Eccentricity is calculated by 
plotting a right-angled triangle from the centre of the shape to the edge of the shape, and 
dividing side c by side a, as shown. B; Cell eccentricity is plotted against E6/E7 RNA 
expression intensity to demonstrate any correlation. Red line plotted is a line of best fit of 
the data shown. Eight discrete lesions from three different mice, n=5 images analysed per 







This chapter examined ways in which the MmuPV1 model of PV infection might be 
improved by more reproducible wounding events, and characterised normal wound healing in 
the tail epithelium of immunodeficient mice to allow better understanding of the timings 
around wound healing and the mechanics of the process. There are varied methods of 
wounding employed by research groups studying mouse PV, including careful scarification of 
the site using a needle (Sundberg, Stearns et al. 2014) and induction of trauma to the tail site 
using a Dremel rotary drill (Jiang, Wang et al. 2017). Brief comparison of two such methods 
determined that scarification with a 27-gauge needle provided a wound site that was most 
reliable to locate. However, this did mean that issues with reproducibility might be introduced 
as a result of human error. Research into replicable in vitro wounding yielded a novel 
stamping method to create almost identical wounds across different samples (Lan, Geng et al. 
2010) but this was not applicable to in vivo studies; the rubber-stamping method described 
could disrupt cell monolayers but would not be forceful enough to effectively injure the full 
thickness of mouse tail skin. 
Figure 3.19 Manual selection of cells on the basis of morphology demonstrates that 
intensity of E6/E7 expression correlates with cell morphology indicative of basal exit 
A; DAPI channel image of infected cells to demonstrate cells selected for morphology 
suggesting basal exit, annotated with white arrows and yellow spots. B; Box plot to show 
the intensity of E6/E7 RNA expression per cell of two groups. Group 1 (red) contains all 
cells selected for a morphology suggesting exit from the basal layer (n=89). Group 2 (blue) 
contains all cells not selected for a basal exit morphology (n=369). P-values were 
calculated with a Kolmogorov-Smirnov t-test; *** = P ≤ 0.0005. Eight discrete lesions 
from three different mice, n=5 images analysed per site. Data were pooled from these to 
build histogram datasets. 
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The identification of discrete stages of wound healing was useful in understanding the 
mechanics behind how a wound heals over following injury. From the activation and 
appearance of K17 positive cells over time, it is clear that keratinocytes with this migratory 
phenotype are crucial in the healing of a superficial wound to the mouse tail. Superficial 
wounding to human skin also results in the induction of K17 in keratinocytes (McGowan 
1998), suggesting that the mouse epithelium is a reasonable comparison to human in this 
respect. K17 has also been shown to be upregulated following stimulation of inflammation 
and proliferation pathways, further validating it as a useful marker of a healing wound 
(Quigley, Kandyba et al. 2016). Investigation into virus titre and speed of lesion formation 
using observational studies and RNAscope clearly demonstrated a relationship between the 
two. Higher virus titres resulted in lesions developing at a quicker pace. In some tissues 
samples, such as those shown in Figure 3.4, positive E6/E7 RNAscope signal can be seen 
beneath the basement membrane. However, examination of these samples using a fluorescent 
microscope found that such RNAscope signal located in the basement membrane was due to 
surplus tissue debris resulting from sample block cutting, and did not indicate true positive 
signal within intact cells.  
 
Examination of the earliest possible stages of lesion formation with the immunodeficient 
athymic Hsd: AthymicNude-Foxn1nu mouse (Envigo, UK) model of PV infection was 
carried out to elucidate expression patterns as a lesion is first beginning to form. The earliest 
stage of lesion formation was detected with E6/E7 RNA expression in basal cells just two 
days following infection, and E4 protein was not yet present in these cells. Similarly, no L1 
protein was present. An important observation was that viral gene expression only began once 
the epithelial denudation had been entirely repaired through re-epithelialisation by K17 
positive keratinocytes. A previous experiment observed that, of the different methods 
examined, only a microwound that retained the basement membrane but removed the entire 
epithelium resulted in infection of basal epithelial cells (Roberts, Buck et al. 2007). This was 
because virus was shown to first attach to the basement membrane prior to entry into the basal 
cells. Such a mechanism might explain the phenotype observed in this experiment; virus 
could adhere to the basement membrane and then only infect basal cells once migratory 
keratinocytes have reepithelialised across the wound site containing infectious virus particles. 
Consolidation of recent research demonstrates that a complicated interplay of factors within 
the wound environment allows successful infection of basal cells (Ozbun 2019). This 
complexity should be kept in mind during future analyses. 
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Observations also suggested that lesions may initially form from multiple foci of infected 
cells expanding in the basal layer to form one continuous region of infected cells. This is 
contrary to previous research in the PV field that has suggested that common warts are clonal 
in origin (Murray, Hobbs et al. 1971). Conversely, analysis of cellular origins in a different 
wart type, condylomata acuminate, suggested that the genital warts examined were of 
multicellular origin (Friedman and Fialkow 1976). A consensus on cellular origins of warts 
has yet to be reached. It is possible that warts are originally multicellular in origin, but that 
competition between cells, and an increased ‘fitness’ of one subset of cells compared with 
another, may eventually lead to elimination of cells of other origins from the wart itself. Such 
mechanisms have been modelled and described previously (Amoyel and Bach 2014), and 
could explain disparate results observed within the PV field. In this instance, apparent 
multiple foci observed within this chapter may also be due to the relatively high titre of virus 
stock used when compared to natural routes of infection, or may be a mechanism exclusive to 
the pi types of PV infection. Further consideration is required. 
 
Immunocompetent C57BL/6J mice were infected in parallel with the immunodeficient model. 
Thorough analysis of 33 discrete wound sites allowed location of two microlesions in these 
immunocompetent mice. Whilst appearing to be briefly productive at one of these sites, no 
macroscopic lesions formed on the tail, which was in agreement with previous research 
(Sundberg, Stearns et al. 2014). It was inferred from their relatively rare occurrence rates 
when compared to the immunodeficient model, that these microlesions occur transiently 
before clearance by the immune system. Or, they may occur at such small, controlled sites 
that they are simply extremely hard to locate. It has been demonstrated that adaptive immune 
surveillance, importantly by T cells, is the likely way in which MmuPV1 is prevented from 
forming macroscopic tail lesions in fully immunocompetent C57BL/6J mice (Handisurya, 
Day et al. 2014). Based on these immune-depletion studies it was shown that depletion of 
either CD4+ or CD8+ cells was sufficient to allow development of MmuPV1 lesions in 
SENCAR mice, a strain bred for high susceptibility for chemical carcinogen induction of skin 
tumours. However, in C57BL/6 mice, depletion of both CD4+ and CD8+ was required for the 
induction of papillomas at the infection site, demonstrating that the C57BL/6 is more resistant 
to MmuPV1 infection through T cell-dependent mechanisms. Therefore, it is likely that in our 
model, development of macroscopically visible papillomas is controlled by T cell infiltration 
at the site of infection. 
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Evidence of established virus infection has been demonstrated in immunocompetent mice 
previously by qPCR, at both cutaneous and mucosal sites in immunocompetent mice (Cladel, 
Budgeon et al. 2017). Another research group has also shown that immunocompetent FVB/NJ 
mice became susceptible to MmuPV1 infection and developed papillomas at infected sites 
following irradiation with UVB (Uberoi, Yoshida et al. 2016). Interestingly, papillomatosis 
still occurred at the infection site even when the ear inoculated with virus had been protected 
during UVB exposure of the mouse prior to infection. These data suggested that an indirect 
systemic immunosuppressive effect of UVB spectra UVR was responsible for the increased 
susceptibility of the mouse to MmuPV1 infection. Exposure to UVR has been correlated to 
incidence of cutaneous HPV in both immunocompetent and immunocompromised individuals 
(Chen, McMillan et al. 2008) (Hampras, Giuliano et al. 2014), demonstrating a role for UVR 
in ameliorating progression of PV infection in humans. Overall, involvement of the immune 
system is clearly important in modulating MmuPV1 infection, which is similar to beta PV 
type infection, suggesting that MmuPV1 is likely to employ similar life cycle mechanisms to 
those observed in the beta types. 
 
More recently, a model of transmissible genital disease was established using 
immunocompetent FVB mice (Spurgeon, Uberoi et al. 2019). FVB mice have an unusually 
high susceptibility to development of chemically induced squamous cell carcinomas 
(Hennings, Lowry et al. 1993). However, discrete lesions have never been observed in 
C57BL/6J mice before. It is likely that the microlesions observed were either too early to 
have been detected and subsequently removed by the adaptive immune system, or were 
already regressing following immune cell interaction. Such immune modulation is similar to 
what is observed in infections with HPV of the beta genus. Although infection with this genus 
is largely asymptomatic, problems often arise with immunosuppression, for example 
following surgery in kidney transplant recipients (Borgogna, Olivero et al. 2018), or in those 
suffering with human immunodeficiency virus (HIV) (van der Burg and Palefsky 2009), 
indicating that presence of a functioning adaptive immune system is what keeps the virus 
from symptomatic infection. In more recent research with the mouse PV model, similar low-
level infection has successfully been shown in NOD/SCID mice (Cladel, Budgeon et al. 
2017). These data are promising for the future use of immunocompetent models of PV 




Following quantitative analysis, a change in cell density in early visible lesion sites analysed 
was found to be statistically significant, when compared to three control groups. Previous 
research has indicated that high-risk type HPV16 is also able to modulate basal cell density 
(Kranjec, Holleywood et al. 2017), therefore MmuPV1 may be able to induce similar 
phenotypes in vivo through the same or alternate mechanisms. It was determined that the 
likely cause of this increase in density would either be increased drive into DNA replication at 
the site of infection, or an ability of the infected cell to persist in the basal layer, overcoming 
normal density restrictions. Quantification of mitotic cells using phosphorylated Histone 3 as 
a marker proved difficult, however using BrdU allowed visualisation of cells that had 
undergone DNA synthesis during the time incubated with the thymidine analogue. An 
increased number of cells undergoing DNA synthesis in the basal layer of both early and 
established lesions when compared to two control groups suggested that this was not the sole 
cause of the increase in density. An increase in infected cells undergoing DNA synthesis was 
similarly shown in a recent paper (Meyers, Uberoi et al. 2017) in what would be termed in 
this set of experiments as an “established” lesion based on the morphology of the lesion 
shown. 
 
The next consideration was whether the process of terminal differentiation was occurring 
normally in virus-infected tissue. Examination of the differentiation status of the lesion 
revealed a delay in differentiation in all lesion sites examined, from early stage to established 
lesions. This is in agreement with research recently carried out (Meyers, Uberoi et al. 2017), 
and it was further demonstrated in our research that this increase in DNA synthesis occurred 
in early lesions as well as established lesions, and that it was not simply a by-product of 
wound healing. HES1 RNA expression was visualised, as the paper by Meyers and colleagues 
had also shown a decrease in HES1 expression in MmuPV1 E6 expressing Tert-immortalised 
human foreskin keratinocytes (iHFKs). Surprisingly, it was found that HES1 expression in 
tissue was not downregulated, and was in fact significantly higher in the basal cells of early 
lesions when compared to uninfected epithelium. From these data, it appeared that the 
presence of MmuPV1 infection in tissue prevented normal terminal differentiation. Whilst 
infected cells do eventually detach from the basal layer they do not immediately progress into 
differentiation, as shown by the delay in K10 staining. In addition, HES1 expression in 
MmuPV1 E6/E7 positive lesions persists to the upper layers. 
 
Recent research into the Notch signalling pathway has found that discrete ligand activation of 
the pathway can have distinct downstream effects. Importantly, it was found that Dll1 and 
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Dll4, two Notch ligands, modulated the Notch receptor in either short frequency-modulated 
pulses or sustained amplitude modulated signals respectively. Notch pathway activation by 
Dll1 led to upregulation of Hes1, whilst Dll4 signalling led to upregulation of Hey1 and HeyL 
(Nandagopal, Santat et al. 2018). Therefore, Hes1 cannot be considered to be directly 
representative of a Notch-directed differentiation phenotype in tissue; it appears two discrete 
pathways can be activated through the Notch receptor. Thorough research into the 
involvement of Notch in epidermal cell fate has distilled three discrete modes of action that 
Notch signalling activates in spinous cells. Firstly, there can be upregulation of genes required 
for suprabasal cell differentiation, along with downregulation of genes required expressed in 
the basal layer. In addition, Notch directs maintenance of a proliferative cell phenotype, but 
can also direct initiation of terminal differentiation. This research showed that Hes1 may in 
fact be required for maintenance of a proliferative phenotype, and that promotion of 
differentiation occurs by a Hes1 independent manner (Moriyama, Durham et al. 2008) An 
earlier paper also indicated that upregulation of Hes2 and Hey1 was dependent on a p63 
mediated downregulation of Hes1, demonstrating p63 modulation of Notch-dependent 
transcription (Nguyen, Lefort et al. 2006). Overall, it seems that HES1 expression in the 
tissue is indicative of Notch activation, however this is not necessarily a differentiation 
phenotype and is much more complex than originally thought. It is likely that the activation of 
HES1 seen in these data results from stimulation of a proliferative phenotype in the cells that 
are also positive for E6/E7 RNA expression. Further research into this interplay of pathways 
in the context of virus infection is required in the future. 
 
A more in-depth analysis of the expression patterns of MmuPV1 E6/E7 RNA in lesions 
revealed a substantial heterogeneity of expression among infected cells. Initial analysis 
carried out by hand selecting cells as regions of interest and quantifying intensity of 
expression per cell found a weak bimodality of expression. While this was not statistically 
significant, proving bimodality in biological systems is known to be difficult (Jackson, 
Tucker et al. 1989). To try to further validate this bimodality, a computer-based algorithm 
was established by a collaborator Dr Alberto Giaretta, wherein pixel intensity was quantified 
by giving each pixel intensity a relative value and normalising by cell area. Unfortunately, the 
bimodality was still not statistically significant using this method, and was in fact weaker. 
This may be due to the fact that an expanded data set was employed for the computer-based 
quantification. So, either the first groups of cells examined were more bimodal by chance 
than the larger population, or the tail effect could be impacting the larger dataset. The tail 
effect is where increasing size of tails in bimodal samples can disguise the bimodality of data 
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when undergoing statistical testing (Fiorio, Hajivassiliou et al. 2010). Further, the 
mathematical algorithm accounted for cell density, which could have altered the resulting 
spread of data.  
 
Additional mathematical examination of bimodality in the next two layers of cells revealed 
increasingly bimodal populations, with a statistically significant bimodal population of basal 
cells from the third layer. These data suggested that the heterogeneity of expression seen in 
the lower layers persists and becomes more extreme as the cells move upwards towards the 
surface of the epithelium. Therefore, the levels of virus gene expression are partially linked to 
detachment from the basement membrane, however a switch to the higher expressing 
subgroup does not occur in all cells. A paper investigating S-phase re-entry in high-risk E7-
expressing NIKS cells found that while some post-mitotic cells were able to re-enter the cell 
cycle after differentiation, a subset of cells instead demonstrated increased levels of 
accumulating cyclin E and p21cip1 protein in a replication incompetent complex (Noya, 
Chien et al. 2001). Formation of these distinct cell populations was attributed to an ability of 
normal cells to overcome unscheduled entry into S phase, and that virus induced cell cycle 
entry could only occur in cells with low levels of cyclin E and p21cip1. It is possible that a 
similar interplay of protective mechanisms between normal cells and levels of viral gene 
expression could be evident in the cells analysed in this experiment, which could explain the 
heterogeneity of gene expression observed.  
 
Further analysis of heterogeneous E6/E7 expression revealed a possible role of gene 
expression in basal exit. Leading on from the increase in bimodality observed through the first 
three layers, linking of intensity of E6/E7 expression to basal cell exit was attempted by 
plotting eccentricity of the cell (Rangamani, Lipshtat et al. 2013) against the E6/E7 
expression of that cell with another mathematical modelling set carried out by Dr Alberto 
Giaretta. Although a correlation was observed, this was not statistically significant. Following 
up on this work with further investigation, manual selection of cells revealed that the subset 
of cells selected for a morphology suggesting basal exit had a statistically significantly higher 
level of E6/E7 expression compared with the unselected cells. This strengthened the idea that 
basal cells might exist in two states of expression, and that the higher expression state might 
trigger or be triggered by exiting from the basal layer, whereas lower level expression is still 
able to mediate an advantageous environment for the infected basal cells. The discovery of 
the bi-stability of cells in recent years has given researchers more to consider when 
investigating the differentiation of cell populations. For example, whilst existing in the same 
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environment, only a small subset of a population of genetically identical Bacillus subtilis cells 
will differentiate into genetically transformable cells (Lopez and Kolter 2010). The 
bimodality of cells can sometimes be interpreted as a sort of feedback loop within the cells, 
self-regulating the expression of certain factors within the population. Given the 
heterogeneity of HES1 RNA also observed within these cell populations, regulation of the 
Notch signalling pathway is a likely candidate for how E6/E7 is mediating an effect on the 
cell population. 
 
The work carried out in this chapter improved the mouse model of PV infection in our lab by 
furthering the understanding of the healing wound and examining virus gene expression and 
protein localisation in a range of early lesion formation stages. The observation of novel 
C57BL/6J mouse tail microlesions supported the current understanding of immune 
modulation being important in keeping viral infection under tight control in an 
immunocompetent host. A role for MmuPV1 in resisting normal basal cell density restrictions 
was also uncovered, and this was potentially linked to MmuPV1 E6/E7 RNA expression in 
particular. Data suggested that heterogeneous expression of E6/E7 RNA occurs in MmuPV1 
cutaneous lesions, and that this may further expose a bimodality in expression linked to the 
modulation of basal exit and the delay in differentiation observed. To better understand and 
expand upon the effect of individual MmuPV1 proteins E6 and E7 on cells, establishment of 





The mouse PV MmuPV1 provides a useful model of PV infection in a small, manageable lab 
animal (Hu, Cladel et al. 2017). Previous research has uncovered an involvement of MmuPV1 
in delay of differentiation (Meyers, Uberoi et al. 2017). Investigations detailed in Chapter 3.0 
confirmed this observation, and further demonstrated that the delay in the differentiation 
programme and an increase in basal cell density could be seen in the earliest stages of lesion 
formation alongside E6/E7 RNA expression, suggesting involvement of E6/E7 in the 
phenotypes observed. However, it was difficult to distil precise mechanisms of these proteins 
individually in tissue due to the length requirements of the ZZ probes. To properly understand 
the roles of E6 and E7 in the phenotypes observed in vivo, it was important to establish an 
appropriate cell culture system, which would allow quantification and analysis of the effects 
of virus proteins on cells. Therefore, in an effort to uncover the individual roles of MmuPV1 
E6 and MmuPV1 E7 in modulation of cell density and differentiation delay, NIKS cell lines 
stably expressing MmuPV1 E6, MmuPV1 E7, or empty LXSN control vector were 
established. Our lab has previously used cell lines exogenously expressing virus proteins to 
investigate the interplay between the HPV E6 and E7 accessory proteins and the replicative 
machinery of the cell (Murakami, Egawa et al. 2019). This approach has been widely used in 
the field of PV research for many years and has been critical in understanding the roles of 
individual viral proteins (Eldakhakhny, Zhou et al. 2018) (Kranjec, Holleywood et al. 2017) 
(An, Hao et al. 2017) (Francis, Schmid et al. 2000, Rozenblatt-Rosen, Deo et al. 2012, 
Eldakhakhny, Zhou et al. 2018) (Halbert, Demers et al. 1991). 
 
Retroviral vectors can be used to transfer genes into eukaryotic cells in a highly efficient 
manner (Miller 1992). To generate infectious virus, 293TT cells are co-transfected with 
plasmids supplying packaging genes viral gag-pol, viral envelope proteins, and the gene of 
interest flanked by LTRs to ensure integration of the transfer plasmid sequence into the host 
following infection. A promoter must also be included in the sequence of this plasmid to 
ensure successful expression following insertion into the host genome. 293TT cells are 
commonly used during this stage of retrovirus generation because they have high transfection 
efficiency and grow predictably, resulting in a high yield of infectious virus. These cells are 
described in Section 2.2.1.5. After co-transfection with these plasmids, virions that contain 
the desired sequence plasmid are produced from the cells; the retroviral vector containing the 
gene of interest also contains a retroviral packaging sequence (Ψ+). Infection of target cells 
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with virus produced in 293TT cells results in stable expression of the desired gene within the 
host, however no further virus is produced; no gag-pol or env is present within the host 
recipient cell (Kurian, Watson et al. 2000). 
 
It was decided that two retroviral vectors would be used to generate cell lines exogenously 
expressing viral proteins: pLXSN and pQCXIN. pLXSN contains wt 5’ LTR for control of 
expression of the gene of interest, a multiple cloning site (MCS) for cloning in of the desired 
sequence using available restriction sites (Clark, 2005), and an SV40 promoter controlling 
expression of the neomycin resistance gene. Similar to pLXSN, pQCXIN possesses a MCS 
and neomycin resistance. Conversely, pQCXIN contains a CMV/MSV promoter and an IRES 
(internal ribosome entry site) which allows co-translation of the desired gene and the 
neomycin resistance gene. Although expression from these promoters varies between cell 
types, CMV has been shown to direct high level expression of genes in 293TT cells (Qin, 
Zhang et al. 2010). In keratinocytes, expression of genes from a CMV promoter is understood 
to be relatively higher than expression of genes directed by LTR (Lathion, Schaper et al. 
2003). Preparing constructs with both of these vectors would provide the means with which to 
express the viral proteins at two different levels, one expressing protein at high levels for 
validation of expression, and another to provide expression levels closer to what are believed 




To investigate how MmuPV1 affects the growth and differentiation of cells in the epithelial 
basal layer in more detail, NIKS cell lines exogenously expressing MmuPV1 E6 
(NIKS/MmuPV1E6-LXSN) or MmuPV1 E7 (NIKS/MmuPV1E7-LXSN) were generated. 
NIKS were chosen because they are a keratinocyte cell line; HPV requires infection of basal 
epithelia to initiate infection, and must complete their life cycle in tandem with keratinocyte 
terminal differentiation, therefore NIKS are an appropriate cell line to choose (Griffin, 
Cicchini et al. 2014). NIKS also have proven utility in successful expression of PV gene 
vectors, as described in Section 1.10.1. First, PCR amplification of MmuPV1 E6 and 
MmuPV1 E7 was carried out. Primers were designed to introduce a HA tag at the 5’ end of 
the E6 sequence, and a FLAG tag at the 3’ end of the E7 sequence. Resulting constructs run 
on a DNA gel are shown in Figure 4.1A (MmuPV1E6) and Figure 4.1B (MmuPV1 E7). 






Figure 4.1 Agarose gel electrophoresis to demonstrate stages of vector construction 
Ladder is always shown in lane 1. A; PCR amplification of MmuPV1 E6 with HA tag, 
expected size was around 500bp. Lane 2 – empty, lane 3 shows PCR amplification of E6. B; 
PCR amplification of MmuPV1 E7 with FLAG tag, expected size was around 400bp. Lane 
2 – empty, lane 3 shows PCR amplification of E7. C; BsrG1 RE digest of MmuPV1 E6 after 
insertion into pDONR221 entry vector. Expected band sizes were around 500bp for the 
insert and around 2000bp for the remaining backbone. Lane 2 – empty, lane 3 – BsrG1 
digest. D; BsrG1 RE digest of MmuPV1 E7 after insertion into pDONR221 entry vector. 
Expected band sizes following RE digestion were around 400bp for the insert and around 
2000bp for the remaining backbone. E; BsrG1 RE digests of MmuPV1 E6 LXSN vector and 
MmuPV1 E7 LXSN vector. Expected band sizes were around 6000bp for LXSN, 500bp for 
E6, and 400bp for E7. Lanes 2-7: replicates of MmuPV1 E6 LXSN construct. Lanes 8-13: 
replicates of MmuPV1 E7 LXSN construct. F; BsrG1 RE digests of MmuPV1 E6 PQCXIN 
constructs. Expected band sizes following RE digestion were around 5000bp, 1500bp and 
1000bp for PQCXIN, and around 500bp for E6. G; BsrG1 RE digests of MmuPV1 E7 
PQCXIN constructs. Expected band sizes following RE digestion were around 5000bp, 
1500bp and 1000bp for PQCXIN, and around 400bp for E7. 
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Wizard SV Gel and PCR Clean-Up kit (Promega, UK), gateway cloning technology 
(ThermoFisher, UK) was then utilised to insert the desired sequences into pDONR221 entry 
vector plasmids, to generate donor plasmids for the subsequent reaction. Success of this 
reaction was confirmed by BsrG1 restriction enzyme (RE) digestion of the resulting construct, 
shown in Figure 4.1C (MmuPV1 E6) and Figure 4.1D (MmuPV1 E7). Entry vector 
pDONR221 is 4762bp. Band sizes were as expected following digestion with Bsrg1; inserts 
were around 500bp, and total vector size following successful insert of the desired sequence is 
around 2000bp. A BP reaction was then carried out to transfer the desired inserts from the 
pDONR221 entry vector into selected vectors pLXSN and pQCXIN. Following this BP 
reaction, pLXSN and pQCXIN constructs were once again subjected to BsrG1 RE digestion 
to check correct insertion of E6 and E7 tagged sequences as shown in Figure 4.1E (MmuPV1 
E6 and E7 LXSN), Figure 4.1F (MmuPV1E6 pQCXIN) and Figure 4.1G (MmuPV1 E7 
pQCXIN). Band sizes for pLXSN vector RE digests were expected to be around 6000bp, 
500bp for E6, and 400bp for E7. BsrG1 RE digests of pQCXIN vectors were expected to 
show bands with sizes that were around 5000bp, 1500bp and 1000bp for pQCXIN, with 
500bp for E6, and 400bp for E7. The expected sizes were observed in all cases, and following 
Sanger sequencing it was confirmed that the sequences had been correctly inserted into the 
expression vectors with no base pair mutations (Eurofins, UK).  
 
An HA tag was present in the E6-containing vectors to allow detection of the protein by 
western blot to confirm expression. Similarly, a FLAG tag was present in the E7-containing 
vectors to allow detection via western blot. Further, these tags would allow any future use of 
cell lines in immunoprecipitation (IP) assays. pQCXIN constructs were transiently transfected 
into 293TT cells to allow detection of expression of E6 and E7 protein via their respective 
tags, as shown in Figure 4.2A. An HA tagged HPV1 construct designed by another member 
of the lab (Ke Zheng, 2019 unpublished) was used as a positive control during western 
blotting. When this experiment was attempted with the proteins expressed in the LXSN 
vectors, it was not possible to detect the proteins by western blotting, or by IP. Therefore, 
successful expression in the LXSN constructs was further tested using RT-PCR to confirm the 
presence of RNA transcripts, as shown in Figure 4.2B. GAPDH primers were used to confirm 
cells were present and that cDNA synthesis had been successful. MmuPV1 E6 primers were 
used to detect E6 expression, which were amplified in the NIKS/MmuPV1E6-LXSN and 
NIKS/MmuPV1E6R130A-LXSN cells, and negative in NIKS/MuPV1E7-LXSN and 
NIKS/LXSN cells. Similarly, MmuPV1 E7 primers were used to detect E7 expression, which 







Figure 4.2 Validation of cell lines exogenously expressing key viral proteins 
A; Expression of protein in cells was validated by transient transfection of PQCXIN 
constructs into 293TT cells and Western Blotting of protein samples to show presence of 
expressed protein. Expression of HA tagged protein can be seen in MmuPV1 E6, MmuPV1 
E6R130A, and HPV1 E6 samples, but not in MmuPV1 E7. Conversely FLAG tagged protein 
was only detected in MmuPV1 E7 samples, and not in the other three. B; Expression in 
LXSN, MmuPV1 E6 LXSN, MmuPV1 E6R130A LXSN, and MmuPV1 E7 LXSN was 
confirmed at the RNA level following cDNA synthesis from each sample, PCR and gel 
electrophoresis to check presence of bands for each sample. A reverse transcriptase (RT) 
negative control was included for each sample (cDNA synthesis was run without addition of 
RT enzyme). C; Viral transcripts from NIKS, MmuPV1 expressing NIKS, 
NIKS/MmuPV1E6-LXSN, NIKS/MmuPV1E7-LXSN, NIKS/MmuPV1E6R130A-LXSN and 
HPV16 expressing NIKS grown to sub-confluence were examined following cDNA 
synthesis and subsequent qPCR analysis. For quantification of MmuPV1-E7 LXSN copies, 
a MmuPV1 E7-specific qPCR probe was used. For quantification of HPV16 genome copies, 
a HPV16 E4-specific qPCR probe was used. The remaining samples were quantified using a 
MmuPV1 E6-specific qPCR probe. Details of qPCR probes used can be found in 2.5.12. 
Data shows the activity of the early promoter in each case and quantity was normalised to 
copies per 1000 GAPDH.  
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NIKS/LXSN cells, and amplified in NIKS/MmuPV1E7-LXSN cells. RT-negative controls 
were included for each sample to further validate the synthesis of cDNA. qPCR of cDNA 
transcripts was employed to quantify the relative expression of RNA in the NIKS cell lines 
versus expression from a cell line transfected with the MmuPV1 genome to estimate early 
promoter activity. Results showed that levels of expression of target RNA from the LXSN 
vector were substantially higher than what was observed in cells transfected with MmuPV1 
genome, as shown in Figure 4.2C. Previous data from our lab has suggested that NIKS cells 
may not be able to support high expression of HPV11 E6 and E7; activity of the HPV11 early 
promoter (p90) was relatively low in NIKS, when compared to that of the HPV16 early 
promoter (p97) (Murakami, Egawa et al. 2019), which was much higher and is also shown in 
Figure 4.2C for comparison. These data demonstrated that PV promoter activity in NIKS can 
vary widely. Therefore, although expression of MmuPV1 E6 and E7 RNA in LXSN cell lines 
appears to be higher than expression levels from MmuPV1 genome, these levels of expression 
from LXSN may still be biologically relevant. It is also plausible that other factors could 
impact upon the levels of protein expression from the promoter. For example, altering codon 
usage has been previously shown to result in increased mRNA stability and subsequent 
alterations in L1 protein expression (Collier, Goobar-Larsson et al. 1998). Expression levels 
of HPV16 genome in NIKS cells is substantially higher, which may reflect that NIKS could 
be a more appropriate cell host for this high-risk PV type. As such, it was considered 
reasonable to progress with experiments whilst remaining aware that exogenous levels of 
protein expression might not be a completely accurate reflection of expression levels in vivo. 
Validation of an E6 mutant (NIKS/MmuPV1E6R130A-LXSN) was also shown in this figure, 




As an increase in cell density and cell proliferation had been quantified in vivo, 2D monolayer 
growth assays were carried out to establish the role of each protein in vitro, as shown in 
Figure 4.3A. From days one to three, before cells had reached confluence, there was no 
significant difference in the growth of cells across all three groups. At day four, when the 
cells had just reached confluence, the number of NIKS/MmuPV1E6-LXSN cells was 
significantly greater than NIKS/MmuPV1E7-LXSN cells (**p ≤ 0.01) indicating a slight E6-
mediated proliferative advantage over the other groups. At day seven there was no significant 
difference between the number of NIKS/LXSN and NIKS/MmuPV1E7-LXSN cells, which  
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Figure 4.3 Exogenous expression of MmuPV1 E6 LXSN leads to higher cell density and 
differentiation delay 
A; NIKS/LXSN, or NIKS expressing MmuPV1 E6 or E7 were counted in triplicate every 
day. Cells were pre-confluent at 3 days, confluent at 4 days, and post-confluent by day 5. 
Three independent experiments, n=3. P-values were calculated with a two-way ANOVA with 
Tukey’s correction; **** = P ≤ 0.0001. three independent experiments, n=3. B; Cells were 
stained with K10 (red) at both pre-confluence (day 3) and post-confluence (day 7). Panels 
show IF detection of K10 at these time points for each cell population. Nuclei were 
counterstained with DAPI to show host DNA. Scale bar: 100 µm. Light microscope images 
for each time point are also shown. Red arrows denote presence of ring-like structures in cell 
monolayer morphology. Black arrows denote the presence of bright, rounded cells. C; 
Quantification of the number of cells positive for K10 per microscope field at 5X 
magnification was carried out for each cell population. Number of K10 positive cells was then 
normalised to number of cells per field in each population to give a percentage of positive 
cells. Two independent experiments, n=5. P-values were calculated with Kruskal-Wallis test 
with Dunn’s correction; * = P ≤ 0.05, ** = P ≤ 0.01. Error bars, SD. 
Figure	4.3	Exogenous	expression	of	MmuPV1	E6	LXSN	leads	to	higher	cell	density	and	differentiation	delay	
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reached 1.55x106 and 1.53x106 cells respectively. In contrast, NIKS/MmuPV1E6-LXSN cells 
reached 3.1x106 cells, a significantly higher density when compared to the other two groups 
(****p ≤ 0.0001). NIKS/MmuPV1E6-LXSN cells are able to grow to much higher cell 
densities than NIKS/LXSN and NIKS/MmuPV1E7-LXSN cells, demonstrating that MmuPV1 
E6 plays an important role in maintaining the proliferative capacity of the cells beyond 
confluence. 
 
As shown in brightfield images (Figure 4.3B), the morphological appearance of the 
NIKS/LXSN cells by day 7 was deemed to be highly differentiated due to the ring-like 
structures often observed within our model in differentiating cultures (shown with red 
arrows), whereas in NIKS/MmuPV1E6-LXSN cells the small, bright, rounded cells are 
indicative of cells that are still undergoing replication (denoted with white arrows). Analysis 
of K10 staining in all three populations indicated that at low densities almost all cells lacked 
K10. However, at high density, while NIKS/LXSN and NIKS/MmuPV1E7-LXSN cells 
showed a similar level of K10 expression per field, NIKS/MmuPV1E6-LXSN cells had 
noticeably lower expression levels of K10. This shows that the effect of MmuPV1 on 
differentiation seen in vivo is also observed in the cell culture model, and that it is reasonable 
to postulate that MmuPV1 E6 is responsible for this phenotypic change. Quantification 
analysis of the number of K10 positive cells per field was carried out on randomly selected 
fields (n = 5) in each category. Analysis showed that when data was normalised by the total 
number of cells per field to calculate the percentage of positive cells per field, there was a 
statistically significant decrease in the percentage of K10 positive cells per field (**p ≤ 0.01) 
in NIKS/MmuPV1E6-LXSN cells when compared to the other two groups. These results are 




During experimentation with K10 staining, it was noted anecdotally that in normal NIKS 
cells, cells that stained positive for K10 often had noticeably differing morphology, wherein 
the K10 positive cells appear large and possibly flatter than cells that are K10 negative. As 
such, a more thorough investigation of this morphology was carried out by staining post-
confluent normal NIKS samples for K10, and examining the samples using confocal 
microscopy. As demonstrated in Figure 4.4, not only do we see that K10 positive cells do 




in the lower layer were largely negative for K10 staining, whereas cells in the upper layer 
were predominantly K10 positive. This revealed a critical aspect to our monolayer culture 
system, demonstrating that cells behaved differently in these discrete layers within monolayer 
culture. It was postulated that this layering of cells could allow a rough recapitulation of the 
basal layer and the parabasal layer in vivo, and that important protein functions might be 
discerned through more thorough analysis of cell populations in this manner. As work 
previously described in Chapter 3 showed that infected cells could be persisting in the basal 
layer by overcoming normal density restrictions, it was decided that growth characteristics 
would be observed by generating a set of fluorescent cell lines for competition assay analysis. 
Figure 4.4 Confocal microscopy shows distinct biologically important layering of cells  
Confocal microscopy Z-stacked image of NIKS cells at day seven cultured in medium with 
10ng/ml EGF. K10 positive cells are shown in green, and nuclei were counterstained with 
DAPI to show host DNA. Central square image shows surface layer of cells from z stack 
cross section. Below and to the right of this image, cross sections down both sides of these 
cells are shown. A layer of K10 negative cells can be seen, forming a lower layer. The cells 




To investigate the idea of the preferential persistence of infected cells in the basal layer in 
vivo leading to the increased density observed as lesions first begin to form, fluorescent 
NIKS/LXSN, NIKS/MmuPV1E6-LXSN and NIKS/MmuPV1E7-LXSN cell lines were 
generated to observe their relative cell growth characteristics over time in a cell competition 
assay system. Construction of the cell lines is shown diagrammatically in Figure 4.5. First, 
early passage NIKS cells were cultured in normal conditions until sub-confluent. Cells were 
then split into two populations. Each population was then transduced to express either EGFP, 
for a green fluorescent cell line, or mCherry, for a red fluorescent cell line. Next, cells were 
transduced with appropriate vectors. It was decided that the green cells should act as the 
control population, and so this population was transduced with LXSN only (NIKS/LXSN 
EGFP). In tandem, mCherry cells were split into three flasks, to allow a control LXSN 
mCherry cell line (NIKS/LXSN mCherry), an MmuPV1 E6 cell line (NIKS/MmuPV1E6-
LXSN mCherry), and an MmuPV1 E7 cell line (NIKS/MmuPV1E7-LXSN mCherry), to be 




Figure 4.5 Diagram demonstrating generation of fluorescent cell lines  
Fluorescence exogenous expression vectors were transduced into normal early passage 
NIKS cells, which were then subsequently transduced with expression vectors. EGFP cells 
were transduced with LXSN control vectors only. Different populations of mCherry 
expressing cells were transduced with LXSN, MmuPV1 E6, or MmuPV1 E7 constructs. 
Cells were then seeded in competition assays at a 1:1 ratio in 4 well slide chamber. 
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Before virus transduction to express MmuPV1 virus proteins, cell lines were observed using a 
fluorescent microscope following transduction to express either EGFP or mCherry. While 
many cells were expressing successfully, expression levels varied widely within each 
population, and expression was so low in some cells that it was undetectable at the highest 
exposures. This could be a result of random integration of the selected genes into the host 
genome during retroviral transduction, which can result in heterogeneous expression of the 
desired target gene within the resulting cell population (Bandeira, Tomas et al. 2017). 
Therefore, I decided that cells should be FACS sorted to allow the sub-population of cells 
expressing higher levels of the fluorescent proteins to be selected for subsequent 
experimentation. FACS sorting was carried out by Nika Romashova at the NIHR Cambridge 
BRC Cell Phenotyping Hub. During FACS sorting, viable cells were first gated for, as shown 
in Figure 4.6A and Figure 4.7A. Singlets were gated for to ensure only single cells were 
selected, as shown in in Figure 4.6B and Figure 4.7B. Cells were then split into four sub-
populations of cells based on intensity of fluorescence as shown in Figure 4.6C and D, and 
Figure 4.7C and D. The lowest expressing cells were excluded entirely as cells that would be 
expressing little or no fluorescent protein. Then four populations comprising of 
approximately, 10, 20, 30 and 10% of the total population were sorted as low, low-medium, 
medium, and high expressing cells respectively. IF images of the resulting cell populations 
are shown in in Figure 4.6E and Figure 4.7E. To minimise unidentifiable cells, the highest 
expression levels for each group were chosen, and subsequent transduction of vectors was 
carried out as described above in preparation for experimentation. 
4.2.5	CELLS	EXOGENOUSLY	EXPRESSING	MMUPV1	E6	PERSIST	IN	THE	‘LOWER’	LAYER	OF	CELLS	IN	
A	HIGH	CELL	DENSITY	CULTURE	ENVIRONMENT	
To investigate the impact of virus protein on cell growth mechanics and dynamics, cells were 
seeded at high density in 4-well slide chambers (ThermoFisher, UK), so that the different cell 
populations were able to grow competitively from confluence onwards. It was important to 
seed cells at a high density to ensure that no growth advantage conferred prior to confluence 
could affect the population densities. This guaranteed that any results observed were the result 
of cell competition within a restricted environment only. For each well, half of the population 
seeded were NIKS/LXSN EGFP cells, whereas the other half of the population were 
NIKS/LXSN mCherry, NIKS/MmuPV1E6-LXSN mCherry, or NIKS/MmuPV1E7-LXSN 
mCherry cells. Cells were then cultured for up to 10 days in this high-density competition 
assay, with the growth of these mixed cell populations being observed by confocal 
microscopy after collection and fixation. 
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Figure 4.6 FACS sorting of EGFP expressing cells 
A; Cells were gated to select out any debris within the sample. B; Cells were gated to remove 
any doublets and to select for single cells only. C; Cells were gated for fluorescence. Both 
EGFP (left) and mCherry (right) fluorescence was shown. Cells were gated in the EGFP 
channel into four populations of low (~9%), low-medium (~19%), medium (~26%), and high 
levels of expression (~9%). B; Microscopy images to show levels of fluorescence in each sub-




Figure 4.7 FACS sorting of mCherry expressing cells  
A; Cells were gated to select out any debris within the sample. B; Cells were gated to remove 
any doublets and to select for single cells only. C; Cells were gated for fluorescence. Both 
EGFP (left) and mCherry (right) fluorescence was shown. Cells were gated in the mCherry 
channel into four populations of low (~8%), low-medium (~17%), medium (~25%), and high 
levels of expression (~10%). B; Microscopy images to show levels of fluorescence in each 
sub-population of cells in culture following FACS sorting. Scale bar: 100 µm. 
Figure	4.7	FACS	sorting	of	mCherry	expressing	cells	
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At day one (Figure 4.8A) all three experimental groups had an approximately 50-50 ratio of 
red versus green cells as was expected. A slight increase in red cells in both the NIKS/LXSN 
EGFP cells versus NIKS/MmuPV1E6-LXSN mCherry cells (LXSN/MmuPV1E6-LXSN) 
group and the NIKS/LXSN EGFP cells versus NIKS/MmuPV1E7-LXSN mCherry cells 
(LXSN/MmuPV1E7-LXSN) group was apparent, and although not statistically significant, 
this may suggest a slight advantage in cell attachment over control cells. At day ten ( 
Figure 4.8B), there were approximately 50% of each cell population occupying both the lower 
and upper layer of cells in the NIKS/LXSN EGFP versus NIKS/LXSN mCherry 
(LXSN/LXSN) group and in the LXSN/MmuPV1E7-LXSN group. The lower layer was 
selected by raising the scanning level of the confocal microscope until the first layer of nuclei 
were apparent and the focus line was approximately half way through these cells. The upper 
layer of cells was determined to be at a scanning level approximately 10 µm higher than the 
first layer; this distance was then kept consistently across all experiments. Conversely within 
the LXSN/MmuPV1E6-LXSN group, the vast majority of cells occupying the lower layer of 
cells in culture were NIKS/MmuPV1E6-LXSN mCherry cells (92.59% red cells), whilst the 
upper layer of cells consisted almost entirely of NIKS/LXSN EGFP cells (94.28% green 
cells). This suggested that NIKS/MmuPV1E6-LXSN mCherry cells were preferentially 
persisting in the lower layer of cells. 
 
To observe these phenotypes in 3D, z-stacks of areas of cells manually selected for high 
density were constructed. Figure 4.9A shows a maximum intensity side view of orthologue 
plots for each of the cell populations. This again demonstrates that in the LXSN/LXSN and 
LXSN/MmuPV1E7-LXSN groups, cells expressing EGFP or mCherry can be seen distributed 
in roughly equal measure in both layers. Conversely, in the LXSN/MmuPV1E6-LXSN group, 
a lower layer of mCherry expressing cells can clearly be seen, whilst the upper layer consists 
of almost exclusively EGFP expressing cells. Finally, the pattern of expression of EGFP and 
mCherry is quantified in Figure 4.9B, shown as the levels of fluorescence intensity against 
distance from the bottom of the slide. Data shows that in the LXSN/MmuPV1E7-LXSN and 
LXSN/LXSN groups, there are roughly equal levels of mCherry and EGFP fluorescent 
intensity in both layers. Conversely, in the LXSN/MmuPV1E6-LXSN group, there is a clear 
pattern of higher mCherry fluorescent expression in the lower layer, and EGFP fluorescent 
expression further away from the surface of the slide in the upper layer. Taken together, this 
data shows that expression of MmuPV1 E6 affords the cell a growth advantage over the 
control cell population to remain in the lower layer when in direct competition for space. This 
competitive advantage was not seen in the NIKS cells exogenously expressing MmuPV1 E7. 
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Figure 4.8 NIKS exogenously expressing MmuPV1 E6 preferentially persist in the lower layer of cells in a high-density competition assay 
Figure 4.8 NIKS exogenously expressing MmuPV1 E6 preferentially persist in the lower 
layer of cells in a high-density competition assay  
A; Proportions of cells at day 1 are shown with representative parts of a whole graphs. B; IF 
of LXSN/LXSN, LXSN/MmuPV1E6-LXSN, and LXSN/MmuPV1E7-LXSN. Cell population 
identity is indicated by colouring of text in the upper left corner of each image. Nuclei were 
counter-stained with DAPI for host DNA. Lower layer panels are shown to the left, alongside 
parts of a whole graphs to demonstrate quantitative data. Upper layer panels and 
accompanying parts of a whole graphs are shown to the right. IF images shown are confocal 
microscope tile scan images taken at 40X magnification with 5 by 5 fields. Two independent 
experiments, n=5. Experimental groups were compared with LXSN/LXSN control groups, 
and P-values were calculated with a two-way ANOVA with Sidak's multiple comparisons 




Figure 4.9 3D Maximum intensity plots demonstrate persistence phenotype  
A; Maximum intensity 3D plots of z-stacks at 63X magnification are shown for each of the 
three groups. Annotations show the location of the lower and upper layers. White dotted lines 
indicate the bottom of the slide glass on which the cells are cultured. The nuclei were counter-
stained with DAPI for host DNA. B; The fluorescent intensity of each channel was quantified 
across 8 different selections of three different z-stack images taken at 63X magnification for 
each group, and the average intensity has been plotted against distance from the bottom of the 




To examine the growth advantage in this lower layer in more detail, NIKS/LXSN, 
NIKS/MmuPV1E6-LXSN, and NIKS/MmuPV1E7-LXSN cells were cultured to high density 
in isolation, without competition with another cell population. Quantitative analysis of the 
lower layer of cells in each of these groups was carried out at day ten, as shown in Figure 
4.10A. Data demonstrated that at day ten, NIKS/MmuPV1E6-LXSN mCherry cells reached a 
significantly higher density in the lower layer of cells when compared to the separately grown 
NIKS/LXSN mCherry cells and the NIKS/MmuPV1E7-LXSN mCherry cells. Further to our 
previous result showing an increased density in NIKS/MmuPV1E6-LXSN cell culture, this 
data indicated that there is an increase in cell density specifically within the lower layer. This 
quantification of lower layer cell density for all three cell populations was repeated at a day 






day ten (Figure 4.10B), NIKS/LXSN mCherry cells and NIKS/MmuPV1E7-LXSN mCherry 
cells show no significant change in the density of the bottom layer of cells, whereas the fold 
change in NIKS/MmuPV1E6-LXSN mCherry cell density in the bottom layer of cells is 
significantly increased. Firstly, these data corroborate earlier results both in vivo and in vitro 
that demonstrated that MmuPV1 E6 expressing cells can grow to higher cell densities than 
control cells. Secondly, these data also suggest that increased basal cell density observed in 
the early mouse lesions in Chapter 3.0 was due primarily to MmuPV1 E6 expression. In 
addition, while not significantly denser, MmuPV1 E7 may also confer a mild growth 
advantage in this bottom layer; the number of cells in the bottom layer of NIKS/MmuPV1E7-
LXSN cell culture was higher than the NIKS/LXSN cell population, although not statistically 
significantly so. Finally, these data could suggest that it is not just the density of cells in the 
bottom layer affected, but the rate at which cells are exiting this bottom layer. To further 
understand the molecular pathways involved in directing this particular competitive 
advantage of MmuPV1 E6-expressing cells, a mutant of MmuPV1 E6 was generated.  
 
Figure 4.10 Differences in cell density of the ‘lower’ layer of cells 
A; Quantification of the number of cells in the bottom layer of each population (field size: 
800.22x800.22 µm). Five random 5 by 5 tile scans were chosen for quantification for each 
category. Quantification was carried out using the analyse particles function in FIJI image 
analysis software. B; Samples were analysed in the same manner at a day 7 timepoint. Five 
random 5 by 5 tile scans were chosen for quantification for each category. Quantification 
was carried out using the analyse particles function in FIJI image analysis software. Fold 
change between day 7 and day 10 was calculated. Two independent experiments, n=3. P-




Previously published research into the similarities between MmuPV1 E6 and HPV8 E6 
interactions with the Notch pathway confirmed that MmuPV1 E6 was able to bind to 
MAML1, and that this interaction delayed differentiation in Ca2+ treated keratinocytes 
(Meyers, Uberoi et al. 2017). It was shown that an E6 MAML1 binding mutant could not 
inhibit Notch signalling and that this mutant was unable to form papillomas in vivo. MAML1 
is a Notch receptor transcriptional co-activator (Wu, Aster et al. 2000) and Notch is known to 
be involved in normal terminal differentiation of keratinocytes (Mumm and Kopan 2000). As 
such, it was postulated that this pathway may be involved in the phenotype observed in the 
high-density competition assay, and that similar interference with MmuPV1 E6 MAML1 
binding in this model could indicate whether the downstream Notch signalling pathway was 
involved in modulation of the persistence phenotype. Therefore, a MAML1 binding mutant of 
MmuPV1 E6 was generated. A single point mutation termed R130A was introduced to the 
MmuPV1 E6 sequence such that binding to the protein was disrupted. Previously published 
data showed that mutation of this site resulted in disruption of E6 binding to MAML1 
(Meyers, Uberoi et al. 2017). Meyers and colleagues chose putative LXXLL contact residues 
as the site of mutation; interaction with MAML1 by MmuPV1 E6 was shown to occur via 
these residues. PCR amplification using the existing NIKS/MmuPV1E6-LXSN plasmid was 
carried out with primers designed to introduce the point mutation at the site of interest. 
Primers are shown in Chapter 2 (Table 2.10). 
 
RE digestion with BsrG1 was used to isolate the E6R130A fragment, as shown in Figure 4.11A. 
Gateway cloning technology was then utilised to insert the mutant construct into a pLXSN 
and pQCXIN vector. RE digestion with BsrG1 confirmed the correct sizes of bands were 
present when run on an electrophoresis gel, demonstrating that the construct had been 
successfully inserted into the vector, as shown in Figure 4.11B and Figure 4.11C. Prior to 
this, E6R130A fragment DNA samples were sequenced, and resulting sequence data was 
aligned with wt MmuPV1 E6 DNA (Figure 4.11D) utilising data and algorithms of the 
National Center for Biotechnology Information, by using the Basic Local Alignment Search 
Tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Mus musculus papillomavirus type 1 viral 
protein E6 mRNA, complete cds Sequence ID: MF350298.1, Length: 423) (Zhang, Schwartz 
et al. 2000). Subsequent sequencing alignment data showed that the two sequences were a 
99% match, with only 2 mismatches found. As shown with further visualisation of these data  
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Figure 4.11 Construction of MAML1 binding deficient MmuPV1 E6 
Ladder always shown in lane 1. A; PCR amplification of MmuPV1 E6R130A with HA tag from 
MmuPV1 E6 pDONR construct, expected size of desired band ~ 3000bp. B; BsrG1 RE 
digests of MmuPV1 E6R130A LXSN vector. Expected band sizes ~ 6000bp for LXSN and 
500bp for E6. C; BsrG1 RE digests of MmuPV1 E6R130A PQCXIN vector. Expected band 
sizes following RE digestion were ~ 5000bp, 1500bp and 1000bp for PQCXIN, and ~ 500bp 
for E6R130A. D; Sanger sequencing of MmuPV1 E6R130A BLAST alignment with wtE6. Sanger 
sequencing data of MmuPV1 E6R130A compared with wtE6 sequence is shown. AGA to GCA 
observed at desired site with DNA of good quality. E; Lysates of 293TT cells expressing HA-
tagged wt or mutant MmuPV1 E6 protein were subjected to an HA IP. Immunoprecipitated 
MmuPV1 E6 and associated MAML1 detected by immunoblotting. Expression levels of 
proteins were assessed by immunoblotting of whole cell extracts (WCE). GAPDH expression 




using SnapGene, the two mismatches were base pairs AG of the original sequence being 
substituted for GC within a AGA codon coding for Arginine. This substitution mutation 
resulted in Arginine being replaced with Alanine, as intended. The substitution can be seen 
highlighted in a red rectangle, and the altered amino acid is shown with red text within the 
sequence. Sequencing data demonstrated the successful introduction of a mutation in the E6 
sequence that should diminish the ability of the E6 protein to bind with MAML1 protein. An 
IP assay was then carried out to determine whether the NIKS/MmuPV1E6R130A-LXSN mutant 
did have a reduced ability to bind to MAML1, in comparison with wt MmuPV1-E6 and an 
empty vector control. Results confirmed that the NIKS/MmuPV1E6R130A-LXSN cells had a 
reduced ability to bind to MAML1 (Figure 4.11E). Presence of an HA-tagged protein was 
only detected in IP of NIKS/MmuPV1E6-LXSN and NIKS/MmuPV1E6R130A-LXSN cells, 
and not in the empty vector control. GAPDH demonstrated similar levels of input in the 
whole cell extract, but was not pulled down in the IP. Validation of successful expression of 




NIKS/MmuPV1E6R130A-LXSN cells were established, and a standard growth assay was 
carried out as shown previously in Figure 4.3. Cells were grown for seven days and sampled 
every day. Data showed that NIKS/MmuPV1E6R130A-LXSN cells had no significant 
difference in cell density at day seven when compared to NIKS/LXSN cells, unlike 
NIKS/MmuPV1E6-LXSN cells, which grew to a significantly higher density 
(****p ≤ 0.0001) by this time point (Figure 4.12A). NIKS/MmuPV1E6R130A-LXSN cells also 
no longer showed a delay in differentiation post-confluence when stained with K10 (Figure 
4.12B). Cell morphology was affected; brightfield microscopy revealed that ring-like 
structures were present in NIKS/MmuPV1E6R130A-LXSN cell populations (shown with red 
arrows) similar to NIKS/LXSN cells described previously in Figure 4.3B. This suggested that 
NIKS/MmuPV1E6R130A-LXSN cell populations were more differentiated than the wt 
NIKS/MmuPV1E6-LXSN cell populations. Quantification of the number of K10 positive 
cells demonstrated that the percentage of K10 positive cells per field was significantly lower 
in the population of cells expressing NIKS/MmuPV1E6R130A-LXSN (**p ≤ 0.05) when 
compared to the other groups. These data are shown in Figure 4.12C, which clearly 
demonstrates that the delay in differentiation observed and quantified in NIKS/MmuPV1E6-
LXSN cells is lost upon introduction of the E6 R130A MAML1 binding mutation.  
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Figure 4.12 MmuPV1 E6 interaction with MAML1 is required for post-confluent 
density increase and differentiation delay 
A; NIKS/LXSN, NIKS/MmuPV1E6R130A-LXSN or NIKS/MmuPV1E6R130A-LXSN cells were 
counted in triplicate each day. Cells were pre-confluent at 3 days, confluent at 4 days, and 
post-confluent by day 5. P-values were calculated with a two-way ANOVA with Tukey’s 
correction; **** = P ≤ 0.0001. Three independent experiments, n=3. B; NIKS/LXSN, 
NIKS/MmuPV1E6R130A-LXSN or NIKS/MmuPV1E6R130A-LXSN cells were stained with 
K10 (red) at both pre-confluence (day 3) and post-confluence (day 7). Panels show IF 
detection of K10 for each cell population. Nuclei were counterstained with DAPI to show 
host DNA. Scale bar: 100 µm. Light microscope images for each time point are also shown 
for all three cell populations. Red arrows denote presence of ring-like structures in cell 
monolayer morphology. C; Quantitation of the number of cells positive for K10 per 
microscope field at 5X magnification was carried out for each cell population. Number of 
positive cells was then normalised to quantity of cells per field in each population to give a 
percentage of positive cells. Two independent experiments, n=5. P-values were calculated 
with Kruskal-Wallis test with Dunn’s correction; * = P ≤ 0.05, ** = P ≤ 0.01. Error bars, SD. 
Figure	4.12	MmuPV1	E6	interaction	with	MAML1	is	required	for	post-confluent	density	increase	and	differentiation	delay	
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Finally, the high-density competition assay was repeated with NIKS/MmuPV1E6R130A-LXSN 
versus NIKS/LXSN EGFP cells (LXSN/MmuPV1E6R130A-LXSN). LXSN/MmuPV1E6-
LXSN was used as a control. Results are shown in Figure 4.13. In LXSN/MmuPV1E6R130A-
LXSN groups, there was a statistically significant difference (****p ≤ 0.0001) between layer 
occupancy when compared to LXSN/MmuPV1E6-LXSN groups at day 10. While the lower 
layer occupancy was 89.44% NIKS/MmuPV1E6-LXSN mCherry cells in the wtE6 
experiment, this was reduced to 60.75% in the MAML1 binding deficient mutant group with 
cells expressing NIKS/MmuPV1E6R130A-LXSN mCherry. Similarly, the upper layer of the 
wtE6 experiment was occupied by 93.15% EGFP positive cells, whereas this was decreased 
to only 64.52% in the LXSN/MmuPV1E6R130A-LXSN experiment. 
 
 
Figure 4.13 MmuPV1 E6 interaction with MAML1 is required for preferential 
persistence in the lower layer of cells in high-density competition assay 
Immunofluorescence of LXSN versus MmuPV1E6-LXSN, and LXSN versus 
MmuPV1E6R130A-LXSN are shown. Cell population identity is indicated by the colouring of 
text in the upper left corner of each image. The nuclei were counter-stained with DAPI for 
host DNA. The lower layer panels are shown to the left, alongside representative parts of a 
whole graphs to demonstrate quantitative data. The upper layer panels and accompanying 
parts of a whole graphs are shown to the right. IF images shown are confocal microscope tile 
scan images taken at 40X magnification with 5 by 5 fields of vision. The lower layer was 
selected by raising the scanning level until the first layer of nuclei were apparent and the 
focus line was approximately half way through these cells. The upper layer of cells was 
determined to be approximately 10 µm scanning level higher; this distance was kept 
consistently across all experiments. Experimental group MmuPV1E6R130A-LXSN was 
compared with the LXSN versus LXSN control experiment (no statistically significant 
difference, not shown) and MmuPV1E6-LXSN group. Two independent experiments, n=5. P-
values were calculated with a two-way ANOVA with Sidak's multiple comparisons test; **** 
= P ≤ 0.0001. Scale bar: 100 µm.  
Figure	4.13	High-density	competition	assay	with	MAML1	binding	deficient	mutant	
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By using confocal microscopy to analyse patterns of fluorescent expression in 3D, it was 
further shown that the NIKS/MmuPV1E6R130A-LXSN mutant cell line did not retain the 
ability of wt E6 to persist preferentially in the lower layer, instead demonstrating a random 
assortment of EGFP positive and mCherry positive cells in the lower and upper layers (Figure 
4.14A). This was also confirmed with quantification of fluorescence against distance from the 
slide surface. Expression patterns of EGFP versus mCherry in the LXSN/MmuPV1E6R130A-
LXSN group were shown to be similar, in contrast to earlier data shown in 
LXSN/MmuPV1E6-LXSN groups in Figure 4.9 where a strong pattern of mCherry 




Figure 4.14 3D confocal z-stack analysis demonstrates loss of persistence phenotype in 
MAML1 binding deficient E6 mutant 
A; Maximum intensity 3D plot of z-stacks at 63X magnification is shown (upper panel). 
Annotations show the location of the lower and upper layers. White dotted line indicates the 
bottom of the slide glass on which the cells are cultured. The nuclei were counter-stained with 
DAPI for host DNA. The fluorescent intensity of each channel was quantified across 10 
different selections of three different z-stack images taken at 63X magnification for each 
group, and the average intensity has been plotted against distance from the bottom of the slide 
upward to demonstrate the distribution of fluorescence throughout the z-stack (lower panel). 
B; Quantification of the number of cells in the bottom layer of each population (field size: 
800.22x800.22 µm). Five random 5 by 5 tile scans were chosen for quantification for each 
category. Quantification was carried out using the analyse particles function in FIJI image 
analysis software. Two independent experiments, n=3. P-values were calculated with 






Finally, quantification of cell density in the lower layer of NIKS/MmuPV1E6R130A-LXSN 
cells cultured in isolation showed that the increase in lower layer density previously observed 
in the NIKS/MmuPV1E6-LXSN group was also lost following the disruption of MmuPV1 E6  
MAML1 binding, as there was no significant difference between NIKS/MmuPV1E6R130A- 
LXSN and NIKS/LXSN lower layer cell density at day ten. Data are shown in Figure 4.14B. 
Conversely there was a significantly higher density of cells at day ten in the 
NIKS/MmuPV1E6-LXSN population of cells (**p ≤ 0.01). These data clearly demonstrated 
that MmuPV1 E6 interference with the Notch pathway via interaction with MAML1 is 
necessary to allow cells to preferentially persist in the lower layer of cells, and may also 
mediate the effect of MmuPV1E6 on basal lower cell layer density regulation. 
 
4.2.9	MATHEMATICAL	MODELLING	OF	LAYER	OCCUPANCY	THROUGH	SPLINE	INTERPOLATION	
To extend our understanding of the dynamics of layer occupancy in the high-density 
competition assay, three time points were examined, and the percentage occupancy of the 
lower layer quantified for each. With these data, a spline interpolation was carried out to 
estimate the growth dynamics of lower layer occupancy over time, without necessitating the 
immediate in-depth analysis of each category for every time point. Mathematical data are 
shown below in Figure 4.15, and were generated by Dr Demetris Demetriou. Using spline 
interpolation to most accurately estimate the curve of the line, the likely progression of lower 
layer occupancy over time was shown. An error margin of 10% was also plotted to allow for 
any miscounting of cell populations. Using this method of interpolation, it was shown that 
NIKS/MmuPV1E6-LXSN cells were predicted to reach 100% occupancy of the lower layer 
in the LXSN/MmuPV1E6-LXSN high-density competition assay at approximately day 12 of 
culture. This demonstrates the strong competitive advantage that expression of MmuPV1 E6 
confers upon cells over the control cell population. No strong phenotypic trend is apparent in 
the LXSN/LXSN control group or the LXSN/MmuPV1E7-LXSN group. The 
LXSN/MmuPV1E6R130A-LXSN group does appear to have a weak trend towards 100% 
occupancy over time, which is due to the slightly increased mCherry positive cell occupancy 
of the basal layer observed at day 10. Without observation of this phenotype over a longer 
time period, it is unclear whether the weak advantage of the NIKS/MmuPV1E6R130A-LXSN 
cell population would eventually result in 100% occupancy of the lower layer, or whether the 
weaker phenotype would mean that it was unable to populate the lower layer any further. 
However, when longer time courses were attempted with this system, all cell populations 
cultured to day 14 were found to have begun apoptosis (data not shown), suggesting that this  
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Figure 4.15 Spline interpolation graph demonstrates predictions of lower layer 
occupancy rates over a 12-day time-course. 
Data shown in Figure 4.8 and Figure 4.13 used to generate these graphs. Green line shows 
occupancy by EGFP expressing LXSN cells. A; LXSN/LXSN spline interpolation graphs. 
Red line shows occupancy by mCherry expressing LXSN cells. B. LXSN/MmuPV1E6-LXSN 
spline interpolation graphs. Red line shows occupancy by mCherry expressing MmuPV1E6-
LXSN cells. C. LXSN/MmuPV1E7-LXSN spline interpolation graphs. Red line shows 
occupancy by mCherry expressing MmuPV1E7-LXSN cells. Ten percent error margin is 
denoted by dashed lines. Blue circles indicate average of original experimental data. 
Figure	4.15	Spline	interpolation	to	predict	layer	occupancy	over	time	
 
high-density competition assay is unsuited for sustaining long term culture of NIKS. In future 
experimentation using this model, spline interpolation can provide a useful and 
mathematically accurate estimation of missing time points to demonstrate predicted lower 
layer occupancy over time. However, to try and extend the understanding of these phenotypes 






It has been shown previously that the life cycle of HPV can be completed in organotypic raft 
cultures, making it an attractive quasi- in vivo system with which to examine the effects of 
virus proteins in a mimic of stratified epithelium (Lambert, Ozbun et al. 2005). 
NIKS/MmuPV1E6-LXSN and NIKS/MmuPV1E6R130A-LXSN rafts were established, along 
with a control set of normal NIKS rafts which was provided by Kara Zheng. To create the raft 
epithelium, cells were differentiated on dermal equivalent for up to 14 days at an air-liquid 
interface. First, H&E staining of rafts was carried out to assess the morphology of the cells in 
the 3D culture. In normal NIKS, recapitulation of the layers of the normal epithelium was 
achieved, as shown in Figure 4.16A.  
 
There was no evidence of dysplasia observed in these rafts, and small, uniformly shaped cells 
can be seen populating the lowest layer. As expected, stratification of cells and normal 
squamous maturation occurred above the basal layer. Pyknotic nuclei indicative of cellular 
necrosis or apoptosis were observed in the uppermost cornified layer (Ross and Pawlina, 
2006). Similarly, structured stratum corneum could be observed throughout much of the 
NIKS/MmuPV1E6-LXSN rafts analysed, although there appeared to be an increase in the 
number of nuclei observed within this layer. Interestingly, the morphology of cells in the 
basal compartment was noticeably altered in cells exogenously expressing 
NIKS/MmuPV1E6-LXSN when compared to the normal NIKS rafts. Nuclei were less 
uniform in their organisation and unstained areas around cells were observed. This 
morphological change was not evident in the NIKS/MmuPV1E6R130A-LXSN rafts, although a 
decrease in thickness of the stratum corneum was observed in the samples analysed. 
 
To examine the effect of viral protein expression on terminal differentiation, staining with 
antibodies targeting K10 was carried out. K10 is usually detected in all layers above the basal 
layer (Watt and Phil 1983). In normal NIKS rafts, K10 was detected in cells immediately 
above the bottom layer of cells. These observations suggest that the process of terminal 
differentiation was occurring normally in the raft system, although occasional K10 positive 
cells were observed in the lowest layer. Therefore, this model was considered sufficient to 
investigate the effect of virus protein expression on differentiation. Rafts established with 
NIKS/MmuPV1E6-LXSN cells were also stained with anti-K10 antibody to allow evaluation 





Figure 4.16 Haematoxylin and eosin staining of rafts cultured from normal NIKS 
compared with NIKS exogenously expressing wt or mutant MmuPV1 E6 viral protein 
A; Organotypic raft culture from normal NIKS is shown at 20X magnification and 1:1 
magnification. Layers of the stratified epithelium are identified with labelling to the left of the 
1:1 image. B; Organotypic raft culture of NIKS exogenously expressing MmuPV1 E6 is 
shown at 20X and 1:1 magnification. C; Organotypic raft culture of NIKS exogenously 
expressing MmuPV1 E6R130A is shown at 20X magnification and 1:1 magnification. Scale 







layers of cells in the lowest layers. However, when rafts were established with the 
NIKS/MmuPV1E6R130A-LXSN cells, this delay in differentiation was lost, and instead K10 
staining was observed in all cells above the basal layer of the rafts. Therefore, these raft 
cultures successfully recapitulated the delay in differentiation observed in NIKS/MmuPV1E6-
LXSN cells, both in monolayer cell culture and in the in vivo mouse model shown in Chapter 
3.0. Similarly, this experiment gave further support to previous data that showed a loss of this 
differentiation delay in NIKS/MmuPV1E6R130A-LXSN cells, indicating that binding of 





Figure 4.17 Differentiation is delayed in 3D organotypic raft culture of MmuPV1 E6 
cells when compared to NIKS only, or cells expressing MmuPV1 E6R130A 
Panels show IF detection of K10 (red) in organotypic rafts collected 14 days following 
seeding for each cell population. Nuclei were counterstained with DAPI to show host DNA. 
Dotted lines indicate the presence of the basal layer. Scale bar: 200 µm in the 5X 









To further investigation of the ability of NIKS/MmuPV1E6-LXSN cells to competitively 
persist in the lower layer of cells in cell culture, 3D organotypic raft culture of NIKS/LXSN 
EGFP cells in co-culture with NIKS/LXSN mCherry, NIKS/MmuPV1E6-LXSN mCherry, or 
NIKS/MmuPV1E6R130A-LXSN mCherry cells was attempted. Cells were seeded at a 50:50 
ratio of NIKS/LXSN EGFP control cells against cells expressing NIKS/MmuPV1E6-LXSN 
mCherry, NIKS/MmuPV1E6R130A-LXSN mCherry, or NIKS/LXSN mCherry control vector 
only, similar to the experiments shown in Figure 4.8. Following culture of cells at an air-
liquid interface for ten days, rafts were collected, fixed, and stained for EGFP and mCherry; 
the fluorescent signal was lost during normal processing, however antibodies targeting these 
proteins were used to visualise locations of the appropriate cells. These rafts are shown below 




Figure 4.18 NIKS expressing MmuPV1 E6 preferentially populate the lower layers of 
the raft culture when compared to LXSN/LXSN control or LXSN/MmuPV1E6R130A  
Panels on the left show IF detection of mCherry (red) and EGFP (green) in each of the three 
populations rafted. Identity of cells is shown with coloured labelling at the top left of each 
image. Nuclei were counterstained with DAPI to show host DNA. Scale bar: 200 µm. Dotted 
lines indicate the presence of the basal layer. The right panel of images shows haematoxylin 
and eosin staining of competition assay rafts. Data shown representative of 2 independent 
experiments, n=2. Scale bar: 200 µm (blue line) and 50 µm (red line) in the higher 





In control raft cultures of LXSN/LXSN groups, the distribution of EGFP and mCherry 
expressing cells appeared to be random, with mCherry and EGFP signal detected throughout 
the raft layers. However, in rafts established with LXSN/MmuPV1E6-LXSN groups, EGFP 
positive cells were rarely observed in the lower layers of the raft epithelium, and were most 
commonly observed in the uppermost layers. Further, H&E staining of rafts showed that the 
cell morphology observed in the basal layers of the NIKS/MmuPV1E6-LXSN only rafts was 
also present in the basal layer of the LXSN/MmuPV1E6-LXSN rafts, suggesting that it was 
cells expressing MmuPV1 E6 populating this lower layer. These results demonstrated that the 
persistence phenotype observed in the high-density competition assay was replicated in 3D 
cell culture. To examine the effect of the E6 MAML1 binding mutation in this model, rafts 
were also established using NIKS/MmuPV1E6R130A-LXSN mCherry cells. As observed in the 
high-density competition assay, abrogation of the MAML1 binding ability of MmuPV1 E6 
resulted in a loss of the ability of cells to persist in the lower layers. Instead, the distribution 
of EGFP and mCherry positive cells appeared to be random throughout the layers of the 





Following experiments that investigated the phenotype of lower-layer persistence in cell 
culture, we wanted to examine the cell cycle activity in these different populations and 
consider whether an increase in cell cycle entry might correlate with the competitive 
advantage observed in cells exogenously expressing MmuPV1 E6. A technique recently 
established in the lab allowed in vivo monitoring of cell cycle activity. During G1 phase of the 
cell cycle, the protein Cdt1 is upregulated to allow licensing of DNA for replication. Cdt1 is 
directly inhibited by geminin, a DNA replication inhibitor, during S phase, M phase, and G2 
phase of the cell cycle. (Wohlschlegel, Dwyer et al. 2000). To investigate any impact of viral 
proteins on cell cycle entry over time, the Fucci (fluorescent ubiquitination-based cell cycle 
indicator) cell system was utilised. This system allows visualisation of progression through 
the cell cycle by the fluorescent tagging of these two discrete proteins, which are reciprocally 
regulated throughout the cell cycle. Abundance of these proteins is controlled by ubiquitin-
mediated proteolysis (Sakaue-Sawano, Kurokawa et al. 2008). The mapping of the cell cycle 
using these two colours is shown in Figure 4.19A, adapted from (Sakaue-Sawano, Kurokawa 






Figure 4.19 The Fucci cell system  
A; Fucci expressing cells fluoresce red during the G1 phase of the cycle, yellow during the 
transition between G1 and S, green during the S, G2, and M phases, and finally are briefly 
colourless during the division of the cells. Adapted from (Sakaue-Sawano, Kurokawa et al. 
2008). B-D shows work carried out by Kara Zheng, who also provided corresponding figures. 
B; Flow cytometry demonstrating the expression levels of Fucci cell population prior to 
sorting. Sorted population is shown selected as mAG+, and constituted roughly 10% of the 
total cells analysed. C; expression levels of Fucci in NIKS following sorting for mAG+ cells. 
D; DNA content of live cells was stained with DRAQ5. Gating of cells for DNA content was 
carried out by sorting cells with 2N and 4N. Fucci expression of each of the consequent sorted 




Fucci cells were established by viral transduction of a commercially available expression 
vector with a pBOB backbone (Addgene, UK). However, observation of initial cell 
populations showed that intensity of fluorescent expression varied a great deal, and a large 
proportion of the cells were not successfully expressing the fluorescent tags. Therefore, FACS 
sorting of the population of cells and subsequent functionality checks described in the 
paragraph below were carried out by Kara Zheng, another member of the research group. 
First, a population of cells with a high level of expression, denoted as mAG+ in Figure 4.19B, 
were selected for through FACS, which roughly constituted 10% of the total cell population. 
Expression levels of the subsequent population of sorted cells is shown in Figure 4.19C. 
Finally, to check that the Fucci system was working correctly, cells were sorted for DNA 
content by staining cell nuclei with DRAQ5, a far-red fluorescent dye that is cell permeable. 
Subsequent sorting by DNA content allowed populations to be split into 2N and 4N, to show 
G1/S and G2/M phase cells separately. Corresponding expression of red and green 
fluorescence is quantified by FACS in Figure 4.19D, showing that cells in G1/S phase had 
high levels of red fluorescence, and cells in G2/M phase had high levels of green 
fluorescence, as expected. As the system was functioning properly, Fucci expressing cells 
were then transduced to express MmuPV1 viral proteins to allow investigation of the effect of 
these proteins on the cell cycle.  
 
NIKS/LXSN-Fucci, NIKS/MmuPV1E6-LXSN-Fucci, NIKS/MmuPV1E7-LXSN-Fucci, and 
NIKS/MmuPV1E6R130A-LXSN-Fucci cells were seeded at low and high density and cultured 
for two days before collection for FACS analysis. Data are shown in Figure 4.20. FACS 
analysis demonstrated that at low density, NIKS/MmuPV1E6-LXSN-Fucci, 
NIKS/MmuPV1E7-LXSN-Fucci, and NIKS/MmuPV1E6 R130A-LXSN-Fucci cells all had 
approximately 1.5 times higher number of cells in G2/M when compared with cells 
expressing NIKS/LXSN only. At high density, this increase in the proportion of cells in G2/M 
in all three experimental populations was much greater, as virus protein expressing cells had 
approximately 8 times higher number of cells in the cell cycle when compared to 
NIKS/LXSN control cells. Surprisingly, NIKS/MmuPV1E7-LXSN-Fucci and 
NIKS/MmuPV1E6 R130A-LXSN-Fucci cells appeared to have a similar cell cycle advantage as 
NIKS/MmuPV1E6-LXSN-Fucci, despite not demonstrating any statistically significant 
growth advantage in cell culture. Previous research in our group has shown that E7 affords a 
more significant growth advantage to cells only when EGF is sparse (Kranjec, Holleywood et 
al. 2017). Therefore, the Fucci experiment was repeated in FI media, which lacks EGF, to 






Figure 4.20 FACS analysis of Fucci cells shows increase in cell cycle entry in virus 
protein expressing cells  
A-H; Flow cytometry data from Fucci cells expressing LXSN, MmuPV1 E6, MmuPV1 E7, 
and Mmu1PV E6R130 seeded at 1x and 8x starting cell density. Percentage of cells expressing 
‘greenness’ (mAG+ quadrant) is shown. I; Quantitative comparative analysis of above FACS 
data to demonstrate fold change in ‘green’ cells. Raw data was used to calculate the 
percentage of green cells in LXSN. Data was then normalised to the LXSN control group 
within each density sub-group. Data are displayed as log2 of percentage greenness to show 














Figure 4.21 FACS analysis of Fucci cells cultured in FI media shows a greater increase 
in cell cycle entry in virus protein expressing cells when compared with cells cultured in 
FC media 
A-H; Flow cytometry data from Fucci cells expressing LXSN, MmuPV1 E6, MmuPV1 E7, 
and Mmu1PV E6R130 seeded at 1x and 8x starting cell density and cultured in F incomplete 
media. Percentage of cells expressing ‘greenness’ (mAG+ quadrant) is shown. I; Quantitative 
comparative analysis of above FACS data to demonstrate fold change in ‘green’ cells. Raw 
data was used to calculate the percentage of green cells in LXSN. Data was then normalised 
to the LXSN control group within each density sub-group. Data are displayed as log2 of 





Growth of these cell populations in FI media increased the growth advantage afforded by 
virus proteins onto the NIKS; at low density, NIKS/MmuPV1E6-LXSN-Fucci, 
NIKS/MmuPV1E7-LXSN-Fucci, and NIKS/MmuPV1E6 R130A-LXSN-Fucci cells all had 
approximately 2 times higher the numbers of cells in G2/M when compared to NIKS/LXSN 
control cells. Similarly, the growth advantage seen at high density in FC media was also 
exaggerated when cells were cultured in FI media, with NIKS/MmuPV1E6-LXSN-Fucci, 
NIKS/MmuPV1E7-LXSN-Fucci, and NIKS/MmuPV1E6 R130A-LXSN-Fucci cells showing a 
roughly 16 times higher number of cells in G2/M when compared with NIKS/LXSN only. 
From this experimental replicate, it appears that NIKS/MmuPV1E6 R130A-LXSN-Fucci cells 
had the most dramatic impact on cell cycle entry in FI media post-confluence, however with 
repeat experiments these values may balance out with no significant difference in growth 
advantage between any of the virus proteins. Unfortunately, time did not allow for repetition 
of these final experiments, however application of this cell culture system in the future will 
discern more useful information about the virus proteins.  
 
4.3	DISCUSSION	
To better understand the involvement of individual virus proteins in the epithelial basal layer, 
NIKS cell lines exogenously expressing virus proteins MmuPV1 E6 and MmuPV1 E7 were 
generated. Standard growth assays demonstrated that cells exogenously expressing MmuPV1 
E6 had an elevated growth rate post confluence, and that these cells also grew to an increased 
density in monolayer culture compared with both LXSN expressing control cells and 
MmuPV1 E7 expressing cells. No statistically significant differences in cell density were seen 
at pre-confluent time points. Modulation of cell proliferation even at high cell density by 
high-risk HPV16 E6 has previously been demonstrated (Kranjec, Holleywood et al. 2017), 
suggesting a common E6 protein function between this high-risk HPV type and MmuPV1, a 
pi PV. Recent research in our lab suggests that low-risk HPV11 is unable to modulate cell-
density post-confluence in the same way as high-risk HPV16 (Murakami, Egawa et al. 2019). 
Less is known about the gamma papillomavirus E6 protein, however recent proteomic studies 
have confirmed that gamma HPV196 E6 is able to interact with MAML1 (Grace and Munger 
2017) and large scale studies into E6 binding preference confirmed that all beta, gamma, mu 
and nu genera E6 proteins tested were able to preferentially bind to MAML1 (Brimer, Drews 
et al. 2017). As the E6 proteins of PV of these genera can bind to MAML1, it is plausible to 
consider they might be able to confer similar growth advantages on cells as shown with 
MmuPV1 E6, which would suggest a common conserved function to prevent cell cycle exit as 
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density increases across PV types. However, this requires further research. Further to this, a 
clear decrease in K10 positive cells was observed post-confluence in NIKS/MmuPV1E6-
LXSN cell populations only. This is similar to phenotypes observed in a recently published 
paper from our lab, which showed that exogenous expression of both high-risk HPV16 and 
low-risk HPV11 E6 afforded a growth advantage and differentiation delay to NIKS cells post-
confluence (Murakami, Egawa et al. 2019). As discussed extensively in Chapter 1 (Section 
1.8), E6 proteins of alpha and beta HPV types have been shown to mediate a delay in normal 
differentiation. Therefore, these data also demonstrates that the E6 protein of MmuPV1 has a 
mechanistic effect on keratinocyte cell fate similar to some HPVs that can cause disease in 
humans, despite their distant evolutionary relation (Uberoi and Lambert 2017).  
 
Utilising confocal microscopy and EGFP/mCherry expressing NIKS cell lines, I was able to 
examine the growth advantages of cell populations in 3D by isolating discrete layers of cells 
within the monolayer culture. Data demonstrated a clear phenotype of persistence in the 
‘lower’ layer of cells in populations expressing NIKS/MmuPV1E6-LXSN mCherry when 
compared with both NIKS/LXSN mCherry control cells and NIKS/MmuPV1E7-LXSN 
mCherry cells. The phenotype observed in NIKSMmuPV1E7-LXSN mCherry cells was 
similar to that observed in NIKS/LXSN mCherry control cells, with no statistically significant 
difference between mCherry-positive cell layer occupancy. The data showed that expression 
of MmuPV1 E6 in high-density cell culture results in a competitive growth advantage over 
uninfected cells, wherein normal cells exit the lower layer and E6-expressing cells persist in 
the lower layer. This competitive advantage may also exist in vivo, allowing the reservoir of 
infected cells to persist in the host by outcompeting their uninfected neighbours. Repetition of 
the growth, differentiation, and high-density competition assays with a MAML1 binding 
mutant of MmuPV1 wtE6 (MmuPV1E6R130A) disrupted the phenotypes observed in 
NIKS/MmuPV1E6-LXSN cell culture experiments, offering strong support for the 
interference of E6 with Notch signalling being important for the persistence phenotype to 
occur.  
 
Mathematical and spatial analysis of HPV-induced lesions has given further support to the 
theory that HPVs are able to modulate the basal dynamics of infected cell populations; 
modelling of HPV-infected cells as having increased tissue density and decreased exit from 
the lower layer produced data that correlated with patterns seen in real infection (Orlando, 
Brown et al. 2013). Recently published work generated a mouse model carrying an inducible 
dominant negative mutant of Maml1, which would result in inhibition of NICD induced 
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transcription in the oesophageal keratinocyte cell populations (Alcolea and Jones 2015). 
Interestingly, results demonstrated that the mutant cells dramatically outcompeted their 
normal counterparts over time in vivo. The persistence of these mutant cells was shown to be 
due to the MAML1 binding deficient cells not being lost from the basal layer by 
differentiation, and by their stimulating normal neighbour cells to differentiate. These mutant 
cell populations also exhibited an increased cell density at confluence of 30%, characterised 
by a buckling of the epithelium as a result (Alcolea, Greulich et al. 2014). Further, it has 
recently been shown that high-risk HPV16 E6 interference with the Notch pathway in NIKS 
cells caused persistence of infected cells in the basal and parabasal layers, along with an 
associated increase in cell density and differentiation delay (Kranjec, Holleywood et al. 
2017). Therefore, it is reasonable to postulate that the impact that MmuPV1 E6 binding with 
MAML1 has upon Notch signalling would also result in cells having a competitive advantage 
over normal cells. The observations described in this chapter that show a MAML1 binding-
dependent role for MmuPV1 E6 in delaying cell differentiation, increasing cell density, and 
allowing E6-expressing cells to preferentially persist in the lower layer, fit with this 
hypothesis.  
 
Research into the binding partners of beta HPV types found that beta genus E6 proteins could 
bind to MAML1 (Rozenblatt-Rosen, Deo et al. 2012). Further, this binding partner is not 
shared by high-risk HPV alpha types, demonstrating an alternate mechanism for Notch 
pathway interaction in this subset of PV types (White, Kramer et al. 2012). BPV has also been 
shown to bind to MAML1, expanding the types of PV that possess this binding ability. It is 
possible that these other PV types could manipulate the Notch pathway through MAML1 
binding to cause similar cell persistence and differentiation delay in vivo. As mentioned in 
Chapter 1 (Section 1.8.5), large scale analysis of the ability of different PVs to bind to 
MAML1 or E6AP demonstrated that PV types physically and functionally interacted with one 
or the other, but not both of these proteins (Brimer, Drews et al. 2017). It is clear that an 
evolutionary split occurred between PV types that can interact with MAML1 and those PV 
types that interact with E6AP. All PVs have evolved to survive in their specific epithelial 
niche over millions of years, and have been shown to employ a variety of mechanisms to 
achieve the overall unifying goal of completing their life cycle (Doorbar, Quint et al. 2012). 
The presence of this shared Notch pathway interaction amongst the different PV types, 
mediated either through E6-AP binding as demonstrated in the high-risk types (Kranjec, 
Holleywood et al. 2017), or by binding to MAML1 seen in other PV types (Tan, White et al. 
2012), suggests that this pathway interaction is important for the successful life cycle of PV in 
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the host. However, there are PV types that lack a functional E6 protein, therefore these types 
must successfully establish an infection in the host through other mechanisms, or may not 
require the competitive advantage that interaction with the Notch pathway can confer upon 
the infected cell (Van Doorslaer, Chen et al. 2018) (Terai, DeSalle et al. 2002) (Tachezy, 
Rector et al. 2002). 
 
Growth of the NIKS/MmuPV1E6-LXSN and NIKS/MmuPV1E6R130A-LXSN cell populations 
in organotypic raft culture demonstrated that the differentiation delay observed in 
NIKS/MmuPV1E6-LXSN cell culture was maintained in 3D stratified epithelium of these 
cells, and that interruption of E6 binding to MAML1 disrupted this phenotype. Interestingly, 
observational analysis of the NIKS/MmuPV1E6-LXSN rafts by H&E staining showed a 
distinct pattern of unstained areas around cells within the lower layers of the epithelium. 
These unstained areas could be interpreted as spaces between the cells. It is possible that 
MmuPV1 E6 is having an effect on junctional proteins between the cells, resulting in spaces 
being observed between cells following processing and H&E staining. High-risk HPV16 and 
HPV18 E6 has previously been shown to degrade MAGI-1, a protein involved in tight-
junction control, which resulted in disruption of tight-junction integrity in both CaSKi and 
HeLa cells (Kranjec and Banks 2011). Similar high-risk E6 interactions have been described 
for other proteins involved in cell to cell contact control, such as PATJ (Storrs and Silverstein 
2007) and Par3 (Facciuto, Bugnon Valdano et al. 2014). However, low-risk HPV types are 
not thought to be able to interact with these proteins due to their lacking a PBM (Pim, Bergant 
et al. 2012). Research by Pim and colleagues demonstrated that by cloning of a PDZ-binding 
sequence onto the C-terminus of low-risk HPV E6 proteins to generate chimeras, these 
proteins could then bind and degrade Dlg protein (Pim, Thomas et al. 2002). However, only 
mucosal low-risk chimera types could bind to and degrade MAGI-1, whereas cutaneous types 
could not. This research demonstrates further significant differences between PV types 
relating to their tissue niches. There is no evidence for PV types lacking a PDZ-binding 
domain being able to negatively affect cell junctions. However, it may be that MmuPV1 E6 is 
able to have an effect on cell junctions via an alternative pathway, which would require 
further investigation in the future. Interestingly, this morphology observed in the rafts of 
NIKS/MmuPV1E6-LXSN cells is similar to that seen during the rafting of cells expressing a 
NIKS-HPV16 clone that was shown to express high levels of viral proteins E6 and E7 
(Isaacson Wechsler, Wang et al. 2012). 
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Growth of rafts using EGFP/mCherry expressing NIKS demonstrated that the persistence 
phenotype of NIKS/MmuPV1E6-LXSN cell lines observed in the high-density competition 
assay was also observed in 3D organotypic rafts. Similarly, this persistence growth advantage 
was lost in the rafts of cells expressing NIKS/MmuPV1E6R130A-LXSN, which again 
demonstrated that an interaction of MmuPV1 E6 with MAML1 protein to disrupt normal 
Notch pathway signalling was necessary for this persistence to occur. This conclusion could 
be further validated by generation of a cell line expressing both a dominant negative mutant 
of MAML1 and normal mCherry protein, which could then be transduced to express wt 
MmuPV1 E6. This cell line could then be co-cultured with NIKS/EGFP cells to generate 
rafts, which would establish whether expression of the E6 protein would still confer the 
persistence phenotype on cells that are lacking normal MAML1 protein. A control group of a 
cell line expressing only a dominant negative mutant of MAML1 and normal mCherry protein 
co-cultured with NIKS/mCherry cells would also be necessary to establish whether the loss of 
MAML1 alone resulted in a persistence phenotype too. Based on research carried out by 
Alcolea and Jones discussed above, this would be an expected result (Alcolea, Greulich et al. 
2014). Use of these cell lines in the high-density competition assay could also further confirm 
this phenotype. 
 
A recently published paper used mathematical modelling to predict the impact of stochasticity 
of cell division on the clearance of infection, and declared that much of the clearance of HPV 
from tissue could be attributed to the randomness of stem cells dividing either symmetrically 
or asymmetrically (Ryser, Myers et al. 2015). The concept that stochasticity plays a key role 
in the ability of PV to successfully infect and maintain an infection is certainly important to 
consider, however this model does not take into account the effect that viral protein molecular 
mechanisms could have on rates of proliferation. In particular, accounting for PV types that 
are known to increase cell cycle entry and proliferation within the bounds of this 
mathematical model would presumably yield data that suggests a more dramatic effect of 
virus infection on the cell. For example, a more recent paper that generated a mathematical 
model to examine the impact of low-risk and high-risk E7 protein on the cell cycle showed 
that G1/S phase transition in basal cells can be altered in response to concentration of E7 
protein, presence of various growth factors, and the binding affinity of E7 to pRB (Miller, 
Munger et al. 2017). Therefore, accounting for the predicted effect of individual viral proteins 
within mathematical models should be considered. 
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However, the data shown here demonstrated that MmuPV1 E6 expression can modulate basal 
cell populations, either by inhibiting the frequency of basal exit in E6 expressing cells, or by 
stimulating basal exit in other normal cells. Alternatively, E6 may be able to modulate the 
patterns of symmetrical and asymmetrical division described by Ryser and colleagues in this 
‘lower’ cell population mimic of basal cells, overcoming the negative effect of random 
chance on the MmuPV1 E6 expressing cell population. Examination of this phenotype within 
the scope of the high-density competition assay could be attempted by using the 
EGFP/mCherry fluorescent cell lines in tandem with 3D live-cell imaging, however this has 
not been possible within the time-frame of this project. In addition to the alteration of cell 
cycle regulation by viral proteins, and oncogenic effects certain viral proteins have been 
shown to have on the infected cell, avoidance of immune surveillance by low level expression 
of viral proteins in the basal layer and HPV modulation of T cell responses are factors that are 
important for persistence of viral infection, particularly in high risk types (Bodily and 
Laimins 2011). Whether any HPV types also possess a mechanism of persistence similar to 
the one shown for MmuPV1 E6 in this chapter has yet to be investigated. Preliminary data 
(not shown) suggested that HPV11 E6 might also confer phenotypes of persistence on the 
cells, however further work will be required to validate this initial observation, which forms 
parts of ongoing research within our lab. 
 
Finally, the Fucci system was used to visualise cell cycle progression in each of the cell lines 
investigated in this chapter. All three cell lines expressing virus proteins had a greater number 
of cells entering the cell cycle at both low and high densities when compared to the LXSN 
control group. As this experiment could only be repeated once due to constraints on time, it is 
impossible to say whether the slight differences in the number of cycling cells between each 
of the virus protein expressing cell populations were statistically significant. However, 
experiments in our lab using the Fucci system with the same FACS-based experimental 
design have reproducibly shown that other E6 HPV types are also similarly able to drive the 
cell cycle, and these results were validated further using an alternate quantification approach 
(Kara Zheng, personal communication). As these data proved to be reproducible, it is 
reasonable to expect that repeated experimentation with the MmuPV1 Fucci cell lines would 
also produce consistent data. 
 
High risk HPV E6 and E7 oncoproteins are known to drive cell cycle entry through an array 
of mechanisms (Pyeon, Newton et al. 2007), and research has demonstrated that some of the 
beta genus PV E6 proteins are also able to impact the normal response of the cell to DNA 
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damage by inhibition of p53 target genes such as cell cycle inhibitor p21 (White, Walther et 
al. 2014). Proteomic studies have shown that some beta genus PV types (HPV38 and HPV92) 
can even bind to p53 directly, having a posttranslational effect on the protein half-life (White, 
Kramer et al. 2012). Whether MmuPV1 E6 and E7 proteins drive cell cycle entry in some 
way is not known for certain, however a recent paper by Meyers and colleagues showed that 
MmuPV1 E6 could inhibit TGF-b activity by disrupting the transcription complex assembly 
(Meyers, Uberoi et al. 2017). Inhibition of TGF-b signalling inhibited the induction of 
keratinocyte growth arrest in this model, which could be the mechanism by which MmuPV1 
was shown to drive cell cycle entry in the Fucci system. High-risk HPV16 E7 has also been 
shown to block TGF-b signalling through interference with the transcription complex (Lee, 
Kim et al. 2002), an ability which is shared by the E7 protein of low-risk HPV1 E7 (Habig, 
Smola et al. 2006). These data could suggest a shared mechanism between PVs to interfere 
with the cell cycle via TGF-b, and it would be plausible to consider whether MmuPV1 E7 
possesses such a mechanism. The preliminary data shown in this chapter suggests that 
MmuPV1 E6 and E7 proteins can also drive cells to enter the cell cycle more often than 
control cells both pre-confluence and post-confluence. Although the mechanism by which 
these proteins drive the cell cycle is not known for MmuPV1, it is unlikely that E6 protein 
utilises MAML1 binding to drive cell cycle entry; disruption of E6 binding to MAML1 did 
not reduce the proportion of the cell population that had entered the cell cycle. 
 
In conclusion, data presented in this chapter demonstrated that the delay in differentiation and 
mediation of basal cell density observed in Chapter 3.0 can likely be attributed to MmuPV1 
E6, and that the molecular mechanisms behind these phenotypes could involve interference 
with the Notch signalling pathway; mutation of E6 MAML1 binding abrogated the effect of 
MmuPV1 E6 on cell density, differentiation delay, and persistence in the lower layer of cells. 
Importantly, careful analysis of the lower and upper layers of cell culture revealed a mode of 
persistence conferred upon the cells by MmuPV1E6 only, which is possibly a key mechanism 
through which PV types that lack so-called ‘oncogenic’ proteins are able to establish and 
maintain a persistent infection in the basal layer. Both MmuPV1 E6 and MmuPV1 E7 were 
shown to increase the number of cells entering the cell cycle at both low and high densities, 
and mutation of E6 MAML1 binding did not appear to affect this phenotype; the 
MmuPV1E6R130A mutant was shown to result in an increase of cells in the cell cycle that was 
similar to wt E6 protein. Therefore, it appears that both MmuPV E6 and MmuPV1 E7 have 





To further investigate the role of E6 in the context of other genes, I attempted to establish a 
cell line that could stably maintain the MmuPV1 genome. PVs are known to maintain viral 
episomes in basal cells at a low copy number following initial infection. As E1 has been 
shown to be possibly dispensable at this stage, it is likely that maintenance replication usually 
occurs once per S-phase (Egawa, Nakahara et al. 2012). Due to these aspects of the PV life 
cycle, the study of PVs by transfecting PV genomes into suitable cells to monitor copy 
number and the effect of the genome on the cell has been used frequently in the field 
(Chesters and McCance 1989). NIKS cells were chosen for this model as their ability to 
successfully maintain PV genomes is well established, and keratinocyte cells are known to be 
naturally infected by PVs (Bedell, Hudson et al. 1991). 
 
Whilst it was thought that experimentation in mouse cell lines may be desirable in the future, 
we wanted to keep the cell background consistent with the previous chapter (Chapter 4.0). 
Also, use of NIKS would allow us to compare the effect of MmuPV1 genome with that of 
HPV11 and HPV16 genomes in the same cell background. While primary keratinocyte cell 
lines are also often used to study PVs, their heterogeneous nature was less desirable when 
compared to the homogeneity of NIKS; use of NIKS allows comparison between experiments 
carried out within a range of passages (Alazawi, Pett et al. 2002). When carrying out 
comparative analyses in our lab, we find it is useful to keep the cell background constant, 
particularly when comparing the effect of different mutants or genomes. This allows the 
examination of subtle differences between cells as a consequence of virus protein or genome 
expression. While this is also possible in primary cells, the differences in genetic background 
or passage number may have an effect on the cells. Although NIKS are an immortalised cell 
line, it has been shown that they respond normally to differentiation signals and contact 
inhibition, which shows that the features most important to our research are maintained 
(Allen-Hoffmann, Schlosser et al. 2000).  
 
In the model used in our lab, NIKS cells containing a transfected PV genome are transferred 
into flasks of culture medium at low density, allowing growth into surrounding empty space. 
Cells are grown to confluence, which takes approximately four days. This period of growth 
parallels the time in which keratinocytes would be growing and migrating to fill a space 
created by a wounding event without differentiating. In wound healing, in vivo keratinocyte 
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cells also proliferate and migrate without differentiating (Paladini, Takahashi et al. 1996). 
Confluence being reached in monolayer culture initiates early events of keratinocyte 
differentiation and triggers the productive stage of the life cycle, similar to what is observed 
during an in vivo infection; cell to cell contact inhibits cell proliferation and triggers 
differentiation (Poumay and Pittelkow 1995). Post-confluence PV-containing NIKS in this 
culture system are therefore representative of an established PV lesion in that cells have 
undergone differentiation and are fully confluent. If keratinocyte cells are triggered to 
differentiate by high density culture, calcium induction, or raft culturing, the culture system is 
more representative of the later stages of the PV life cycle (Poumay and Pittelkow 1995) 
(Pillai, Bikle et al. 1990) (Kyo, Klumpp et al. 1997). In this way, the culture model can be 
used to investigate PVs in representations of different environments. Epidermal keratinocytes 
have previously been shown to switch between two interconvertible modes of growth 
dependent on cell density when cultured in vitro, therefore careful monitoring of growth pre-
confluence and post-confluence allows consideration of these different cell states (Roshan, 
Murai et al. 2016). 
 
The transfected genome model was chosen to examine the effects of the whole MmuPV1 
genome in NIKS cells, to follow up on work carried out with exogenous expression of single 
proteins as described in the previous chapter. To evaluate the efficacy of the newly 
established MmuPV1 cell culture model, experiments were attempted in parallel with a 
16NIKS cell line, which had previously been successfully carried out in our lab (Murakami, 
Egawa et al. 2019). In addition, HPV11 NIKS were established, to provide a low-risk HPV 
comparison (Thomas, Oh et al. 2001). Existing MmuPV1, HPV16, and HPV11 genome 
vector constructs (shown in Table 2.4) were digested with appropriate restriction enzymes to 
release the PV genomes, which were subsequently re-ligated to generate circular genomes. 
Genomes were then transfected into NIKS cells to investigate the effect of the presence of 




First, genome copy number was tracked over a period of seven days, to ascertain whether the 
genomes were successfully maintained in the NIKS cells. The results showed (Figure 5.1) that 
the 16NIKS cell line was successfully established, with maintenance of genomes from days 
one to four, and a statistically significant genome amplification post-confluence at day seven. 
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Conversely, neither the MmuPV1 genomes nor the HPV11 genomes were maintained in their 
respective cell cultures, and instead the number of copies per cell decreased by roughly 50% 
each day. These results suggested that during cell doubling, MmuPV1 and HPV11 genomes 







Figure 5.1 Graph to show genome copy number in MmuPV1 NIKS, 11NIKS, and 
16NIKS over a period of seven days  
The graphs show data from samples collected on days one to four, and day seven. Pre-
confluence and post-confluence conditions are indicated with labelling. Bars represent the 
mean and standard deviations are shown with the error bar plots. Three independent 
experiments, n=3 for each experiment set (MmuPV1/HPV11/HPV16). P-values were 
calculated with a two-way ANOVA with Tukey’s correction; **** = P ≤ 0.0001. A; 







Previous work carried out with 16NIKS in our lab has demonstrated that culturing of cells in 
a higher concentration of EGF media than was usually used in FC media (10 ng/ml EGF) 
resulted in an increase in genome copy number prior to confluence (Pagliarulo, 2015). 
Therefore, the genome copy number assay was repeated with cells cultured in FC media with 
a concentration of 100 ng/ml EGF (termed FC100 media within the text), compared with cells 
cultured in FC media with the standard EGF concentration of 10 ng/ml EGF (termed FC10 
media within the text). Results are shown below in Figure 5.2. 
 
 
Figure 5.2 Graph to show the effect of EGF concentration on genome copy number in 
MmuPV1 NIKS, 11NIKS, and 16NIKS over a period of seven days 
Two different concentrations of EGF were used: 10 ng/ml and 100 ng/ml. The graphs show 
data from samples collected on days one to five, day eight, and day ten (day one not shown), 
at two different EGF concentrations. Pre-confluence and post-confluence conditions are 
indicated with labelling. Bars are representative of the mean average and standard deviations 
are shown with the error bar plots. Three independent experiments, n=3 for each experiment 
set (MmuPV1/HPV11/HPV16). P-values were calculated with a two-way ANOVA with 
Tukey’s correction; * = P ≤ 0.05, ** = P ≤ 0.01. A; MmuPV1 genome. Asterisks colour 




Growth of the cell populations in a higher concentration EGF did not allow successful 
maintenance of genomes in either the MmuPV1 NIKS or the 11NIKS cell culture systems. 
Pre-confluence, genome copy number was not maintained over the first four days of culture in 
either the 11NIKS or the MmuPV1 NIKS when cultured in either FC10 or FC100 media. 
Interestingly, data showed that EGF concentration may have a mild effect on copy number 
post-confluence; a slightly higher genome copy number was observed in the FC100 group 
when compared with the FC10 group in all of the post-confluent time points collected for 
each group. However, statistical analysis demonstrated that there was no significant 
difference in genome copy number between cells cultured in FC10 media versus cells 
cultured in FC100 media.  
 
5.2.3	IMPACT	OF	EGF	CONCENTRATION	ON	GROWTH	OF	GENOME-CONTAINING	NIKS	CELLS		
In parallel to the genome copy number experiments, growth assays with cells cultured in both 
FC10 media and FC100 media were carried out. Cells were cultured for 9 days, and data are 
shown below (Figure 5.3A). In 11NIKS, 16NIKS, and MmuPV1 NIKS cell lines, the cell 
populations cultured in FC100 media grew to a higher density than the corresponding FC10 
media groups once post-confluent. In contrast, there was no such EGF-mediated difference in 
cell count prior to confluence being reached at day five. To simplify comparative analysis, all 
groups at day nine were first compared with normal NIKS cultured in either FC100 or FC10 
media as the control group. At day nine, 16NIKS and MmuPV1 NIKS cultured in FC100 
media had both reached a density significantly higher than normal NIKS cultured in FC100 
media (****p ≤ 0.0001, **p ≤ 0.01). Statistically significant higher densities at day nine were 
also observed in 16NIKS cultured in FC10 media (***p ≤ 0.001) compared with the 
appropriate control group (NIKS cultured in FC10 media) (****p ≤ 0.0001).  
 
It was noted that it may be more relevant to consider the rate of cell growth after reaching 
confluence at day five, rather than to only consider total cell number at each time point. To 
analyse the effect of EGF concentration on post-confluent growth rates of each group, the fold 
change in cell number from day one to day three and day five to day nine was calculated, and 
plotted into graphs shown in Figure 5.3B and Figure 5.3C respectively. Analysis showed that 
while there was no significant effect of EGF on rate of growth from day one to day three in 
any of the groups, both HPV16 NIKS and MmuPV1 NIKS showed a statistically significant 
response to culture in FC100 media post-confluence from day five to day nine. These data 




Figure 5.3 Increased EGF concentration has a density-dependent effect on the growth of 
different cell lines over the course of nine days 
Two different concentrations of EGF were used: 10 ng/ml and 100 ng/ml. NIKS, 16NIKS 
(HPV16 genome), 11NIKS (HPV11 genome) and MmuPV1 NIKS (MmuPV1 genome) were 
grown in both concentrations of media for comparison of effect of genome, treatment and 
genome plus treatment. Cell samples were collected on day one, three, five, and nine. A; Data 
shows the growth of cells over nine days. Each data point represents the mean cell count, and 
the standard deviations are shown with error bars. Three independent experiments, n=3. P-
values were calculated with a two-way ANOVA with Tukey’s correction; **** = P ≤ 0.0001. 
B; The fold change in cell density was calculated by normalising each replicate for the day 
three time point by the average cell count for day one in each experimental group. C; The fold 
change in cell density was calculated by normalising each replicate for the day nine time point 
by the average cell count for day five in each experimental group. Three independent 
experiments, n=3. P-values were calculated with a one-way ANOVA with Tukey’s 






changes in EGF concentration to impact cell growth at high cell density with a mechanism 
that HPV11 lacks. It is also important to consider these data in parallel with previous data 
which showed that MmuPV1 and HPV11 genomes were not maintained in NIKS cell culture. 
The effect of EGF could be different if genomes were properly maintained, and the more 
significant effect on genome copy number observed in 16NIKS cells post-confluence may be 
due to the amplification of genomes detected at this time point. If this were the case, it may be 
reasonable to suspect that the MmuPV1 post-confluent response to EGF concentration 
increase could be even more significant if genomes were successfully maintained. After 
repeated attempts to stably maintain MmuPV1 and HPV11 genomes in NIKS were 
unsuccessful, it was decided that work with these cell lines would cease due to time 




For 16NIKS in particular, a significant post-confluent impact on cell density was observed in 
cells cultured in FC100 media. Although not statistically significant, genome copy number 
was also higher at both post-confluent time points in cells cultured in FC100 media when 
compared with cells cultured in FC10 media. Therefore, a further experiment was carried out 
to investigate the effect of culture in FC100 media on the differentiation status of both 
16NIKS and normal NIKS cell populations. NIKS and 16NIKS were cultured in 8-well slide 
chambers (ThermoFisher, UK). Cells were seeded into wells and fixed at day three and day 
seven after seeding to provide pre-confluent and post-confluent samples for immunostaining 
analysis. Prior experimentation within our lab has repeatedly shown that K10 staining is 
present in normal NIKS at day 7 (Murakami, Egawa et al. 2019), so this therefore acted as a 
positive control. As mentioned in Chapter 3.0, K10 is an early stage marker of differentiation. 
 
Immunostaining data shown below in Figure 5.4 showed that there was no positive K10 
staining detected at day 3 in either NIKS or 16NIKS cells cultured in either FC10 media or 
FC100 media, confirming that cells had not begun to differentiate at this pre-confluent time 
point irrespective of EGF concentration. Immunostaining results also confirmed that at day 
seven of the tissue culture model, normal NIKS demonstrated high positivity for K10 staining 
as expected. Cell culture in FC100 media was shown to notably decrease K10 staining in 
NIKS cells, whilst in 16NIKS cells cultured in FC100 media, K10 was almost entirely absent. 







Figure 5.4 A delay in differentiation is observed in cells cultured in media with a higher 
concentration of EGF, which is more pronounced in cells containing HPV16 genomes 
Panels show IF detection of K10 (red) at day three and day seven. Nuclei were counterstained 
with DAPI to show host DNA. Images show DAPI and K10 stains separately, and then 
merged. NIKS are shown in the upper panels, while 16NIKS are shown in the lower panels. 







these conclusions, as shown below in Figure 5.5. The intensity of K10 staining in NIKS 
cultured in FC10 media was significantly higher than all three other groups (****p ≤ 0.0001). 
Intensity of K10 staining in the NIKS cells cultured in FC100 media was significantly higher 
than both 16NIKS groups, and the 16NIKS FC10 media group also had significantly higher 
intensity of K10 staining than the 16NIKS FC100 media group (***p ≤ 0.001). These results 
confirmed that cells were differentiating normally in the standard culture model, and that the 
presence of HPV16 genomes resulted in a decrease in the number of K10 positive cells 
observed, separate to the decrease in cell differentiation seen in response to increased EGF 
concentration. As an increase in concentration of EGF in culture media had been shown to 
have an effect on the genome copy number, the cell growth, and the differentiation status of 
16NIKS cells, a third experiment was carried out to look at the effect of a higher 






Figure 5.5 Higher concentration of EGF delays differentiation in NIKS and 16NIKS 
Graph indicates intensity of K10 fluorescence in arbitrary units. All values were normalised 
by subtraction of background intensity. One independent experiment, n=18. P-values were 










Experiments to investigate the effect of increasing EGF concentration on genome copy 
number were repeated, and an extra experimental group of cells cultured in FC media with a 
higher concentration of 500 ng/ml of EGF was added (termed FC500 within the text). Results 
are shown below in Figure 5.6. Prior to confluence, no significant difference in genome copy 
number per cell was observed between any of the experimental groups. However, genomes of 
16NIKS cells cultured in FC500 media reached a significantly higher genome copy number 
than both other groups at day ten (****p ≤ 0.0001), and the genome copy number per cell of 
16NIKS cultured in FC500 media was also significantly higher than cells cultured in FC10 
media at day eight (**p ≤ 0.005). To try to understand the effect of EGF concentration on 
genome copy number in more detail, an investigation into the post-confluent effect of FC500 
media versus FC10 media on RNA expression was carried out. A previous publication has 
demonstrated that changes to EGF concentration can affect splicing of HPV16 E6, therefore 
we expected to see some effect on gene expression in this experiment (Rosenberger, De-
Castro Arce et al. 2010). RNA had been extracted from the cell samples at the same time as 
DNA was extracted, so these RNA samples could be interpreted in relation to the observed 
change in genome copy number. 
 
Figure 5.6 The effect of 500 ng/ml EGF concentration on 16NIKS genome copy number 
per cell 
Graph shows genome copy number of cells collected cultured in three different 
concentrations of EGF: 10 ng/ml, 100 ng/ml, and 500 ng/ml. Cell samples were collected on 
days one to five, seven and nine (day one not shown). The bars show the average and the 
standard deviations are shown with error bars. Three independent experiments, n=3. P-values 
were calculated with a two-way ANOVA with Tukey’s correction; **** = P ≤ 0.0001, ** = P 
≤ 0.01.  
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Figure	5.6	The	effect	of	500	ng/ml	EGF	concentration	on	16NIKS	genome	copy	number	per	cell	
Analysis of RNA by cDNA synthesis and qPCR (Figure 5.7) showed that while no significant 
difference was seen in levels of expression of any of the transcripts investigated at day five or 
day eight, at day ten there was a significantly higher level of expression of all transcripts 
examined in 16NIKS cells cultured in FC500 media when compared to those cultured in 
FC10 media. Expression of target genes was normalised to levels of GAPDH within each 
sample, to allow for control of experimental variation between the samples. E1 was chosen 
because it is a DNA helicase, and therefore a likely candidate in mediating an effect on 
genome copy number. Similarly, E5, E6, and E7 were chosen because these three proteins are 
often referred to in the field as oncoproteins, and were therefore also considered as likely 
candidates for involvement in the increase in genome copy number and cell density observed 
(Roden and Stern 2018). 
 
All primers used in this section were designed by Dr Heather Griffin. For E6, primers that 
could distinguish between the total level of E6 transcript (E6T) and primers specific to full-
length E6 only (E6FL) were used. The HPV16 E6 intron contains one 5’ splice site, as well as 
a further three 3’ splice sites. If this intron is not spliced, full length E6 is expressed by the 
resulting E6E7 mRNA. However, if E6E7 pre-mRNAs are spliced using one of the alternative 
3’ splice sites, E6 splice variants are produced (Zheng and Baker 2006). Data shows 
expression of E6FL relative to E6T, which indicated a shift in splicing preference from 
around 8% to 17% of E6FL relative to total E6 transcripts expressed at day ten. Overall the 
results show a significant increase in viral RNA transcript expression in 16NIKS cells 
cultured in FC500 media as opposed to those cultured in FC10 media. 
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Figure 5.7 Effect of EGF on HPV16 RNA transcription in post-confluent cells 
Expression of RNA transcripts in HPV16 genome-containing cells cultured two different 
concentrations of EGF: 10 ng/ml and 500 ng/ml. A; relative expression levels of E6 full 
length (FL) transcript. B; relative expression levels of total E6 transcripts (E6FL plus all 
splice variants). C; expression levels of E6FL transcripts relative to total E6 transcripts. D; 
relative expression levels of E1 transcript. E; relative expression levels of E5 transcript. F; 
relative expression levels of E7 transcript. Three independent experiments, n=3. P-values 






The propagation of cells containing high-risk PV genomes is a well-established technique in 
the PV field (Doorbar 2016), therefore generation of NIKS cells containing MmuPV1 
genomes was a reasonable investigation to pursue. Unfortunately, it was not possible to 
maintain the MmuPV1 genome or the HPV11 genome in NIKS cell culture, with or without 
culture in media with a higher concentration of EGF. Although a previous publication from 
our lab did manage to maintain the HPV11 genome in NIKS cells during pre-confluent 
growth (Murakami, Egawa et al. 2019), few other studies have successfully propagated cells 
containing low-risk HPVs, and maintenance of these genomes proved difficult due to the lack 
of any conferred growth advantage (Thomas, Oh et al. 2001, Oh, Longworth et al. 2004). 
Another paper did demonstrate maintenance of HPV11 genomes in N-Tert cells, and 
described induction of a productive life cycle in organotypic rafts of these cells, however this 
work has not since been reproduced (Fang, Meyers et al. 2006). Therefore, the difficulties in 
establishing NIKS cells that could stably maintain the MmuPV1 or HPV11 genomes were 
understandable. It may be that MmuPV1 and HPV11 promoter activity is not high enough to 
sustain the viral life cycle in NIKS; as shown in Figure 4.2, expression levels from the 
MmuPV1 genome were much lower than that of the LXSN-based vectors. In contrast, the 
genomes in the HPV16 NIKS cell line were successfully maintained and amplified post 
confluence as expected. Attempts to improve genome maintenance in the cell lines by 
increasing the concentration of EGF present in the culture media demonstrated a mild effect 
of EGF on genome copy number, as well as statistically significant effects on growth and 
differentiation status of the cells. All of these effects were observed at post-confluent time 
points. 
 
Physiological relevance of the use of FC10, FC100 and FC500 was considered. Standard 
methods for the culture of keratinocytes use media with a concentration of 10 ng/ml of EGF 
(Davy & Doorbar, 2005). However, little is known for certain about physiological levels of 
EGF, either in normal skin or in a wounded site. One study employing radiolabelling of EGF 
found that in adult male mice, levels of EGF in the submaxillary glands (the major EGF 
production site in mice) rose to around 1000 ng/ml (Byyny, Orth et al. 1972) whilst the skin 
was shown to contain around 0.06 ng/ml. In humans, wet tissue has been shown to contain 
around 1.3-5.5 ng/g of EGF (Hirata and Orth 1979). Hauner and colleagues postulated that as 
serum concentration of EGF in human blood has been found to be in the range of 0.5-2 ng/ml, 
this may at least reflect a level at which physiological effects might occur (Hauner, Rohrig et 
al. 1995). Although the actual physiological levels of EGF in the skin of humans or mice 
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remain unclear, it is likely that the medias used in these experiments provide experimental 
conditions of EGF that are higher than what is present in vivo. EGF is known to inhibit 
terminal differentiation and stimulate cell proliferation (Blumenberg 2013). The growth factor 
is present in high concentrations at the basal layer, which then decreases as cells move 
towards the epidermal surface whilst differentiating (Fuchs 2008). EGFR and its ligands are 
also known to increase during wound healing, to improve the migratory potential and 
proliferative capabilities of keratinocytes in the wound area (Werner and Grose 2003). In our 
model, pre-confluent culture of PV genome-containing NIKS is representative of wound 
healing and the establishment phase of HPV infection. 
 
Data collected from the growth assays carried out in parallel to the first genome copy number 
experiments clearly showed that there was little difference between cell growth in FC10 
media and FC100 media up to confluence. However, post-confluence, cells cultured in FC100 
had a slight growth advantage over their counterparts grown in FC10 media. Similar general 
pro-proliferative effects of EGF on keratinocytes have been shown in other research (Hebert, 
Wu et al. 2009, Puccinelli, Bertics et al. 2010). However, recent computational modelling of 
the effect of local high EGF concentration on the migration of keratinocytes found a negative 
correlation between high EGF and the distances keratinocytes had migrated across, 
suggesting a more complex and potentially biphasic role for EGF in keratinocyte migration 
(Andasari, Lu et al. 2018). Whilst migratory phenotypes were not important for the 
phenotypes of cells examined post-confluence, it is something to bear in mind for future work 
that may investigate pre-confluent samples in greater detail. 
 
Post-confluence, 16NIKS cultured in FC100 media had a notable growth advantage over 
16NIKS grown in FC10 media, as well as all other cell types cultured, which was shown to be 
statistically significant at day nine (****p ≤ 0.0001). MmuPV1 NIKS cultured in FC100 
media also showed a significant increase in cell density at day nine when compared to normal 
NIKS cultured in FC100 media (**p ≤ 0.01) and MmuPV1 NIKS cultured in FC10 media 
(****p ≤ 0.0001). More in-depth analysis considering the effect of increased EGF 
concentration on the rate of cell growth pre-confluence and post-confluence indicated that the 
actual rate of growth in cells between day five and nine was statistically significantly higher 
in response to the EGF concentration in 16NIKS cells and MmuPV1 NIKS cells only. This 
analysis also allowed more detailed examination of growth rates in all groups. For example, 
although the cell counts of 16NIKS and NIKS shown at day nine are statistically different, 
16NIKS cultured in FC10 did not increase in density from day five to day nine at a greater 
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rate than that of normal NIKS. Overall, these data suggests that HPV16 and MmuPV1 may be 
able to respond to density-dependent micro-environmental changes in EGF concentration in a 
manner that affords the infected cell a competitive advantage over normal keratinocyte cells. 
Unfortunately, as MmuPV1 and HPV11 genomes were not maintained day by day, these data 
are somewhat difficult to interpret. With successful genome maintenance, the growth 
advantage of MmuPV1 cells cultured in FC100 might be even more significant, and HPV11 
may in fact show a significant response to changes in EGF concentration. 
 
K10 staining was employed to investigate the differentiation status of the 16NIKS cells and 
the effect of culture in media with a higher concentration of EGF on differentiation of the 
cells. Culture in FC100 media resulted in a statistically significant decrease in K10 staining 
intensity in NIKS, whereas in 16NIKS cultured in FC100 media the K10 signal was almost 
entirely absent. The effect of HPV16 on differentiation has long been known, with studies on 
whole genomes and expression of individual proteins also demonstrating that differentiation 
is delayed by HPV16 proteins (McCance, Kopan et al. 1988) (Woodworth, Mcmullin et al. 
1995). It has previously been shown that E6 can inhibit differentiation and keeps cells in 
cycle by directing degradation of p53 (Thomas, Hubert et al. 1999). Further, research in our 
lab suggests that E6 may mediate continued cell proliferation by inactivation of Notch 
signalling as well as p53, allowing avoidance of normal differentiation (Kranjec, Holleywood 
et al. 2017). Studies have shown that the activation of the Notch pathway acts as a definitive 
switch in keratinocyte cell status from proliferative to differentiating (Kolly, Suter et al. 
2005). Taken together with the data collected, it is evident that increased EGF concentration 
delays the differentiation of keratinocytes, whilst presence of HPV16 genomes leads to 
inhibition of differentiation to a greater extent. This more significant delay in differentiation 
observed could be the result of inactivation of Notch signalling, which could also be 
responsible for the additional cell growth advantage observed in 16NIKS. Recent studies in 
lung cancer cell lines have suggested that crosstalk between Notch and EGFR pathways can 
occur, so changes in EGF concentration may even be influencing Notch directly, although this 
would have to be further investigated for confirmation (Giannopoulou, Nikolakopoulos et al. 
2015). 
 
Taking this decrease in K10 positive cells into account along with the significant increase in 
cell number shown at day nine for 16NIKS cultured in FC100 media, it was interesting to 
consider how these cells were physically growing beyond confluence; general interpretation 
of K10 staining patterns in normal NIKS suggested that cells piling up into the upper layers 
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would be positive for K10, however in 16NIKS, little to no K10 was seen despite the greater 
density of cells. One potential mechanism by which HPV16 could form lesions in infection 
may be by overcoming normal cell density restrictions and growing to greater densities 
beyond confluence. A recent study into growth of keratinocytes divulged two distinct and 
interconvertible growth modes in human keratinocytes, and found that the switch between 
these two was regulated by confluence (Roshan, Murai et al. 2016). Control of this switch 
could possibly be modified in PV infected cells, and overcoming the control of these modes 
of growth through an EGF related mechanism may be involved in cell growth to higher 
densities in 16NIKS and also in MmuPV1 NIKS post-confluence.  
 
Further investigation into the effect of a higher concentration of EGF in 16NIKS revealed a 
significant increase in genome copy number at day 9 between the cells cultured in FC10 
media and those cultured in FC500 media. Comparative RNA analysis between these post-
confluent time points was carried out. Previous studies have confirmed that changing the EGF 
concentration can influence splicing of HPV16 E6 transcripts in immortalised keratinocyte 
cell lines (Rosenberger, De-Castro Arce et al. 2010). Rosenberger and colleagues showed that 
an increase in EGF concentration led to a shift in splicing patterns towards increased 
expression of full length E6. However, this experiment was only carried out over 9 hours 
whereas the above experiments were carried out over 10 days, which makes any direct 
comparison difficult. At day five and day eight, there was no significant difference in RNA 
expression between the FC10 and FC500 groups. However, at day 10 there was a 
significantly higher level of RNA expression in all transcripts examined in the FC500 group 
compared with the FC10 group. Although abundance of mRNA is not always predictive of 
protein level (Payne 2015) (Maier, Guell et al. 2009), increased transcription of genes could 
result in a subsequent increase in the protein levels within the cells. The oncogenic potential 
of the E6 and E7 proteins has been thoroughly described in Chapter 1 (Section 1.8), and an 
increase in these proteins within the cell could contribute to the post-confluent growth 
advantages observed in the 16NIKS cells cultured in FC100 media. HPV16 E5 protein could 
similarly be expressed at higher levels as a result of increased levels of E5 viral transcripts. 
HPV16 E5 protein has been shown to alter the endocytic trafficking of EGF molecules 
(Suprynowicz, Krawczyk et al. 2010) and also possibly plays a role in upregulation of EGFR-
mediated signal transduction by interfering with normal ubiquitination of EGFR (Zhang, 
Srirangam et al. 2005). Increased levels of E5 protein could therefore amplify the existing 
EGF-mediated effects on cell growth and differentiation, which could contribute to the 
growth advantage observed in the cells cultured in higher concentrations of EGF. However, 
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increased expression of E5 transcript is difficult to interpret; all early HPV16 mRNA products 
contain the E5 sequence, which therefore means an increase in detected expression of E5 
transcript does not necessarily equate to an increase in E5 transcript expression alone 
(transcript map can be accessed at https://pave.niaid.nih.gov/).  
 
E1 is the HPV DNA helicase (Hughes and Romanos 1993), therefore a rise in transcription of 
E1 mRNA could result in an increase in protein levels, which could in turn lead to an increase 
in genome replication and consequent higher copy numbers per cell. Studies carried out by 
Egawa and colleagues suggested that E1 was required for both initial establishment of 
infection and the final productive stage of the life cycle, but was dispensable for the 
maintenance phase (Egawa, Nakahara et al. 2012). These results indicate two different ways 
in which HPV genomes can be replicated, an E1-dependent and an E1-independent method of 
replication. Further evidence for two methods of genome replication was shown in 
experimentation with HPV31 and HPV16 DNA replication. Results indicated that both HPV 
types were capable of replicating once per cell cycle at S phase along with the cell replication, 
as well as being able to replicate independently of the cell cycle at random (Hoffmann, Hirt et 
al. 2006). Considering these results, it is plausible that a higher concentration of EGF could 
be stimulating replication of genomes to occur through both mechanisms. In cells cultured in 
FC10 media post-confluence, genomes must be replicating in an E1-dependent manner; this is 
required for the amplification stage of the virus life cycle to occur (Egawa, Nakahara et al. 
2012). Additionally, research has shown that HPV16 E1-dependent replication requires E6; 
expression an HPV16 E6 binding deficient mutant in HPV16 genome-containing cells meant 
that E1-dependent genome amplification was not supported post-confluence. HPV16 E7 was 
also shown to modulate the cellular environment to facilitate E1-dependent replication 
(Murakami, Egawa et al. 2019). Therefore, the observed increase in E6 and E7 mRNA 
expression and possible resulting increase in protein levels could also be making the cellular 
environment more favourable for E1-dependent replication to take place. 
 
Previous studies have established that phosphorylation events can influence E1 protein 
intracellular localisation. HPV 11 E1 was shown to shuttle in and out of the nucleus via 
nuclear import and export signals located within the E1 protein, with overall regulation being 
controlled by phosphorylation. Nuclear import was stimulated by phosphorylation events 
triggered by signalling from the MAPK signalling cascade (Yu, Lin et al. 2007). Further, 
phosphorylation of key residues by Cdk2 was shown to promote HPV 11 E1 accumulation in 
the nucleus, by inhibition of nuclear export (Deng, Lin et al. 2004). In this way, 
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phosphorylation and subsequent inactivation of the NES by CDKs allows E1 to build up in 
the nucleus, which in turn would support replication of viral DNA. Further research has 
shown that mutation of the HPV16 E1 protein within its MAPK phosphorylation sites resulted 
in inhibition of E1 nuclear accumulation, which again demonstrates the importance of 
phosphorylation in localisation of E1 to the nucleus (Egawa, Wang et al. 2017). As current 
understanding shows phosphorylation events as crucial in localisation of E1, it is plausible 
that increased EGF concentration could stimulate MAPK or Cdk2 signalling via the EGFR, 
resulting in prolonged localisation of E1 in the nucleus. This could be a mechanism by which 
higher EGF concentration leads to an increased genome copy number during the post-
confluent phase of the cell culture model.  
 
Culture of 16NIKS in media with a higher concentration of EGF led to a two-fold increased 
splice preference for E6FL. Splice variants of high-risk HPV16 E6 have been shown to have 
many different oncogenic effects in cell culture, including induction of DNA damage as a 
result of increased ROS (Williams, Filippova et al. 2014), directing the degradation of cellular 
adhesion proteins (Pim, Tomaic et al. 2009), and stabilising the oncoproteins E6 and E7 
(Ajiro and Zheng 2015). Such research suggests that splice variants have pro-oncogenic 
effects that are beneficial to the virus in infection. However, in vivo analysis of splice variants 
showed that overexpression of the small splice variant of E6 (E6*) led to a decrease in tumour 
growth in a nude mouse model (Filippova, Evans et al. 2014). Research has also shown that 
E6* may lack the ability to immortalise keratinocyte cells in culture, or at least is not required 
for the immortalisation of the cell to be successful (Sedman, Barbosa et al. 1991). Therefore, 
the impact of the splice preference shift observed is somewhat difficult to interpret. However, 
coupling of the splicing preference shift towards E6FL with the post-confluent increased 
genome copy number and cell growth in 16NIKS cells cultured in higher concentrations of 
EGF suggests that, within the context of this assay, the effect of increased levels of E6FL 
expression relative to the amount of total E6 expression is beneficial to the virus. 
 
As HPV needs to first infect basal cells to establish an infection, the virus may need to tightly 
regulate gene expression in response to external factors of the microenvironment such as 
EGF. Whilst the changes observed may appear small, current interpretation in the lab suggests 
that in normal conditions, careful regulation of E6 is required to allow a precise response to 
the surrounding environment; slight changes in E6 expression are believed to have significant 
effects. It is also important to bear in mind that the changes observed occur in a 
heterogeneous population. As shown previously in Section 3.2.10, there is a heterogeneity of 
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expression of E6/E7 RNA in vivo which is likely to be represented in cell culture. The 
presence of a heterogeneous population in cell culture is further demonstrated by the K10 
staining analysis shown in both Chapter 4 and Chapter 5; not all cells in a post-confluent 
culture stained positive for K10, indicating that cells within a population are heterogeneous. 
Heterogeneity is further emphasised by the confocal analysis shown in Figure 4.4, showing 
that cell states can also differ depending on the layer in which the cells are present. Therefore, 
even slight shifts in total expression levels and splice preferences overall can represent a 
significant change in the status of cells within the population. A different effect or mechanism 
than splicing preference change would be expected in low-risk or mouse mRNA expression 
analysis if the experiments had been carried out; HPV11 and MmuPV1 lack an internal splice 
site in E6 (Sedman, Barbosa et al. 1991, Xue, Majerciak et al. 2017). Based on data shown in 
the previous two chapters, it is reasonable to postulate that MmuPV1 may also be able to 
delay differentiation by interference with the Notch signalling pathway through MAML1 
binding. Future studies could attempt to confirm this if issues around maintenance of the 
genome are overcome. 
 
In conclusion, the data presented in this chapter demonstrates a role for EGF in delaying 
differentiation in NIKS in agreement with previously published data. A role for high level 
EGF concentration in mediation of HPV16 RNA transcript expression levels was also shown, 
suggesting that HPV16 can respond to external stimuli of the microenvironment in a density-
dependent manner. The precise mechanisms by which this effect on transcript expression 
might be involved in the increase in genome copy number and growth advantage are not fully 
understood, although several potential interactions were discussed. While it was not possible 
to maintain the MmuPV1 genome, which was the primary goal of this experiment, 
preliminary data suggest that the MmuPV1 genome could afford a post-confluent EGF-
dependent growth advantage on NIKS cells even at relatively low copy numbers within the 
population. This is in agreement with data from the previous chapter that showed that 








In this thesis, the mouse model of PV infection has been utilised alongside cell culture 
techniques to elucidate a role for MmuPV1 E6 in establishing infectious lesions. 
Improvements to the model have been made by consideration of wounding techniques, and a 
more thorough understanding of the timing and mechanisms of wound healing. Stages of 
early lesion formation were characterised, and an increase in cell density unique to these 
earlier stages was observed. This could not be properly explained by increased mitosis or cell 




A delay in differentiation was observed in tandem with a surprising HES1 RNA expression 
pattern. Although differentiation was delayed in infected cells, HES1 RNA expression 
appeared to be elevated in the infected cells relative to uninfected cells. This gave further 
credence to the idea that while HES1 expression is commonly understood to be downstream 
of the Notch signalling pathway, it’s presence does not mean that those cells have begun to 
differentiate. As MmuPV1 E6 is expected to interfere with Notch signalling by binding to 
MAML1 to disrupt formation of the ternary complex required for downstream signalling, it 
was surprising that HES1 RNA expression was relatively high in infected tissue. Previous 
data showed that MmuPV1 E6 expression in human cells led to a decrease in expression of 
HES1 RNA (Meyers, Uberoi et al. 2017). However, we observed a relative increase in levels 
of HES1 RNA expression in MmuPV1 E6/E7 expressing cells. This suggested that the 
interaction of MmuPV1E6 with MAML1 in vivo is not able to fully disrupt signalling 
downstream of the ternary complex. Alternatively, it could be possible for Notch signalling to 
progress in the absence of MAML1 in certain conditions. Previous research has suggested 
that other isoforms of MAML could compensate for the loss of MAML1, which could also 
explain the expression patterns described above (Oyama, Harigaya et al. 2011). Although 
commonly associated with Notch signalling, expression of HES1 can be upregulated by other 
pathways, such as Hedgehog and Wnt pathways (Liu, Dai et al. 2015). Therefore, signalling 
through these pathways could be having a Notch-independent effect on HES1 expression and 
should be investigated in future experiments. Irrespective of the relatively high HES1 
expression levels, differentiation was delayed in E6/E7 expressing cells. Future work can 
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examine this phenotype in greater detail. Excitingly, productive microlesions were located in 
a small subset of infections of fully immunocompetent mice. Although evidence of infection 
has been visualised in some immunocompetent mice previously (Uberoi, Yoshida et al. 2018, 
Spurgeon, Uberoi et al. 2019), this was the first time that microlesions had been observed in 
situ in C57BL/6J mice. Both the delay in differentiation and the relative increase in HES1 
RNA expression were also observed in immunocompetent mice. 
 
6.1.2	HETEROGENEOUS	E6/E7	EXPRESSION	COULD	CORRELATE	WITH	BASAL	LAYER	EXIT	
Mathematical modelling of the expression levels of MmuPV1 E6/E7 RNA in collaboration 
with Dr Alberto Giaretta suggested a potential bimodality of expression in cells. Expression 
of E6/E7 RNA was significantly higher in a sub-group of basal cells with cell morphology 
indicative of basal exit when compared to the remainder of the cell population. This suggested 
that expression of MmuPV1 E6/E7 may occur at two levels: one larger subgroup of cells 
expressing E6/E7 RNA at a lower level may be modulating maintenance of viral genomes in 
the basal layer, and a second smaller sub-group with higher levels of E6/E7 RNA expression 
could be those cells exiting the basal layer. Whether increased E6/E7 expression within these 
selected cells is triggered by initiation of the exit from the basal layer, or whether the 
increased expression of E6/E7 RNA itself is in some way causative of basal exit is not clear, 




From the various phenotypes observed using the mouse model of PV infection, it was clear 
that MmuPV1 was able to affect differentiation status, cell growth, and cell density in vivo. 
To further understand the mechanisms and proteins involved in these phenotypes, cell lines 
exogenously expressing MmuPV1 E6 and E7 were established. Experimentation with these 
cell lines revealed that MmuPV1 E6 was involved in an increase in cell density and delay in 
differentiation in post-confluent NIKS cells. Further, investigation into the layers of the cell 
culture system by using EGFP/mCherry expressing cell lines showed that cells expressing 
MmuPV1 E6 were able to persist in the lower layer of culture, whilst control NIKS/LXSN 
cells were located mostly in the upper layer after a period of ten days. In comparison, cells 
expressing MmuPV1 E7, control LXSN-expressing cells, and an E6 MAML1 binding mutant, 
demonstrated a random distribution of experimental cells and control cells between the lower 
and upper layers. This phenotype was also observed in 3D organotypic raft culture, giving 
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further evidence in support of the suggested growth advantage afforded by MmuPV1 E6. 
Repetition of cell culture experiments with the mutant E6R130A suggested that the effects that 
expression of MmuPV1 E6 protein had on cell growth, differentiation delay and lower layer 
persistence in post-confluent NIKS cells were dependent on E6 interaction with MAML1 
protein; abrogation of E6 binding to MAML1 led to a loss of these phenotypes in NIKS cells. 
 
6.1.4	CELL	LINES	STABLY	EXPRESSING	PV	GENOMES	
While establishment of NIKS that could stably maintain MmuPV1 genomes or HPV11 
genomes during pre-confluent growth was not possible within this thesis, a role for HPV16 
genomes in relation to changing concentrations of EGF was examined. Culture of cells in 
FC100 media resulted in a delay in differentiation of NIKS cells post-confluence, which was 
further exaggerated by the presence of HPV16 genomes. These data suggested that 16NIKS 
cells can respond to changes in micro-environmental EGF in a density-dependent manner. 
Post-confluent transcription of key early RNA transcripts was higher in cells cultured in 
FC500 media as opposed to those cultured in FC10 media, and a significant post-confluence 
increase in genome copy number per cell was also quantified in cells cultured in FC500 
media. Mechanisms were suggested to explain how 16NIKS could respond to external 
microenvironment changes to increase expression of viral genes and genome copy number. A 
potential response to increased EGF concentration post-confluence was also demonstrated 
with MmuPV1 genome-containing cells, despite the relatively low copy number. Future 
experiments with HPV11 and MmuPV1 genomes could uncover similar mechanisms for these 




One aspect of the research that could not be more thoroughly pursued during the course of 
this PhD was the immunocompetent mouse. Discovery of the microlesions in tail tissue was 
exciting, and demonstrated the suitability of the C57BL/6J mouse for use in studying PV 
infection, given accurate and thorough analysis of a large enough sample size of infection 
sites. It is generally understood that the immune response plays a large role in whether an 
infection will persist, or be cleared from infected individuals. Some HPV types have been 
shown to modulate the immune response in a variety of ways, such as interference with IFN 
signalling pathways, induction of regulatory T cell infiltration, and low level expression of 
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class I MHCs, which impedes the function of cytotoxic T cells (Song, Li et al. 2015). In 
particular, some beta papillomaviruses have been shown to interfere with expression of toll-
like receptors to impact upon the innate immune response and possibly deregulate the cell 
cycle (Pacini, Savini et al. 2015). In addition, HPV 8 E7 has been shown to impede the 
recruitment of Langerhans cells to the site of infection through sequestration of C/EBPb, 
preventing it from binding to the promoter of the chemoattractant CCL20, which is necessary 
for successful recruitment (Sperling, Oldak et al. 2012). Further research using this model 
will allow detailed analysis of the immune system in relation to MmuPV1 infection. Analysis 
of infection in a fully immunocompetent mouse may glean important new information as to 
how MmuPV1, a pi papillomavirus, interacts with the innate immune response. Given 
previously discussed similarities between MmuPV1 and beta genus papillomaviruses, 




Examination of high density cell culture using confocal microscopy revealed that cells can 
behave differently in discrete layers of cells. For example, cells in the upper layer of a high-
density culture of NIKS predominantly stained positive for K10, whereas few cells in the 
lower layer were K10 positive. This suggested that high density monolayer culture can 
somewhat mimic the basal and parabasal layers of the epithelium. Generation of cell lines 
exogenously expressing EGFP and mCherry allowed establishment of a method by which to 
observe the effect of viral protein expression on growth within these layers. Combination of 
EGFP/mCherry expressing cells with precise confocal analysis revealed that MmuPV1 E6 
could impact upon relative occupancy of the layers through a mechanism involving E6 
binding to MAML1. 
 
The scope for future experimentation with this high-density competition assay system is vast 
due to the different aspects that can be manipulated. Other virus proteins can be exogenously 
expressed in the fluorescent cell lines, including any mutants generated. This will allow 
rigorous investigation of any effect of other PV proteins on layer occupancy when competing 
against LXSN control cells. It would also be possible to ‘compete’ cells expressing virus 
proteins with cells expressing other virus proteins, to ascertain whether cells expressing one 
protein might have a competitive advantage over cells expressing another. Furthermore, one 
could generate NIKS cell lines exogenously expressing a fluorescent marker that can only be 
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visualised in the ‘far red’ channel (λem ∼ 600–700 nm), and compete three different cell lines 
within one experiment. In addition to this, the medium in which cells are cultured can be 
altered. In this way, this culture system can be used to investigate the effect of various factors 
on observed phenotypes, to mimic naturally occurring changes in the basal and parabasal 
layers of infected cells. This system can also be used to test different drug candidates on the 
persistence phenotype, to establish whether any experimental molecules can disrupt the 
observed competitive advantage. A more ambitious project would be the generation of 
EGFP/mCherry cell lines to introduce into a mouse. Transplantation of human cells into 
immunocompromised mice has been described previously (Paquet-Fifield, Redvers et al. 
2005) (Kolodka, Garlick et al. 1998). Therefore, EGFP/mCherry-expressing keratinocytes 
could be transduced to express viral proteins or control vectors, and then be implanted into 
immunocompetent mice. The cell fates over time could then be observed by fluorescent 
microscopy following sample collection. For example, it would be possible to investigate 
whether cells exogenously expressing MmuPV1 E6 protein would persist preferentially in the 
basal layer of mouse epidermis following repopulation of the experimental site with a mixed 
population of MmuPV1 E6 expressing cells and control cells. 
 
6.3	CONCLUDING	REMARKS	
In conclusion, this work provides strong evidence of a role for MmuPV1 E6 protein in 
competitive persistence of infected cells at a greater density in the lower layer of high-density 
monolayer culture, likely mimicking the dynamics of cells in vivo. I expect that MmuPV1 E6 
plays a key role in the ability of single infected cells to persist in the basal layer of the 
epithelium over time to allow establishment of a productive lesion. These alterations of the 
cell status by the virus keep cells in a state that may be optimal for the virus life cycle to 
continue into the parabasal layers, whilst maintaining infected cells in the basal layer. It is 
likely that MmuPV1 has other complex interactions within the microenvironment that allow 
the successful establishment of a lesion. For example, recent research has demonstrated that 
some PVs can alter cell adhesion (Woo, Kim et al. 2015), and it is reasonable to consider that 
similar mechanisms may also be involved in the persistence phenotype observed in this thesis. 
It is also important to note that keratinocytes have been shown to contribute to the formation 
of the basement membrane itself, and that the basement membrane and underlying dermis can 





Based on observations made both in vivo and in vitro, I postulate the following for a life cycle 
model of MmuPV1 infection (a schematic to show this proposed model of the MmuPV1 life 
cycle is shown in Figure 6.1). MmuPV1 genomes persist in the basal layer of the epithelium. 
The relatively high concentration of EGF in the basal layer could give cells containing the 
MmuPV1 genome a growth advantage over uninfected cells in the confluent cell state of the 
basal layer. MmuPV1 interferes with normal Notch pathway signalling through E6 protein 
interaction with MAML1 protein to affect downstream transcription. As a result, MmuPV1 
infected cells persist in the basal layer competitively over the surrounding uninfected cells, 
which are forced to exit and begin the process of terminal differentiation. Cells expressing 
MmuPV1 E6 are also able to overcome normal cell density homeostasis, leading to an 
increase in basal cell density. In these ways, infected cells further populate the basal layer, 
providing a larger reservoir of infection by overcoming the normal modulation of basal layer 
homeostasis. 
 
When MmuPV1 cells do exit the basal layer, a delay in differentiation of the infected cell is 
observed, keeping cells in a state similar to that of the basal cells. The amplification stage of 
the MmuPV1 life cycle could begin from the parabasal layer. This is unlike the general high-
risk PV life cycle. However, patterns of expression investigated in an HPV1 wart were shown 
to also have amplification of viral DNA occurring in the parabasal layers (Egawa, Iftner et al. 
2000). Therefore, rapid entry into genome amplification could be a life cycle strategy shared 
by some PVs. A model of high-risk infection is currently developing in our lab based on 
observations from other group members, wherein high-risk HPV gene expression is absent in 
the first few layers of the epithelium, followed by a ‘re-entry’ supported by E5 protein in the 
upper layers. This presents another novel life cycle mechanism, demonstrating that PVs 
employ a wide variety of strategies to persist and develop in their niches. MmuPV1 E4 
protein is also expressed from the parabasal layer upwards, while L1 and L2 proteins are 
expressed near the surface of the skin. This is based on observations in immunodeficient 
mouse samples, however it is important to note that in C57BL/6J mice, expression of E6/E7 
RNA appeared more restricted to the lower layers, with higher levels of expression in the 
cytoplasm. Lower quantities of E4 protein were similarly observed. This could be due to 
microlesions observed being at an early stage of development, similar to lesions categorised 
between stages 2 and 3 (discussed in 3.2.7). Conversely, this low-level expression may reflect 
immune modulation at the site of infection, and limited expression of E6/E7 RNA and E4 





Figure 6.1 The life cycle strategies of MmuPV1 
Virus initially infects basal cells and expresses E6/E7 RNA at relatively low levels. Normal 
basal cell density restrictions are overcome, leading to an increase in cell density in infected 
cells. Expression of E6 allows infected cells to preferentially persist in the basal layer, 
whereas uninfected cells are forced to leave. When infected cells do exit the basal layer, a 
delay in differentiation occurs, which results in an absence of K10 in E6/E7 expressing cells. 
BrdU analysis suggests that cells remain in cycle in the first 1-2 parabasal layers, after which 
viral genome amplification must occur. Infectious virus particles are then shed from the 





Cells expressing MmuPV1 E6 can outcompete their neighbours to persist in the lower layer of 
a high-density competition assay, which is likely indicative of mechanisms that occur in vivo. 
While it is expected that multiple MmuPV1 interactions with various pathways together result 
in the observed phenotypes, it is clear that E6 interaction with MAML1 is an important one. 
Disruption of this competitive advantage of lower layer persistence could stimulate the 
detachment, differentiation and subsequent loss of the infected reservoir of cells, providing a 
mechanism by which such low-level infection could be treated. If similar mechanisms of 
persistence are present in papillomaviruses that can cause human disease, therapeutics 
targeting this pathway could be utilised in tandem with established treatment methods aiming 
to surgically remove infected cells. Total removal of the reservoir of infected cells in 
papillomavirus infection is the only way in which infection can be fully eradicated, therefore 
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